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Zusammenfassung 
Transmembranproteine machen 25% des Proteoms aus und sind verantwortlich für 
wichtige biologische Funktionen wie dem Transport von Molekülen, der 
Signaltransduktion und der Katalyse. Aufgrund dessen sind Transmembranproteine 
häufige pharmakologische Ziele und das Verständnis ihrer Aktivierungsmechanismen und 
Interaktionspartner ist eine der wichtigsten Aufgaben der pharmazeutischen und 
biochemischen Forschung. Als Forschungsobjekte stellen Transmembranproteine eine 
besondere Herausforderung dar, da sie in wässriger Lösung instabil sind und zur 
Aggregation neigen, sobald sie von der Plasmamembran getrennt werden. 
Artifizielle membranähnliche Systeme erlauben es, die Strukturen der 
unterschiedlichen Membranproteine und deren Interaktionen mit der Membran oder mit 
anderen Proteinen zu analysieren. In dieser Doktorarbeit wurden mehrere 
Membranmodelle verwendet, um die Aktivierung und Regulierung des EGFR (engl: 
Epidermal Growth Factor Receptor) durch intrazellulare Faktoren, insbesondere 
Cytohesin-2 (auch: ARNO, engl.: Arf nucleotide binding site opener), zu erforschen. Der 
EGFR kontrolliert unterschiedliche Zellfunktionen und verstärkte Aktivität kann zur 
Entwicklung von Krebs führen. ARNO ist ein Guaninnukleotid-Austauschfaktor für Arf 
(ADP-Ribosylierungsfaktor) GTPasen. ARNO besitzt, neben der katalytisch aktiven 
Sec7-Domäne, ein PH-Modul (Pleckstrin Homologie), welches mit anionische Lipiden 
auf der Plasmamembran interagieren kann. Durch die Benutzung von einem artifiziellen 
Membransystem, hier Nanodiscs, wurden die Bedingungen für die Interaktion zwischen 
ARNO und der Plasmamembran nachgestellt. Darüber hinaus wurden Nanodiscs als 
Plattform für die Untersuchung von niedermolekularen Inhibitoren der PH-Domäne, 
nämlich Cyplecksine (Cytohesin Pleckstrin Homologie Inhibitoren) verwendet. Es lässt 
sich schließen, dass Nanodiscs nicht nur geeignete Systeme sind, um Protein-Membran-
Interaktionen zu untersuchen, sondern auch genutzt werden können, um niedermolekulare 
Inhibitoren zu testen. 
Des Weiteren wurden EGFR-Interaktionen und die ARNO-abhängige EGFR-
Aktivierung, die sich in einer Autophosphorylierung des Rezeptors widerspiegelt, 
zunächst in Mizellen und anschließend in komplexeren artifiziellen Systemen wie 
Bizellen, Nanodiscs und Plasma Membrane Sheets untersucht. Aus der Literatur ist 
bereits bekannt, dass ARNO die Phosphorylierung von EGFR in Zellsystemen und bei 
löslichen interzellularen Domänen des EGFR in membranfreien Experimenten verstärkt. 
Zusammenfassung 
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Abhängig von dem Membransystem wurde eine schwache Interaktion zwischen der Sec7-
Domäne von ARNO und dem JM (Juxtamembran) Segment des EGFR beobachtet. 
ARNO-abhängige EGFR-Stimulation wurde jedoch im Membransystem nicht festgestellt. 
Eine mögliche Erklärung hierfür ist, dass mehrere Kofaktoren für die Phosphorylierung 
und Aktivierung des EGFR notwendig sein können, die in vereinfachten 
Membransystemen nicht anwesend sind. 
Dennoch wurde mit Hilfe von Membrane Sheets eine Kolokalisierung von ARNO 
und EGFR auf der Plasmamembran beobachtet, die einer Interaktion zwischen den beiden 
Proteinen entsprechen kann. Außerdem wurden auch Effekte von ARNO auf die EGFR- 
Cluster beobachtet. Durch die Verringerung des Ausmaßes der Cluster-Bildung könnte 
der intrazellulare Teil des Rezeptors für cytosolische Faktoren zugängig werden. Diese 
Erkenntnisse können den Weg für ein tieferes Verständnis von EGFR-
Aktivierungsmechanismen durch ARNO bereiten. 
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I. Abstract 
Transmembrane proteins are involved in important biological functions, such as in 
transport of molecules, and in signal transduction. They represent almost 25 % of the 
proteome and constitute important drug targets. The study of transmembrane proteins has 
been a major challenge for biochemical research over the past decades. Transmembrane 
proteins are unstable and prone to aggregation when examined apart from the plasma 
membrane. Artificial, yet native-like membrane systems have allowed for the 
identification of the structure and function of several transmembrane proteins. In this 
thesis, the analysis of different membrane-model systems to study a particular 
transmembrane protein, namely EGFR (epidermal growth factor receptor) is reported. 
Moreover, the interactions of EGFR with a cytosolic factor, i.e. ARNO (Arf nucleotide 
binding site opener), is analyzed. EGFR is involved in many cellular functions and 
alteration of its activity often leads to cancer development. ARNO acts as a GEF (guanine 
nucleotide exchange factor) for Arf (ADP ribosylation factor), due to its Sec7 domain. 
Furthermore, ARNO contains a PH (pleckstrin homology) domain, important for 
interactions with anionic lipids at the plasma membrane. By using nanodiscs, the 
conditions for the interaction between ARNO and anionic lipids in a membrane-like 
system were recreated. In addition, nanodiscs were used as a system to study a recently 
developed small-molecule inhibitor for the PH domain. Summarizing, nanodiscs were 
identified to be not only a suitable system to study protein-membrane interactions, but to 
be a viable in vitro system to study small-molecule compounds. Moreover, starting with 
receptor-micelles and proceeding to more complex artificial systems, such as bicelles, 
nanodiscs, and membrane sheets, ARNO-dependent EGFR phosphorylation and the 
interaction between the two proteins were evaluated. It has been previously reported that 
ARNO enhances EGFR phosphorylation in living cells, as well as the phosphorylation of 
the soluble intracellular domain of EGFR in membrane-free experiments. Depending on 
the membrane system, weak interactions between the Sec7 domain of ARNO and the JM 
(juxtamembrane) region of EGFR were observed. Nevertheless, ARNO-dependent EGFR 
activation was not observed in membrane-like systems. By using membrane sheets, the 
co-localization between ARNO and EGFR at the plasma membrane was detected. 
Furthermore, ARNO may have an effect on EGFR by decreasing receptor clustering and 
making EGFR more accessible for intracellular co-factors. These findings can open the 
way for a deeper understanding of the activation mechanisms of EGFR via ARNO.  
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II. Introduction 
II.1 The plasma membrane - an overview  
The plasma membrane is a biological barrier that controls which substances can 
enter cells. The major constituent of the eukaryotic plasma membrane are phospholipids. 
The other components are sphingolipids and cholesterol (Simons, Sampaio 2011). 
Phospholipids are composed of two hydrophobic fatty acid chains and one polar head 
group (O'Connor, Adams 2010). The fatty acids can have different lengths, normally 
ranging between 14 to 24 carbon atoms. The fatty acid chains are arranged in a back-to-
back bilayer, minimizing their contact with the aqueous environment. Meanwhile, the 
hydrophilic head group faces towards the external part and the cytoplasmic side of the 
cell (Alberts et al. 2002). The phospholipid bilayer is largely stabilized by the cholesterol, 
which makes up ~30 % of the membrane. 
The first model of the plasma membrane proposed by Singer and Nicolson in 1972 
described the phospholipid bilayer as a fluid mosaic in which proteins are randomly 
distributed into the membrane (Singer, Nicolson 1972). In their fluid mosaic model, 
Singer and Nicolson distinguished between two different types of membrane proteins: 
peripheral membrane proteins and integral membrane proteins (or transmembrane 
proteins). Peripheral proteins are only weakly associated with the membrane, and their 
interaction can be modulated by changing the pH or ionic strength. On the other hand, 
transmembrane proteins span through the phospholipid bilayer, meaning they can be 
removed using strong conditions, such as detergents. 
The model proposed by Singer and Nicolson in 1972 has been refined during the 
years (Goñi 2014). Recent biochemical and biophysical research has focused on the role 
of protein-lipid and protein-protein interaction at the cell membrane (Krause, Regen 
2014).  
Negatively charged phospholipids, like PS (phosphatidylserine) and PI 
(phosphatidylinositol), are present in the inner leaflet of the plasma membrane. Between 
20-25 % of all negatively charged lipids are PS, making them the most abundant 
negatively charged lipids at the plasma membrane (Leventis, Grinstein 2010). In contrast, 
PIs are relatively rare and can be phosphorylated at the positions of 3, 4 and/or 5, forming 
PIPns (phosphatidylinositol polyphosphates) (Lemmon 2008). The amount of PIP2 
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(phosphatidylinositol-4,5-bisphosphate) at the plasma membrane is estimated to be 
between 0.5-1 % of all negatively charged lipids (Li et al. 2014). 
While PIP2 has many different functions, it can be broken into two main roles: it 
regulates the organization of transmembrane proteins, such as EGFR (epidermal growth 
factor receptor), and the recruitment of membrane proteins to the plasma membrane. As 
recently published by Wang et al. (2014), EGFR is organized in cluster at the plasma 
membrane, due to the ionic interaction between PIP2 and a particular domain of the 
receptor. The formation of EGFR clusters is implicated in the receptor activation and 
signaling. Furthermore, peripheral proteins can be recruited at the plasma membrane due 
to lipid-protein interactions. Specific protein domains are responsible for the binding to 
the plasma membrane, or with particular phospholipid groups in the membrane (Lemmon 
2008). One such example is the PH (pleckstrin homology) domain. The PH domain, as 
described in Section II.4.1.1, was first identified as a ~100 amino acids sequence presents 
twice in pleckstrin, the major substrate of PKC (protein kinase C) in platelets (Imaoka, 
Lynham, Haslam 1983). The PH domain is responsible for the interaction with anionic 
lipids, such as PIP2 and PIP3 (phosphatidylinositol-3,4,5-triphosphate) at the plasma 
membrane. In the past years, the classes of proteins containing a PH domain has been 
extremely enlarged (Lemmon, Ferguson 2000).  
As previously mentioned, the plasma membrane is also an important site of 
protein-protein interaction. One example is provided by the Ras (rat sarcoma) superfamily 
of small GTPases, which is composed of several subfamily like Ras family, the Rho (Ras 
homolog gene) family and the Arf (ADP Ribosylation Factor) family (Wennerberg et al. 
2005). The activity of the Ras superfamily is regulated via GEFs (guanine nucleotide 
exchange factors) and GAPs (GTPase-activating proteins). GEFs and GAPs allow GTP 
loading and hydrolysis, respectively (Di Paolo, De Camilli 2006). The Ras superfamily 
switches between a GDP-inactive to a GTP-active conformation. In turn, this process is 
made possible by the recruitment of GEFs and GAPs to the plasma membrane by the 
interaction with PIPns. One example of a class of GEFs is cytohesins. Cytohesins interact 
with PIP2 or PIP3 at the plasma membrane (Kolanus 2007). A detailed description of 
cytohesins can be found below in Section II.4.1. 
Transmembrane proteins are also key components of the plasma membrane. They 
regulate the traffic of substances from the extracellular to the intracellular space, are 
important for the activation of signaling cascades, and for the cellular homeostasis 
(Rigaud 2002). The three major classes of transmembrane proteins that are found at the 
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plasma membrane are: ion channels, G protein-coupled receptors (GPCRs) and receptor 
tyrosine kinases (RTKs). For the purpose of this thesis, only RTKs will be treated in 
Section II.3.1.  
Following the model proposed by Singer and Nicolson, transmembrane proteins are 
considered to be “swimming” in a lipid sea and are not concentrated on particular spots 
on the membrane. This model was adapted across the years, to come to a more complete 
representation of the plasma membrane depicted by Engelman (2005). Engelman 
affirmed that “membranes are more like a mosaic then a fluid” due to the presence of 
organized transmembrane protein patches. Furthermore, there is additional evidence that 
lipids at the plasma membrane are organized into microdomains, termed lipid rafts 
(Simons, Vaz 2004). Lipid rafts consist of sphingolipids and cholesterol groups that can 
be used as a platform for membrane proteins clustering. In the model of Simons and Vaz 
(2004), the sphingolipids associate laterally and any void spaces remaining are filled by 
cholesterol that functions as a spacer. Sphingolipid–cholesterol rafts are insoluble in the 
detergent Triton X-100 and they partition into a low density layer during gradient 
centrifugation (Simons, Ikonen 1997). Moreover, lipid rafts can recruit specific proteins: 
for example, it is reported that SNAREs (soluble N-ethylmaleimide-sensitive-factor 
attachment receptor) are not homogeneously distributed on the plasma membrane, but 
they are concentrated in ~100 nm cholesterol-dependent microdomains. The depletion of 
cholesterol causes the destruction of SNAREs clusters (Lang 2003). The formation of 
protein clusters can therefore be induced by lipid-lipid interactions, and lipid-protein 
interaction and second messengers, such as calcium (Zilly et al. 2011).  
II.2 Membrane-model systems 
The extreme complexity of the plasma membrane leads to the necessity of 
developing of membrane-model systems. Membrane surrogates provide a useful tool for 
studying lipid-protein and protein-interaction in a native-like environment. To overcome 
the complexity of biological membranes, different membrane-model systems have been 
developed. Several parameters have to been taken into consideration to select an accurate 
artificial system. For example, the architecture of the membrane system and the lipid 
composition depend on the type of protein or on the biological question that are analyzed. 
Furthermore, there are several obstacles during the purification of transmembrane 
proteins, e.g. solubility, precipitation and inactivity once proteins are extracted from the 
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membrane. Membrane-model system can be used to stabilize transmembrane proteins, 
once they are extracted from the natural environment, and to study their structure and 
function. In the following sub-sections, several membrane-model systems are described, 
highlighting their advantages and disadvantages, and pointing out some of their possible 
applications.  
II.2.1 Micelles 
Detergents are the most commonly used agents to solubilize membrane proteins. 
Detergents form micelles in aqueous solutions. Figure 1 illustrates the micelle structure. 
Micelles are defined according to the IUPAC (international union of pure and applied 
chemistry) terminology (Nic et al. 2009) as a “particle of colloidal dimensions that exists 
in equilibrium with the molecules or ions in solution from which it is formed”. During the 
formation of micelles in aqueous solution, the hydrophobic tails of the detergent tend to 
orient themselves away from the water, forming the core of the micelle. This re-
orientation also has the effect of pointing the hydrophilic heads of the detergent towards 
the water solvent. There are several parameters that influence the formation of micelles, 
such as pH, temperature, and ionic strength (Tanford 1974). The CMC (critical micelle 
concentration) is the concentration of detergent above which micelles are formed. Above 
the CMC, micelles and monodispersed molecules co-exist in a dynamic equilibrium 
(Domingues et al. 1997). The hydrophobic core of the micelles interacts with the 
hydrophobic region of the protein and forms a soluble detergent-protein complex 
(Garavito, Ferguson-Miller 2001).  
 
Figure 1: Micelle structure 
The hydrophobic tails (blue) form the core of micelle, while the hydrophilic head groups (yellow) are in 
contact with the surrounding solvent. 
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Detergents are often the first choice solution to extract proteins from the lipid 
environment for further biophysical and biological studies (Arnold, Linke 2008). 
Since micelles are an extremely simple membrane system, they also have 
limitations. First, micelles are not bilayers as opposed to the plasma membrane, and 
second, certain detergents used for the formation of micelles can disrupt lipid-lipid or 
protein-lipid interactions, which are important to conserve the structure of proteins. The 
choice of the detergent to stabilize the membrane protein must be determined empirically 
on a case-by-case basis, and thus can be a time-consuming process. For these reasons, 
other membrane-like systems were considered. 
II.2.2 Bicelles  
Bicelles are a phospholipid bilayer formed from short- and long-chain 
phospholipids, typically 1,2-dihexanoyl-sn-glycero-3-phosphocholine (DHPC) and 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC), respectively. The structure of bicelles 
is depicted in Figure 2. The ground work for the study of bicelles was established by 
Sanders and Prestegard (1990) when they investigated the formation of phospholipid 
bilayer formed by DMPC and detergent, typically CHAPSO. The first investigation on 
the structure of bicelles was performed by Sanders, Landis (1995). The central part of the 
bicelle is formed by long-chain phospholipids, while the edges of the rim of the bicelle 
are protected by short-chain phospholipids.  
Several parameters affect the structure and formation of bicelles. One such 
parameter is the ratio between the long- and short-chain phospholipids, typically denoted 
by the parameter “q”. Another common parameter is the total lipid concentration (cL). For 
q ratios roughly ˃3, bicelles are big aggregates that can be oriented by a magnetic field. 
For this reason, they are often used for solid-state NMR (nuclear magnetic resonance) to 
study the structure of phospholipid bilayers and membrane proteins (Prosser et al. 2006). 
In contrast, when the q ratio is small (q<1), the bicelles are small and cannot be aligned 
with the magnetic field. In this situation, they are termed isotropic bicelles and they were 
often used for high-resolution NMR (Whiles et al. 2002). Furthermore, Glover et al. 
(2001) showed that bicelles at low q ratio are stable in a wide range of temperatures. 
However, they also showed that if cL≤1 % w/w, the short-chain lipids dissociate from the 
bicelles (Glover et al. 2001). 
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Bicelles are used to study proteins interacting with the membrane or for the 
reconstitution of transmembrane proteins. Several proteins were successfully studied and 
reconstituted in bicelles, such as Arf1 (Liu et al. 2010) and GPCR (Serebryany et al. 
2012). 
 
Figure 2: Bicelle structure 
The long chain phospholipids (yellow) form the lipid bilayer, while the short chain lipids (red) surround the 
central part, protecting the hydrophobic chains from the surrounding solvent. The hydrophobic tails all 
point towards the inside of the bicelles.  
Different protocols are available for the reconstitution of transmembrane proteins 
(Avanti Polar Lipids Website a). One such example, transmembrane proteins can be 
lyophilized and mixed with a phospholipid powder. Upon rehydration, bicelles containing 
the transmembrane protein are spontaneously formed. However, this procedure only 
works if the proteins are highly resistant and highly stable. Moreover, if proteins are 
soluble without detergents, they can be simply added to pre-formed bicelles for the 
reconstitution into the bilayer. Other approaches require the presence of pre-formed lipid 
vesicles. Upon the addition of protein and a detergent, the vesicles are disrupted and the 
bicelles containing the desired proteins are formed. Nevertheless, this requires a careful 
detergent titration and furthermore, the determination of the q ratio can be challenging, 
since some phospholipids can be difficult to solubilize. 
Bicelles present two major advantages compared to micelles: 1) bicelles resemble 
the structure of biological membranes, since they present a bilayer structure; 2) The 
presence of lipids and not only detergent creates a more native-like environment for the 
reconstitution of transmembrane proteins (Lu et al. 2012). Furthermore, recent studies 
showed that the composition of the bicelles can be modified with negatively charged 
phospholipids, allowing for the study of important protein-membrane interactions 
(Struppe et al. 2000).  
Other studies have shown that the structure of proteins inserted into micelles is 
significantly different than the structure of proteins inserted into bicelles. For example, 
Sanders and Landis (1995) showed that the enzyme DAGK (diacylglycerol kinase) is 
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active only in bicelles, while no activity was detected in micelles. Dürr et al. (2012) 
reported a list of proteins that conserved their activity and/or structure in bicelles, but 
where important protein features were lost in micelles. The same properties were recently 
collected by Mineev et al. (2015) for the transmembrane region and juxtamembrane 
region of EGFR. 
All these facts show that bicelles present a good membrane model system for the 
reconstitution of transmembrane proteins. Nevertheless, bicelles require careful titration, 
and the insertion of the proteins can be challenging and time-consuming.  
II.2.3 Nanodiscs  
Nanodiscs are another membrane model system suitable for the study of 
membrane proteins and their interactions with the phospholipid bilayer. Bayburt and 
Sligar (2003) were the first to identify the self-assembly properties of lipid mixtures into a 
disc-shaped bilayer when incubated with a modified form of the human Apo A-1 
(Apolipoprotein A-1). Apo A-1 is composed of 243 amino acid residues, and contains an 
N-terminal domain of 44 amino acid residues, as well as a C-terminal lipid binding 
domain formed mainly of by α-helices. 
Apo A-1 is the major component of the HDL (high density lipoprotein) and it 
constitutes almost 70 % of HDL total mass (Brouillette et al. 2001). Apo A-1 is involved 
in the reverse transport of the cholesterol from peripheral tissue to the liver. Apo A-1 has 
been studied for its ability to bind free lipids in the serum and to form nascent discoidal 
HDL (Nath et al. 2007). Bayburt and Sligar (2003) have produced a mutated form of the 
Apo A-1, without its N-terminal globular domain, not required for lipid binding. This 
mutated form of Apo A-1 is named MSP1 (membrane scaffold protein 1). Two membrane 
scaffold proteins surround the edges of the disc bilayer in a head-to-tail conformation. 
Figure 3 shows the structures of nanodisc. 
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Figure 3: Nanodisc structure 
a) Side view of nanodiscs formed by two membrane scaffold proteins (in orange and in blue). b) Top view 
of nanodiscs. Figure taken from Bayburt, Sligar (2010). 
The diameter of nanodiscs is regulated by the length of the scaffold protein. 
Different membrane scaffold proteins are available to generate nanodiscs of variable 
sizes. Typically nanodiscs contain around 150 phospholipid molecules and have a 
diameter between 10 and 16 nm, depending on the type of MSP used. For example, the 
MSP1D1 (membrane scaffold protein 1 deleted 1) contains an N-terminal deletion of 11 
amino acid residues and it is used to produce nanodiscs with a diameter of 10 nm. 
Furthermore, the thickness of the nanodiscs ranges between 4.5 and 5.5 nm, depending on 
the length of the fatty acid chain of the phospholipids used (Denisov et al. 2004).  
Nanodiscs can self-assemble starting from a detergent, phospholipids and scaffold 
protein mixture. Once the detergent is removed with hydrophobic beads or by dialysis, 
the nanodiscs are formed. The ratio between MSP and phospholipids is critical for proper 
nanodiscs formation: an excess of phospholipids causes the formation of aggregates. If on 
the other hand, the amount of lipids is too low, MSP can form unstable lipid-poor 
structures (Bayburt, Sligar 2010). 
Nanodiscs were used to reconstitute a lot of different transmembrane proteins, 
such as bacteriorhodopsin, cytochrome P450 and some GPCRs. For the insertion of 
transmembrane proteins into nanodiscs an important parameter is the ratio between the 
concentration of scaffold protein and the transmembrane proteins. Once the ratio is 
established, depending on the type of detergent used for the solubilization of the 
transmembrane protein, the amount of the hydrophobic beads should also be titrated.  
Since nanodiscs are suitable for the reconstitution of transmembrane proteins, they 
are commonly used for NMR study to determine protein structures (Glück et al. 2009). 
Another of the advantages of using nanodiscs is that their lipid composition can be 
a) b) 
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variated. One such example, the insertion of anionic lipids into nanodiscs is useful to 
study the membrane recruitment of proteins containing PH modules.  
Nanodiscs are stable for weeks, and became recently commercially available, 
avoiding the tedious protein purification procedures. Nanodiscs are commonly used for 
NMR (Hagn et al. 2013), cryo EM (electron microscopy) (Pandit et al. 2011) and SPR 
(surface plasmon resonance) (Glück et al. 2011). For the preparation of nanodiscs, it is 
crucial to carefully establish the correct proportions of the membrane scaffold protein and 
phospholipids. Furthermore, also the insertion of the transmembrane protein into the disc 
bilayer required well defined settings. For example, if an excess of the transmembrane 
protein is added to the MSP-phospholipids solution, the protein can precipitate and forms 
aggregates. On the other hand, if a low protein amount is added, only a small part of the 
formed nanodiscs could contain the transmembrane protein. 
II.2.4 Membrane sheets  
The membrane models described above are completely artificial systems, in which 
the structure of the plasma membrane is rudimental maintained, but the composition and 
heterogeneity of the plasma membrane cannot be reached. Membrane sheets provide the 
right system to conserve not only the architecture of the membrane, but also its 
composition. 
The preparation of membrane sheets begins by leaving the cells to adhere 
overnight onto a glass support coated with poly-lysine. Subsequently, adherent cells are 
immersed in an appropriate buffer and a single ultrasound pulse is used to “unroof” the 
cells. Through this pulse, only the basal membrane, attached secretory vesicles and some 
intracellular proteins interacting with the membrane remain attached to the cover slip 
(Lang 2003). The preparation of membrane sheets is described in Figure 4. Afterwards, 
the sheets are fixed with PFA (paraformaldehyde).  
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Figure 4: Schematic preparation of membrane sheets 
Cells are adherent onto poly-lysine coated cover slips. An ultrasound pulse causes the cells to be 
“unroofed”, leaving behind only the basal membrane, which remains attached to the glass support.  
Membrane sheets can be used for direct membrane imaging usually with 
fluorescence or light microscopy, or further incubated with immunofluorescent 
antibodies. Membrane sheets are used in several applications and, in contrast to whole 
cell assay, allow exposing the intracellular membrane leaflet directly to reagents. They 
are often used for atomic force microscopy (AFM) and electron microscopy (EM), since a 
high protein density at the plasma membrane is necessary for these methods (Perez et al. 
2006). Furthermore, plasma membrane sheets were recently used to monitor endocytosis 
(Wu et al. 2010) and in modulation studies of ion channels (Tsuboi et al. 2004). Yet 
another particularly interesting application of membrane sheets is their use in protein 
clustering (Lang 2001).  
Since membrane sheets are tightly attached to the cover slip via their basal 
membrane, the use of antibodies against the extracellular part of membrane proteins can 
be difficult. Membrane sheets must be used directly after preparation. The plasma 
membrane sheets conserve their structure for only ~1 hour after preparation, otherwise 
degradation processes are initiated.  
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II.3 The epidermal growth factor receptor 
(EGFR) 
II.3.1 Receptor Tyrosine Kinases (RTKs) 
As mentioned above, RTKs are one of the major classes of transmembrane 
proteins present at the plasma membrane. RTKs are a crucial regulator of different 
cellular functions, such as cellular growth, differentiation and survival. Transmembrane 
receptors receive extracellular stimuli and transmit these signals to different intracellular 
pathways. The function of RTKs is to transfer a γ-phosphate of the adenosine-5´-
triphosphate (ATP) to hydroxyl groups of tyrosine residues on target proteins (Hunter 
1998). RTKs are normally present as monomer on the cell surface in the inactive state. 
The IR (insulin receptor) and IGF1 (insulin-like growth factor 1) receptor are exceptions 
because they exist as a disulfide linked dimer at the cell surface. IR is a member of the 
RTKs family involved in the regulation of glucose homeostasis (Taniguchi et al. 2006). It 
is present as α2β2 heterotetramer at the cell membrane (Hubbard 2013). 
EGFR also represents a peculiar case: recent studies showed that the receptor can 
be present as inactive dimer at the cell surface (Clayton 2005; Whitson et al. 2004).  
Humans have 58 known RTKs, which can be further grouped into 20 subfamilies, 
based on their primary structure (Figure 5). RTKs are composed of an extracellular 
domain (ECD), which is important for the ligand binding, a single α-helix transmembrane 
(TM) domain and an intracellular component. The intracellular section can be further 
divided into a kinase core, a C-terminal tail containing phosphorylatable tyrosine 
residues, and a regulatory juxtamembrane (JM) region (Lemmon, Schlessinger 2010).   
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Figure 5: The 20 members of the human RTKs families  
Humans known RTKs are divided into 20 families. The different domains are listed in the legend. The 
family names are indicated with bold letters. ErbB: Named from the viral oncogene v-erb-B, an avian 
erythroblastosis virus. Ins: Insulin receptor family. PDGF: Platelet-derived growth factor receptor family. 
VEGF: Vascular endothelial growth factor receptor family. FGF: Fibroblast growth factor receptor family. 
PTK: Protein tyrosine kinase receptor family. Trk: Tropomyosin receptor kinase family. Ror: Receptor 
orphan family. MuSK: Muscle-specific kinase family. Met: Hepatocyte growth factor receptor family. Axl: 
A Tyro3 protein tyrosine kinase receptor family. Tie: Tyrosine kinase receptor family in endothelial cells. 
Eph: Ephrin receptor family. Ret: Rearranged during transfection receptor. Ryk: Receptor related to 
tyrosine kinases. DDR: Discoidal domain receptor family. Ros: Proto-oncogene tyrosine-protein kinase 
family. LMR: Lemur receptor family. ALK: Anaplastic lymphoma kinase receptor family. STYK1: 
Serine/threonine/tyrosine kinase 1 family. This figure is taken from Lemmon and Schlessinger (2010); The 
figure caption is adapted from Blume-Jensen and Hunter (2001). 
For the activation of RTKs, an extracellular ligand binds to the extracellular part 
of the receptor. Upon the ligand binding, the oligomerization and conformational 
rearrangements of the extracellular domain take place. Subsequently, the intracellular 
domains dimerize. In this way, the receptor can phosphorylate several tyrosine residues 
that act as docking sites for intracellular proteins.  
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 II.3.2 The EGFR and the ErbB family 
The EGFR/ErbB1 receptor is a 170 kDa transmembrane protein belonging to the 
ErbB family of RTKs. The ErbB family is comprised of three other members, namely 
Her2/ErbB2, Her3/ErbB3, and Her4/ErbB4 receptors (Olayioye 2000). The EGFR and 
the ErbB family present a homology in the domains division comparable to the other 
RTKs.  
In particular EGFR has a glycosylated ECD of 620 amino acid residues, a TM 
region with a single α-helix, a JM domain, a large tyrosine kinase domain (TKD) 
followed by a C-terminal tail containing 5 phosphorylation sites (Lemmon et al. 2014). 
The ECD can be further divided into 4 subdomains (I, II, III and IV). Details are provided 
in Section II.3.3. 
 
Figure 6: Domains organization of EGFR 
The extracellular region (1-620) contains four domains: domain I (1-165), domain II (165-310), domain III 
(310-480) and domain IV (480-620). The transmembrane region is connecting the extracellular domain with 
the intracellular part. The juxtamembrane region (643-685) separates the tyrosine kinase domain from the 
membrane. The C-terminal tail contains five phosphorylation sites. This figure is adapted from Lemmon et 
al. (2014). 
The ErbB family regulates important cellular functions, such as cell growth, 
proliferation, survival, and differentiation. Aberrant function of EGFR is a hallmark of 
different human cancers, such as breast cancer, non-small cell lung cancer and colorectal 
cancer (Johnston et al. 2006). 
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ErbB receptor family has different ligands that can interact with the ECD and can 
activate different intracellular pathways. An exception is Her2, since no specific ligand 
has yet been identified and it forms heterodimers with other members of the ErbB family 
(Yarden 2001). Several ligands are known for ErbB family members. For example, 
epidermal growth factor (EGF), transforming growth factor α (TGF-α), and amphiregulin 
bind exclusively to EGFR, while the heparin-binding EGF-like growth factor (HB-EGF), 
epiregulin and betacellulin can bind also to Her4. Neuregulins are produced from four 
different genes and can bind to Her3 as well as Her4 (Fuller et al. 2008). Upon ligand 
binding, the dimerization of the receptor monomer on the plasma membrane takes place. 
EGFR can dimerize with another EGFR monomer, forming a homodimer, or it can 
dimerize with other members of the ErbB family, forming heterodimers (Figure 7). Her3 
has impaired kinase activity, and it can only form heterodimers to be activated (Berger et 
al. 2004).  
The phosphorylated tyrosine residues on the C-terminal tail, serve as binding sites 
for intracellular proteins containing Src homology 2 (SH2) domain and phosphotyrosine-
binding (PTB) domain (Schlessinger, Lemmon 2003). The two major downstream 
signaling pathways activated by ErbB receptors are MAPK (mitogen-activated protein 
kinase) and PKB (protein kinase B), also known as Akt, pathways (Mendelsohn, Baselga 
2000). MAP kinase signaling starts upon that Grb2 (growth factor receptor-bound protein 
2) binds to the phosphorylated receptor via its SH2 domain. Subsequently, the protein 
SOS (son of sevenless), a guanine nucleotide exchange factor, docks to Grb2 via a SH3 
domain. Active SOS catalyzes the GDP-GTP exchange on Ras (rat sarcoma) protein. Ras 
can bind to Raf (rapidly accelerated fibrosarcoma), a serine-threonine protein kinase, then 
Raf can phosphorylate and activate MEK (mitogen-activated protein kinase kinase). MEK 
can then activate the MAP kinase downstream signaling. MAPK cascade is an important 
regulator of gene transcription and cell proliferation (Haley, Gullick 2009). 
The second classical pathway activated by ErbB receptors is PI3K 
(phosphatidylinositol-4,5-bisphosphate 3-kinase)/Akt signaling. PI3K, once activated, 
starts to catalyze the conversion of PIP2 to PIP3. The second messenger PIP3 can interact 
with the PH domain of Akt at the plasma membrane. The protein Akt can then indirectly 
phosphorylate the protein mTOR (mammalian target of rapamycin), which is important 
for the activation of survival stimuli (Cantley 2002; Haley, Gullick 2009).  
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Figure 7: ErbB homo- or hetero-dimerization at the plasma membrane and activation of 
different intracellular cascades 
Upon ligand binding, receptors of the ErbB family dimerize, forming homodimers (for example EGFR-
EGFR) or heterodimers (EGFR-Her2/ EGFR-Her3/ EGFR-Her4). The dimerize receptors are then 
phosphorylated and can activate different signal cascades. The major signal pathways activated are the 
RAS–RAF–MEK–MAPK pathway, which controls gene transcription, cell-cycle progression and the PI3K-
Akt cascade that regulates the production of anti-apoptotic and pro-survival signals. Reproduced with 
permission from Ciardiello and Tortora (2008), Copyright Massachusetts Medical Society. 
II.3.3 The EGFR activation mechanism 
II.3.3.1 The ligand binding induces a conformational 
rearrangement of the extracellular domain 
The extracellular domain of the EGFR is responsible for ligand binding. Two 
ligand molecules bind to two different receptor monomers leading to receptor 
dimerization. Crystallographic structures have clarify the structure of the EGFR 
extracellular domain upon ligand binding (Garrett et al. 2002; Ogiso et al. 2002). EGFR 
extracellular domain can be divided in four subdomains: I, II, III and IV. The domains I 
and III contain leucine rich regions, while domains II and IV contain disulfide-bound 
modules (Burgess et al. 2003). One ligand molecule simultaneously contacts domain I 
and III. The activation is driven by a “dimerization arm” that is protruding from domain II 
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and induces a dramatic conformational change that leads to the dimer formation. In the 
absence of the ligand, the dimerization arm is hidden, contacting domain IV in an auto-
inhibited or tethered conformation (Figure 8a). Ligand binding disrupts the auto-inhibited 
structure and exposes the dimerization arm resulting in the extended conformation 
(Figure 8b) (Ferguson et al. 2003; Ferguson 2008). Domain IV plays a minor role in the 
stabilization of the ligand binding (Dawson et al. 2005). The dimerization interface 
between two receptor monomers presents a back-to-back conformation, due to the 
extended contact of domains II (Figure 8c).  
 
Figure 8: Structure of the human EGFR extracellular domain before and after ligand 
binding  
a) Tether conformation upon EGF binding (PDB 1NQL). Domains I and III are green, while domains II and 
IV are blue. b) Model for the monomeric extended conformation upon EGF binding (PDB 3NJP). The 
ligand contacts domains I and III. The dimerization arm is now exposed. c) The structure for the 2:2 
(EGF:EGFR) back-to-back dimer (PDB 3NJP). The dimerization arm contact is circled in red. This figure is 
taken from Bessman et al. (2014). 
II.3.3.2 The activation of the kinase domain requires the 
formation of the asymmetric dimer 
The ligand binding and dimerization of the extracellular domain also lead to the 
dimerization of the kinase domain. The kinase domain is composed of a small N-lobe and 
a larger C-lobe. Between the N- and C-lobe there is an important regulatory element, 
namely the activation-loop. The phosphorylation of one or several tyrosine residues in the 
activation loop is critical for the activation of several RTKs, such as IR (insulin receptor) 
(Bose, Zhang 2009). EGFR represents a peculiar case, because the phosphorylation of the 
activation-loop is not necessary for the activation of the kinase domain (Gotoh et al. 
1992). Zhang et al. (2006) were the first to understand that for complete activation, the 
a) b) c) 
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formation of an asymmetric dimer is necessary. In the asymmetric dimer, the C-lobe of 
one kinase domain (activator) contacts the N-lobe of the other kinase domain (receiver) 
(Figure 9). The formation of the asymmetric dimer for EGFR is similar to that of a cyclin 
bound to a cyclin-dependent protein kinase (Jura et al. 2009a; Zhang et al 2006). The N-
lobe contains five β-strands and one αC-helix that is important for the receptor regulation, 
while the C-lobe is mostly formed by α-helices (Roskoski 2014; Stamos et al. 2002). ATP 
binds between the β1- and β2 strands of the N-lobe to a conserved GxGxxG (G: glycine; 
x: variable amino acid residues) ATP-phosphate binding loop, which is referred to as a P-
loop. The P-loop is important in positioning the β- and γ-phosphate of ATP for catalysis 
(Roskoski 2014). 
A conserved glutamate residue in the αC is fundamental for the formation of a salt bridge 
with a lysine residue in the β3-strand, as well as for the formation of the active 
conformation (Roskoski 2014). Furthermore, a conserved DFG (D: aspartic acid; F: 
phenylalanine; G: glycine) motif is present at the N-terminal part of the activation loop. 
An aspartic acid residue coordinates one magnesium ion, which is important for ATP 
binding (Jura et al. 2011). The JM region located subsequently to the TM domain helps to 
keep the kinase domains in the asymmetric conformation (Jura et al. 2009a). The detailed 
role of the JM domain is discussed in Section II.3.3.3. A general activation mechanism is 
described in Figure 10.  
 
Figure 9: Asymmetric dimer formation  
The kinase domain of the ErbB family forms an asymmetric dimer in the active state. The monomer, which 
is called the activator, contacts the N-lobe of the second monomer (i.e. the labelled receiver) with its C-
lobe. Her3 presents only low kinase activity and for this reason its kinase domain cannot function as 
receiver (Jura et al. 2009b). The αC-helix, activation loop and ATP binding pocket are represented 
schematically. This figure is taken from Jura et al. (2011). 
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Figure 10: Schematic activation model for EGFR 
In the left panel, the receptor is present at the membrane as a monomer or an inactive dimer (middle panel). 
EGF binding leads to receptor dimerization and formation of the asymmetric dimer (right panel). As a 
result, the phosphorylation of the tyrosine residues takes place. This figure is taken from Jura et al. (2009a). 
II.3.3.3 The role of the transmembrane and juxtamembrane 
regions in EGFR activation 
The conformational change on the extracellular side of the receptor has to be 
transmitted to the intracellular side for the complete receptor activation. The exact 
mechanisms by which the signals are transduced from the ECD (extracellular domain) 
remain largely unknown. The transmembrane (TM) region is a hydrophobic segment 
made up of 23 amino acids that spans from residues 621 to 644 of the EGFR sequence, 
which connects the extra- and intracellular domains. Studies from Mendrola et al. (2002) 
have led to reconsideration of the role of the TM domain in the receptor dimerization. 
Mendrola et al. (2002) reported that the TM domain of the ErbB family can self-associate 
in the membrane due to GxxxG (G: glycine; x: not specific amino acid residue) 
dimerization-specific modules. The EGFR TM region contains two GxxxG motifs, one at 
the N-terminal and one at the C-terminal. These motifs are commonly used in 
transmembrane α-helices as dimerization surfaces (Russ, Engelman 2000). Furthermore, a 
mutation from valine to glutamic acid in position 645 of the TM region of the related 
ErbB2 receptor is sufficient to drive oncogenic transformation. This is probably due to a 
significant orientation change in the α-helix of the TM motif that enhances the activation 
of the receptor (Sharpe et al. 2000). It was also shown that the ECD and TM region of 
EGFR can dimerize with a 105-fold higher affinity than the single ECD in solution 
(Tanner, Kyte 1999). Arkhipov et al. (2013) and the related study of Endres et al. (2013) 
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published a NMR-model in which the N-terminal GxxxG motifs on the TM regions 
interact to help the dimer formation.  
In addition, the JM region plays a key role for the regulation of EGFR. The JM 
domain spans residues 645-682 and it can be further divided in two parts: JM-A (645-
663) and JM-B (664-682) (Jura et al. 2009a).  
Normally, the JM of the other members of the RTK family has an auto-inhibitory 
function. For example, the JM of IR contains ~35 amino acids and three tyrosine (Tyr) 
residues (965, 972 and 984). Tyr965 is important for endocytosis, while the Tyr972 is a 
docking site for IRS (insulin receptor substrate) proteins. Mutations on these two tyrosine 
residues, however, do not affect receptor kinase activity. Tyr984 is not a phosphorylation 
site, but mutating it drastically increases the catalytically activity of the receptor. In the 
unphosphorylated state, the JM masks a part of the kinase domain which is important for 
ATP coordination (Hubbard 2004). Other auto-inhibitory mechanisms are described for 
Ephrin receptors, MuSK (Muscle-specific kinase) receptor and PDGF (Platelet-derived 
growth factor) receptor (Hubbard 2004).  
For EGFR, the JM plays a crucial role for the activation. Thiel and Carpenter 
(2007) showed that the deletion of the JM domain causes the loss of phosphorylation on 
the intracellular domain. In particular, the JM-B segment forms a structure referred to as 
the “juxtamembrane latch”. The juxtamembrane latch starts from the N-lobe of the 
receiver and has the effect of stabilizing the C-lobe of the activator in the asymmetric 
conformation.  
The JM-A segment contains several basic amino acid residues. Jura et al. (2009a) 
showed that the JM-A segments on both kinase domains are necessary to form 
antiparallel α-helices, helping the dimerization and stabilization of the asymmetric dimer. 
Endres et al. (2013) and the related paper of Arkhipov et al. (2013) both propose that the 
TM and JM domains are also presented in an auto-inhibited conformation. As mentioned 
above, the TM region presents two GxxxG dimerization motifs, one at the N-terminal and 
one at the C-terminus. According to this model, based on NMR data, the TM domain 
dimerizes at the C-termini in the inhibitory state. The basic JM regions are sequestered at 
the membrane. In particular the “LRRLL” (L: leucine; R: arginine) motif on the JM-A 
can interact with anionic lipids at the plasma membrane. The TM domain forms a dimer 
at the N-terminal GxxxG module and the JM domains are pulled out from the membrane 
to stabilize the asymmetric dimer only upon ligand binding and a rearrangement of the 
extracellular module (Lemmon et al. 2014). This possible activation mechanism is 
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reported in Figure 11. Further investigation on the role of the TM and JM regions is 
necessary to understand the complete activation mechanism of EGFR. 
 
Figure 11: Model for the structural rearrangement of the TM, JM and kinase domains 
a) The model shows the TM and JM-A domains as monomers in the inactive state or as an inactive dimer. 
Upon activation, the rearrangement of the TM domain displaces the JM region from the membrane to form 
the antiparallel α-helices. The LRRLL motif on the JM-A is highlighted: the leucine side chains are in 
yellow and green, while the arginine side chains are in blue. b) The model shows the asymmetric dimer 
formation at the plasma membrane. The juxtamembrane latch helps to position a glutamate residue (E666) 
of the receiver close to an arginine residue (R949) of the activator to anchor the JM-A segment. This Figure 
is taken from Endres et al. (2013). 
 
b) 
a) 
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II.4 Cytoplasmic regulators of EGFR activity 
The activity of EGFR is regulated by several negative feedback signals. Inhibitory 
mechanisms are initiated directly after EGFR activation. The receptor activity is 
modulated via endocytosis and dephosphorylation. Other mechanism involves de novo 
protein synthesis. For human EGFR, four different inducible feedback inhibitors (IFIs) 
are known: leucine-rich and immunoglobulin-like domains protein 1 (LRIG1), suppressor 
of cytokine signaling 4 and 5 (SOCS4 and SOCS5) and mitogen-induced gene 6 (MIG6) 
(Segatto et al. 2011). The MIG6 protein is a well-known IFI that stabilizes the catalytic 
domain in the inactive conformation, probably preventing the formation of the 
juxtamembrane latch (Jura et al. 2009a; Zhang et al. 2007).  
Positive cytosolic regulatory elements for RTKs are extremely rare. Until now 
only two are known: Dok-7 (docking protein 7) for MuSK (muscle-specific receptor 
tyrosine kinase) (Inoue et al. 2009) and cytohesins for EGF-receptor (Bill 2011). 
Cytohesins were identified by Bill (2011) as positive regulatory elements for the EGFR. 
They were postulated to enhance the formation of the asymmetric dimer. Cytohesins are 
described in Section II.4.1.  
II.4.1 The Cytohesins and Arfs protein 
The cytohesins are a group of proteins acting as guanine nucleotide exchange 
factors (GEFs) for Arfs (ADP rybosilation factors) (Kolanus 2007). Arf proteins are 
member of the small-guanine nucleotide-binding proteins of the Ras superfamily. Arfs 
regulate several biological processes such as vesicular trafficking and organelle 
structures. Arf proteins switch between a GTP-bound active state and a GDP-bound 
inactive state (Donaldson, Jackson 2011). The hydrolysis of the GDP is operated by 
GAPs, while the exchange to GTP is operated by GEFs. Arf proteins can be divided into 
three classes based on the amino acid sequence. Specifically, class I, which is composed 
of Arf1, Arf2 and Arf3, regulates vesicles formation and budding; class II comprises Arf4 
and Arf5 and they play a role in Golgi transport; finally, Arf6, the only member of class 
III, regulates the structural organization of the cell membrane and the transport from 
endosomes to the membrane (D'Souza-Schorey, Chavrier 2006). 
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Cytohesins promote the GDP-GTP exchange on Arf1 and Arf6. The cytohesin 
family includes four members: cytohesin-1, cytohesin-2 (ARNO), cytohesin-3 (Grp-1) 
and cytohesin-4. Cytohesin-4 is only present in the immune cells (Kolanus 2007).  
The cytohesins are small proteins of around 47 kDa. All cytohesins share homology in the 
domain division: an N-terminal coiled-coil region, a central Sec7 domain, and a C-
terminal PH domain, which is flanked by a short polybasic region (PBR). The coiled-coil 
region is important for protein-protein interactions and dimerization of cytohesins. The 
Sec7 domain is responsible for GEF activity. The PH domain is necessary for membrane 
interactions, and the polybasic region is important for the interaction with PS on the cell 
plasma membrane (Figure 12).  
 
Figure 12: Schematic of domain division of cytohesins 
Starting from the N-terminal (N-term) part, cytohesins contain a coiled-coil (CC) domain (blue), a central 
Sec7 domain (green), and a C-terminal (C-term) pleckstrin homology (PH) domain (purple), flanked by a 
short polybasic region (PBR) (grey). This Figure is adapted from Kolanus (2007) 
 Kolanus et al. (1996) identified cytohesin-1 as an interacting partner for integrin-β 
in immune cells. The overexpression of cytohesin-1 or its Sec7 domain induces the 
binding of integrin-β to ICAM-1 (intercellular adhesion molecule 1). Hafner et al. (2006) 
showed that the inhibition of the Sec7 domain via SecinH3 leads to insulin resistance in 
human hepatic cells, probably hindering the binding of IRS1 to insulin receptor. ARNO 
was recently identified as a cytoplasmic enhancer for EGFR (Bill 2011). The Sec7 
domain of ARNO was sufficient to enhance the phosphorylation of the receptor 
independently from its GEF activity. This led to the conclusion that ARNO acts as an 
allosteric enhancer for EGFR, probably contributing to the formation of the asymmetric 
dimer. 
II.4.1.1 The PH domains of cytohesins and their inhibitor 
The PH domain is an approximately 100 amino acid domain present at the C-
terminal part of the cytohesin sequence. The PH domain was first discovered in 
pleckstrin, the substrate of PKC (protein kinase C) in platelets (Imaoka, Lynham, Haslam 
1983). PH domains are presents in a variety of proteins and it is estimated that around 252 
human proteins possess a PH domain. However, only 10 % of the identified PH domains 
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can specifically interact with the cell membrane, while the function for most of them still 
remains unknown (Lemmon et al. 2002). The structure of the PH domain comprises a 
seven-stranded β-sandwich with a C-terminal α-helix (Lemmon, Ferguson 2000). The 
surface of the PH domain is extremely polarized, presenting a negative and a positive 
charge on the two opposite sides. Of the 10 % of PH domains responsible for the 
interaction with the plasma membrane, the positive surface interacts with 
phosphoinositides on the cell surface in a concentration-dependent manner (Lemmon et 
al. 2002). In particular, the PH domain of the cytohesins can interact with PIP3 or PIP2 
depending on the splicing variants present at the β1/β2 loop. The two glycine variant 
binds PIP3 with high affinity, while the three glycine variant can bind to PIP2 and PIP3 
with micromolar affinities (Kolanus 2007).  
To further elucidate the function of cytohesins, a new PH-inhibitor was recently 
identified via an aptamer displacement assay in Famulok’s group (Hussein et al. 2013). 
Cyplecksins (cytohesin pleckstrin homology domain inhibitors) belong to the family of 
the bromo-barbituric acids and they contain one substituent in position 1 and two in 
position 5. The mechanism involves a covalent attachment of cyplecksins to the PH 
domain. These small molecule compounds inhibit the PH domain-dependent recruitment 
of cytohesins to the plasma membrane. 
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III. Aim of the Project 
The study of membrane proteins in a native-like environment is an interesting 
perspective and one of the major challenges in pharmaceutical and biochemical research. 
The understanding of the activation mechanism of membrane proteins, e.g. receptor 
tyrosine kinases, in a native-like environment can lead to the development of new 
pharmacological strategies to counteract their uncontrolled activation in pathological 
conditions. However, transmembrane proteins are often hard to study due to purification, 
aggregation and instability problems (Bayburt, Sligar 2003). The activation mechanism of 
the receptor tyrosine kinase EGFR is only partially understood. Recently, ARNO was 
identified as an interaction partner for EGFR (Bill 2011). It was suggested that ARNO 
has a direct influence on EGFR phosphorylation in cellular systems. The effect of ARNO 
on EGFR phosphorylation was also observed in membrane-free experiments using the 
soluble intracellular part of the receptor.  
Thus, the aim of this research project was to test different native-like membrane 
systems for their suitability to analyze EGFR-ARNO interactions and EGFR activation. 
In particular, micelles, bicelles, nanodiscs and membrane sheets were used for this 
purpose.  
At first, nanodiscs were used as a platform to observe the recruitment of ARNO to 
membranes. The phospholipid composition of the nanodiscs was optimized by adding 
anionic lipids for the binding of the ARNO PH domain to the nanodiscs. In order to test 
this model system, small-molecules targeting the PH domain of cytohesins, called 
cyplecksins, were investigated for their ability to inhibit membrane recruitment of 
ARNO.  
In a second step, the insertion of purified EGFR or particular subdomains of the 
receptor into micelles, bicelles and nanodiscs was optimized. Biochemical and 
biophysical assays were performed to answer the questions: Is it possible to reproduce the 
effect of ARNO on EGFR phosphorylation in artificial membrane systems? And: Are 
simplified membrane-model systems a suitable model to study ARNO-EGFR 
interactions? 
As none of the reconstituted membrane systems were determined to be completely 
suitable for these purposes, a more complex, native-like membrane system, i.e. membrane 
sheets, were used. Membrane sheets were used to understand whether ARNO directly 
interacts with EGFR and, if so, which domains are necessary for the interaction. 
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IV. Results 
IV.1 Nanodiscs as a model system to study 
membrane-ARNO interactions 
In order to understand protein functions in a native-like environment and their 
interactions with the surrounding lipids, artificial membrane system are required. Sligar 
and co-workers first described and produced nanodiscs for the insertion and study of 
transmembrane proteins (Sligar's Laboratory Website). Nanodiscs are a phospholipid 
bilayer, surrounded by two amphipathic helical molecules, termed membrane scaffold 
proteins (MSPs) (Bayburt et al. 2002).  
The production of nanodiscs using natural phospholipids and the interaction with 
the pleckstrin homology (PH) domain of the cytohesin-2 (also termed ARNO) are 
described in this Section. The PH domain of ARNO binds to PIP2 or PIP3 on the inner 
leaflet of the plasma membrane (Kolanus 2007). Nanodiscs were used as a platform to 
observe the PIP2-dependent membrane recruitment of ARNO PH domain. Recently, 
small-molecules targeting the PH domain of cytohesins, namely cyplecksins (cytohesin 
pleckstrin homology domain inhibitors) were identified in the Famulok’s laboratory 
(Hussein et al. 2013). Cyplecksins bind the PH domain covalently and compete for the 
binding of soluble PIP-derivatives. Nanodiscs were used to test whether cyplecksins are 
able to inhibit the membrane recruitment of the PH domain of ARNO in a native-like 
environment. 
IV.1.1 Proteins Expression and Purification 
IV.1.1.1 Cytohesin-2 (ARNO) PH domain 
The PH domain interacts with PIPns present on the plasma membrane. This 
construct contains a SBP-tag (streptavidin-binding peptide, S) at the N-terminus followed 
by a TEV (tobacco etch virus, T) cleavage site. ST-ARNO-PH construct used is the three 
glycine variant and it binds PIP2 and PIP3 with similar affinity. ST-ARNO-PH was 
expressed and purified as reported in Paragraph VII.2.1 and it has a molecular weight of 
19 kDa. Fractions from expression and purification were analyzed by SDS-PAGE (Figure 
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13). All the original gels can be found in the Appendix. The streptavidin-binding peptide 
tag on the protein was used for following pull-down experiments.  
 
Figure 13: ST-ARNO PH expression and purification 
15 % SDS-PAGE stained with Coomassie Brilliant Blue. Prestained molecular weight marker is loaded on 
lane 1. The induction of protein expression is observed comparing the total cell sample before (lane 2) and 
after induction (lane 3). ST-ARNO PH is visible at approximately 20 kDa. Lane 4 shows the cellular debris 
after centrifugation, lane 5 shows the cell lysate. Lane 6 shows the lysate after incubation with Strep-tactin 
beads. Lane 7 shows the wash step. From lane 8 to lane 10 the elution fractions are visible. Contaminants 
traces are visible at around 13 kDa and 11 kDa. Eluted fractions are pooled together and a buffer exchange 
step against ARNO storage buffer was performed. The sample after buffer exchange is not shown on the 
gel. 
IV.1.1.2 Membrane scaffold protein 1 deleted 1 (MSP1D1) 
MSP1 (membrane scaffold protein 1) is a truncated version of the human 
Apolipoprotein A-1, termed Apo A-1, in which the first 43 N-terminal amino acid 
residues are removed (Shih et al. 2007). MSP1 was modified as a further N-terminal 
deleted mutant, i.e. MSP1D1 (membrane scaffold protein 1 deleted 1), first expressed and 
purified by Denisov et al. (2004). MSP1D1 has a molecular weight of 24 kDa.  
MSP1D1 was expressed as reported in Paragraph VII.2.1. MSP1D1 contains a Histidine-
tag at the N-terminus followed by a spacer sequence and a TEV protease site. Fractions 
from expression and purification were analyzed by SDS-PAGE (Figure 14). 
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Figure 14: MSP1D1 expression and purification  
12.5 % SDS-PAGE stained with Coomassie Brilliant Blue. Prestained molecular weight marker was loaded 
on lane 1. The induction of protein expression was observed comparing the total cell sample before (lane 2) 
and after induction (lane 3). MSP1D1 is visible at approximately 24 kDa. Lane 4 shows the cell lysate and 
lane 5 the cellular debris after centrifugation. Lane 6 shows the lysate after incubation with Ni-NTA beads. 
Lane 7 shows the eluted fraction. Contaminant traces are visible at around 13 kDa. Lane 8 shows the final 
protein product in dialysis buffer. Lane 9 shows the precipitate after overnight dialysis.  
IV.1.2 The production of nanodiscs with natural 
phospholipids 
Nanodiscs were used as a membrane model system to observe the recruitment of 
ARNO PH domain to the plasma membrane. The PH domain of cytohesins, depending on 
the splicing variants, contains two or three glycine residues that bind phosphoinositides 
with different affinities (Cronin et al. 2004; Klarlund et al. 2000). Two glycine residue 
splicing variants bind to PIP3, while the three glycine residue splicing variants bind to 
PIP2 and PIP3 (Kolanus 2007). 
Two different nanodisc types were produced. Nanodiscs containing only 80 mol % 
PC (phosphatidylcholine, egg, chicken) and 20 mol % PE (phosphatidylethanolamine, 
liver, bovine) were used as control. Nanodiscs containing 75 mol % PC, 20 mol % PE and 
5 mol % PIP2 (brain, porcine) were used to study the binding between ARNO PH domain 
and the membrane. 
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IV.1.2.1 Biophysical assays to confirm nanodiscs assembly with 
natural phospholipids 
IV.1.2.1.1 Analytical gel filtration 
Nanodiscs were prepared as reported in Section VII.2.5.1.1. High pressure liquid 
chromatography (HPLC)-analytical gel filtration on Superdex 200 10/300 column 
(packed by Volkmar Fieberg) with a 0.2 ml/min flow in MSP standard buffer was 
performed. Sligar and co-workers have shown that the protein catalase has the same 
retention time as nanodiscs (Figure 15) (Sligar's Laboratory Website). The absorption at 
280 nm was used for the detection of proteins. Catalase was used as a reference for 
nanodisc assembly. Catalase has a molecular weight of 250 kDa and the elution time was 
13.297 min.  
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Figure 15: HPLC-analytical gel filtration of catalase 
Gel filtration was performed on Superdex 200 10/300 GL column in MSP standard buffer with a 0.2 ml/min 
flow. Catalase eluted at 13.297 minutes. An aggregate peak at 9.577 minutes was eluted at the column void-
volume. 
In Figure 16 and 17 are reported the chromatograms of PCPE-nanodiscs and PIP2-
nanodiscs, respectively, with three different ratios of MSP1D1 to lipid: 1:20, 1:40 and 
1:60. 
For PCPE-nanodiscs, at the 1:60 ratio, a large aggregate peak was visible from the 
chromatogram and the nanodiscs peak was not eluted at the same retention time of the 
reference protein. At the 1:40 ratio, the elution time was comparable to the elution time of 
catalase, but still an aggregate peak was visible at around 10 minutes. At the 1:20 ratio, 
traces of free MSP1D1 were visible at around 16 min. To avoid aggregate formation and 
the presence of free MSP1D1 in solution, a 1:30 molecular ratio of MSP1D1:lipid was 
used. 
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Figure 16: HPLC-analytical gel filtration of PCPE-nanodiscs 
Gel filtration was performed on Superdex 200 10/300 GL column in MSP standard buffer with a 0.2 ml/min 
flow. Three different MSP to phospholipids molar ratio were tested: 1:60 in black, 1:40 in green and 1:20 in 
pink. In the 1:60 chromatogram, one aggregate peak was visible at 9.421 min, while the nanodiscs peak 
eluted at 12.834 min. In the 1:40 chromatogram, the nanodiscs peak was eluted at 13.289 min, while an 
aggregate peak was still visible at around 10 min. In the 1:20 chromatogram, nanodiscs eluted at 13.704 
min, while the MSP1D1 shoulder was lightly visible at around 16 min. This indicated the presence of free 
MSP in the mixture. To avoid aggregate formations and the presence of free MSP1D, an intermediate ratio 
of 1:30 was chosen. 
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For PIP2-nanodiscs, the 1:60 ratio showed a small aggregate peak eluting at the column 
void-volume. The main peak was not eluted at the same time as catalase. At the 1:40 
ratio, the elution time was comparable to the elution time of catalase, but traces of 
aggregates were present at 9.8 minutes. At the 1:20 ratio, traces of free MSP1D1 were 
visible. For the PIP2-nanodiscs a MSP:lipid ratio of 1:30 was also used. 
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Figure 17: HPLC-analytical gel filtration of PIP2-nanodiscs 
Gel filtration was performed on Superdex 200 10/300 GL column in MSP standard buffer with a 0.2 ml/min 
flow. Three different MSP to lipids molar ratio were tested: 1:60 in black, 1:40 in green and 1:20 in pink. In 
the 1:60 chromatogram, the nanodiscs peak eluted at 13.150 min, before the catalase reference at 13.297 
min and an aggregates peak was visible at around 10 min. In the 1:40 chromatogram, the nanodiscs peak 
was eluted at 13.291 min, as was the catalase reference but a small aggregates peak was visible at 9.8 min. 
In the 1:20 chromatogram, nanodiscs eluted at 13.855 min, after the catalase reference. Free traces of MSP 
were indicated by the shoulder at around 16 min visible in the chromatogram. Also for PIP2-nanodiscs, to 
avoid aggregate formations and the presence of free MSP1D, an intermediate ratio of 1:30 was chosen. 
IV.1.2.1.2 Dynamic light scattering (DLS) 
The 1:30 MSP to phospholipid ratio for the nanodiscs assembly was confirmed 
with DLS (dynamic light scattering). DLS allows to measure of the volume of particles in 
solution according to their Brownian motions. PCPE-nanodiscs had a diameter of 16.18 
nm and PIP2-nanodiscs of 15.34 nm (Figure 18a and 18b, respectively). The nanodisc 
dimensions measured with DLS are around 5 nm bigger than the nanodisc dimensions 
reported in the literature, probably due to the presence of natural phospholipids that can 
alter the nanodisc dimensions (Bayburt et al. 2002).  
Results 
 
34 
 
Figure 18: DLS analysis of nanodiscs with natural phospholipids 
DLS was performed in the laboratory of Professor Gerd Bendas (University of Bonn). The x-axis indicates 
the hydrodynamic diameter (d) of the particles in nanometers. Qr indicates the distribution function of the 
particle size in percentage. qIr indicates the frequency distribution of the particle size in percentage. a) The 
measured diameter for PCPE-nanodiscs was 16.18 nm with a 94 % volume distribution. b) The measured 
diameter for PIP2-nanodiscs was 15.34 nm with a 98 % volume distribution. 
IV.1.2.2 ARNO PH domain interacts with PIP2-nanodiscs 
To validate the nanodiscs as a native-like membrane system to detect the PIP2-
dependent membrane recruitment of ARNO, a pull-down assay was performed. 
Nanodiscs with or without PIP2 were incubated with ST-ARNO-PH. A general 
experiment schema is reported in Figure 19.  
 
Figure 19: Pull-down assay with Strep-tactin magnetic beads 
Strep-tactin magnetic beads were incubated with ST-ARNO PH and PIP2-nanodiscs or PCPE-nanodiscs. A 
wash step was performed to remove unspecific interactions. Elutions were analyzed by SDS-PAGE. 
Eppendorf picture modified from Recenttec Website. 
PCPE-nanodiscs PIP2-nanodiscs 
Results 
 
35 
The pull-down assay was performed as reported in Section VII.2.9.1. In the 
Coomassie stained gels, only the protein fraction of the nanodiscs, i.e. MSP1D1, is 
visible.
 
Figure 20: ARNO PH interacts with PIP2-nanodiscs 
The figure shows the pull-down assay performed with ST-ARNO PH and nanodiscs. ST-ARNO PH was 
immobilized on strep-tactin beads with PCPE-nanodiscs or PIP2-nanodiscs in presence of 2 % DMSO. 
After incubation on ice, the bound proteins were eluted. The input or total (T) fractions and the pull-down 
(PD) fractions were analyzed by SDS-PAGE and visualized by Coomassie staining. 
In the pull-down fraction PCPE-nanodiscs were not visible. ARNO PH binds only 
to PIP2-containg nanodiscs (Figure 20), indicating that nanodiscs are a suitable model to 
reliably detect the PIP2-dependent membrane recruitment of cytohesins. 
IV.1.2.3 Cyplecksins inhibit the membrane recruitment of 
ARNO PH domain 
ARNO PH binds to PIP2-nanodiscs, as reported in Figure 20, while no interaction 
was detected with PCPE-nanodiscs. To analyze if cyplecksins (cytohesin pleckstrin 
homology domain inhibitors) inhibit membrane targeting of ARNO PH, PIP2-nanodiscs 
were used. Cyplecksins were synthetized and tested by Dr. Mohammed Hussein from 
Famulok’s group. In Figure 21 the structures of cyplecksins 1-3 and the inactive 
analogues MH 40 A and MH 40 B are reported.  
Results 
 
36 
 
Figure 21: Structure of cyplecksins 1-3 and the inactive analogues MH 40 A and MH 40 B 
A pull-down assay was performed as reported in Section VII.2.9.2. Cyplecksins or 
the inactive analogues MH 40 A and B were used at the concentration of 100 µM. The 
compounds were pre-incubated with bead-coupled ARNO PH and subsequently PIP2-
nanodiscs were added. Figure 22 shows the results of the pull-down assay. 
 
Figure 22: Cyplecksins inhibit ARNO PH interaction with PIP2-nanodiscs 
The pull-down assay was performed in presence of 2 % DMSO, 100 µM cyplecksins 1-3 (Cyp. 1, Cyp. 2 
and Cyp. 3), MH 40 A (4) or MH 40 B (5). ARNO PH was pre-incubated with DMSO, cyplecksins or the 
inactive analogues. Subsequently PIP2-nanodiscs were added. The mixtures were incubated with strep-
tactin beads. The input or total (T) fractions and the pull-down (PD) fractions were analyzed by SDS-PAGE 
and visualized by Coomassie staining. Cyplecksins inhibit PIP2-dependent membrane binding, while the 
interaction was still present when the inactive analogues MH 40 A and MH 40 B were used. 
Cyplecksins 1-3 inhibit the binding between ARNO PH and PIP2-nanodiscs. The 
co-elution between ARNO PH and PIP2-nanodiscs was not affected by the inactive 
analogue MH 40 A and MH 40 B. Therefore, nanodiscs are a reliable system to test 
small-molecule inhibitors for protein-membrane interactions. 
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IV.2 Different membrane-like environments 
to study protein-protein interaction and 
activation 
Cytohesins were identified as enhancer for the activation of the EGFR in living 
cells and for the intracellular domain of the receptor in solution by Bill (2011). Previous 
data from the Famulok’s laboratory (personal communication from Anton Schmitz and 
Michael Famulok) suggested a direct interaction between the Sec7 domain of ARNO and 
the JM (juxtamembrane) region of EGFR. Starting from this point, the idea was to 
investigate the activation of EGFR via Sec7 using the phosphorylation level as a readout 
in evaluating different membrane surrogates. Furthermore, this PhD work intended to 
observe the interaction between ARNO and EGFR, starting from simplified system such 
as micelles, and ending with the more complex system, like membrane-sheets. Membrane 
surrogates provide a native-like environment to study protein activation and interaction.  
IV.2.1 Micelles  
Detergents are a tool to solubilize membrane proteins and they form micelles in an 
aqueous environment. The head group of the detergent is hydrophilic and it is in contact 
with the water, while the lipophilic tails form the core of the micelle. The formation of 
micelles occurs when the detergent concentration is above a threshold level, or CMC 
(critical micelle concentration) (Versace, Lazaridis 2015).  
In the following chapters, the reconstitution of EGFR activity in micelles and the 
interaction studies with ARNO are presented. 
IV.2.1.1 EGFR activity in micelles 
To test the activity of EGFR reconstituted in a membrane-like environment, a 
phosphorylation assay was used. For this purpose, an already dimerized form of the 
receptor (lz-EGFR-TS) was expressed and purified from Sf9 (Spodoptera frugiperda) 
cells, as reported in Paragraph VII.2.1.9. The EGFR contains three major (Tyr 1068, 
1148, and 1173) and two minor phosphorylation sites (Tyr 992 and 1086) located on the 
C-terminal tail (Bishayee et al. 1999; Downward et al. 1984). Phosphorylated tyrosine 
residues are used as docking sites for intracellular factors containing SH2 domain or PTB 
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domains, responsible for the activation of different signal cascades (Yarden, Sliwkowski 
2001).  
IV.2.1.1.1 Expression and Purification of lz-EGFR-TS 
The lz-EGFR-TS contains an N-terminal leucine zipper (lz) dimerization motif 
replacing the extracellular domains. The construct has a Flag-tag at the N-terminal part 
and a C-terminal TEV (T) cleavage site followed by a SBP-tag (streptavidin binding 
peptide, S). A schematic representation of the construct is depicted in Figure 23. 
 
Figure 23: Schematic representation of the lz-EGFR-TS construct 
Lz-EGFR-TS has an N-terminal Flag-tag and a C-terminal SBP-tag. The extracellular domain is replaced 
by a leucine zipper dimerization module. The Figure is taken from Bill (2011). 
The constructs has a molecular weight of 76.6 kDa and was purified using the 
SBP-tag at the C-terminus. Purification conditions are reported in Section VII.2.1.9. In 
Figure 24 the SDS-PAGE and Coomassie staining of the purification is shown.   
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Figure 24: Purification of lz-EGFR-TS from Sf9 cells 
10 % SDS-PAGE stained with Coomassie Brilliant Blue. Prestained molecular weight marker was loaded 
on lane 1. The cell lysate after infection is visible in lane 2. Lane 3 shows cellular debris and lane 4 presents 
the supernatant after beads incubation. Lanes 5 and 6 show the washing steps. From lane 7 to lane 9 the 
elution fractions 1, 2 and 3 are visible. Lz-EGFR-TS eluted at molecular weight of 77 kDa, as a double 
band. Due to high detergent concentrations used to solubilize the protein in the elution buffer, no further 
purification via gel filtration was performed. Contaminant traces are visible at between 55 kDa and 20 kDa.  
Lz-EGFR-TS eluted as a double band at around 77 kDa. The upper band 
corresponded to the desired and expected protein, while some degradation products were 
visible at a lower molecular weight. To confirm that the eluted band at 77 kDa 
corresponded to lz-EGFR-TS, two different Western Blots using a streptavidin-
conjugated dye and an anti-Flag antibody were performed (data not shown). The receptor 
was solubilized in 0.1 % Triton X-100. 
IV.2.1.1.2 Phosphorylation Assay in micelles 
To test if lz-EGFR-TS was active after purification in micelles, EGFR 
phosphorylation was used as readout. For a detailed protocol see Section VII.2.7.1. Lz-
EGFR-TS after purification already had a measurable basal phosphorylation level. For 
this reason, the protein YopH, a tyrosine-protein phosphatase from Yersinia 
pseudotuberculosis at the concentration of 200 nM was used to dephosphorylate EGFR 
before the phosphorylation assay. The receptor at the concentration of 100 nM, 
solubilized in 0.1 % Triton X-100 micelles, was incubated with 1 mM ATP for 10 
seconds or 20 seconds. The reaction was stopped by the addition of 20 mM EDTA, to 
chelate the magnesium present in the buffer and block ATP activity. Samples before and 
after ATP addition were taken and analyzed by SDS-PAGE and Western Blot (Figure 25) 
using an anti-pTyr antibody. 
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Figure 25: lz-EGFR-TS phosphorylation in micelles 
Western Blot analysis is performed with anti-pTyr antibody. At time 0 seconds the receptor before ATP 
addition is visible. The receptor phosphorylation level measured within 10 seconds, and 20 seconds 
increased after ATP addition. Phosphorylation leads to the appearance of a double band. 
Lz-EGFR-TS conserved its kinase activity upon purification. In Triton X-100 
micelles, the receptor reached a high phosphorylation level within 20 seconds, similar to 
results reported in literature (Kholodenko et al. 1999; Wu et al. 2006). Micelles provide a 
membrane-like environment in which receptor activity can be studied.  
IV.2.1.1.3 Influence of ARNO on EGFR phosphorylation in micelles 
Bill (2011) reported that ARNO has a direct influence on EGFR activation in 
living cells and on EGFR soluble intracellular fraction in membrane-free assays. 
Furthermore, it was affirmed that the Sec7 domain is sufficient to enhance EGFR 
phosphorylation (Bill 2011). The Sec7 domain is known to be responsible for GEF 
function of the cytohesins (Cherfils et al. 1998). Starting from this background, to analyze 
EGFR phosphorylation in membrane-like systems, micelles containing lz-EGFR-TS were 
incubated with ARNO Sec7 (kindly provided by Yin Dongsheng from Famulok’s group) 
or GST (glutathione S-transferase). GST protein was used as a negative control, to verify 
that only ARNO influences the EGFR phosphorylation level. The phosphorylation level 
was measured with a specific anti-pTyr antibody. Figure 26 shows the Western Blot with 
anti-pTyr antibody of micelles containing lz-EGFR-TS in presence of ARNO Sec7 or 
GST protein.  
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Figure 26: Influence of ARNO Sec7 on lz-EGFR-TS phosphorylation in micelles 
Western Blot analysis is performed with anti-pTyr antibody. 0 second was evaluated to visualize the 
receptor prior to ATP addition. The receptor embedded in micelles was incubated with 1 mM ATP in 
buffer, 600 nM ARNO Sec7, or 600 nM GST, for 10 and 20 seconds, respectively. GST protein was used as 
negative control and it had no effect on EGFR stimulation. No enhancement of the phosphorylation level of 
the receptor was observed in presence of ARNO Sec7.  
The reaction was started by adding ATP at the concentration of 1 mM, and 
samples were taken after 10 seconds and 20 seconds. BSA (bovine serum albumin) was 
added to the reaction to avoid unspecific interactions. No influence of ARNO on lz-
EGFR-TS phosphorylation in micelles was observed. The same phosphorylation intensity 
was visible in presence or absence of ARNO and with the negative control.  
IV.2.1.2 EGFR-ARNO interaction in micelles 
As ARNO Sec7 did not enhance the phosphorylation of EGFR in micelles, other 
characterization of the physical interactions between ARNO and EGFR were evaluated. 
For this purpose, only the TM (transmembrane) and the JM (juxtamembrane) segments of 
the receptor were used. EGFR-TMJM is composed of amino acid residues 618 to 682 of 
EGFR (Red Brewer et al. 2009). The TM region contains a single α-helix spanning 
through the membrane. The JM domain helps to maintain the kinase domain in the active 
conformation, forming a structure termed “juxtamembrane latch” (Jura et al. 2009a).  
Previous data collected by Famulok’s group (personal communication from 
Benjamin Weiche, Anton Schmitz and Michael Famulok) suggested that the JM domain 
is the interaction site for ARNO Sec7 domain. Taking that into account, micelles 
containing a truncated EGFR construct were evaluated for ARNO Sec7 domain 
interaction by pull-down assay and crosslinking. 
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IV.2.1.2.1 Pull-down assay in micelles 
IV.2.1.2.1.1 Expression and purification of HST-EGFR-TMJM  
HST-EGFR-TMJM contains TM region and JM domain of EGFR fused to a His-
tag (H) and a SBP-tag (S) at the N-terminus followed by a TEV (T) cleavage site. The 
construct was expressed and purified in E. coli in a pET28 expression system as reported 
in Section VII.2.1.8.1. A schematic representation of the protein structure is reported in 
Figure 27. 
 
Figure 27: Schematic representation of HST-EGFR-TMJM construct 
HST-EGFR-TMJM contains a His-tag and a SBP-tag (both in green) at the N-terminus. The TEV cleavage 
site is indicated by the red line. The TM domain (purple) is followed by the JM segment (yellow). 
EGFR-TMJM could not be expressed as a soluble protein in bacteria, probably 
due to the presence of the hydrophobic TM segment that leads to the accumulation of the 
construct in inclusion bodies (Palmer, Wingfield 2012). Protein expression was induced 
by the addition of IPTG (isopropyl β‐D‐1‐thiogalactopyranoside) in the culture medium, 
as visible in Figure 28. To extract the protein from the inclusion bodies, high 
concentrations of denaturing agents were required (Palmer, Wingfield 2012). Urea at a 
concentration of 8 M was used for this purpose. Cell extracts were then used for affinity 
chromatography with Ni-NTA beads allowing for interactions with the His-tag. HST-
EGFR-TMJM after purification still contained visible traces of contaminants. The 
construct has a molecular weight of ~15 kDa. Due to the presence of high detergent 
concentrations, no further gel filtration step to purify the protein was possible. EGFR-
TMJM micelles were formed with 0.2 % of sodium cholate.  
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Figure 28: HST-EGFR-TMJM expression and purification from inclusion bodies 
15 % SDS-PAGE stained with Coomassie Brilliant Blue. Prestained molecular weight marker was loaded 
on lane 1. In lane 2 is the total cell before induction, while in lane 3 after induction. HST-EGFR-TMJM is 
visible at ~15 kDa, but the expression was weak, and no induction band was visible. Lane 4 shows the cell 
lysate. From lane 5 to 8 the washing steps are visible. Lane 9 shows the cellular extract after incubation 
with 8 M urea. Lane 10 shows the cellular debris after centrifugation. Lane 11 shows the supernatant after 
incubation with Ni-NTA beads. Lane 12 illustrates another wash step before elution, visible in lane 13. 
Contaminant traces are visible at around 100 kDa, 50 kDa and 25 kDa. In lane 14 the supernatant after 
overnight dialysis in MSP standard buffer with 0.2 % sodium cholate is visible. In lane 15 no precipitate 
after dialysis is visible. 
IV.2.1.2.1.2 Expression and purification of GST-ARNO Sec7  
ARNO Sec7 was expressed as an N-terminal GST-fused construct. For the 
purification protocol see Paragraph VII.2.1. Samples, before and after protein induction, 
were collected and analyzed by SDS-PAGE (Figure 29). After protein induction, a band 
at 48 kDa became visible. This corresponds to the molecular weight of GST-ARNO Sec7. 
Glutathione beads, which bind the GST-tag on the protein complex, were used for the 
purification. 
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Figure 29: GST-ARNO Sec7 expression and purification 
12.5 % SDS-PAGE stained with Coomassie Brilliant Blue. Prestained molecular weight marker was loaded 
on lane 1. The induction of protein expression was observed comparing the total cell before (lane 2) and 
after induction (lane 3). GST-ARNO Sec7 is visible at 48 kDa. Lane 4 shows the cell lysate, lane 5 cellular 
debris after centrifugation. Lane 6 shows the lysate after incubation with glutathione beads. Lanes 7 and 8 
show the washing step. Lane 9 shows the eluted GST-ARNO Sec7 protein in high amount. In lane 10 the 
final protein product is visible. Contaminant traces are visible at around 25 kDa and 15 kDa. 
To verify the functionality of GST-ARNO Sec7, its catalytic activity was then 
evaluated with a fluorescent-based guanine nucleotide exchange assay. For the protocol 
see Paragraph VII.2.8. Figure 30 shows the GDP-GTP exchange on a mutant Arf1 
catalyzed by GST-ARNO Sec7. The deletion mutant Arf1 (NΔ17Arf1) is lacking the first 
N-terminal 17 amino acids, corresponding to its myristoylation site. The construct lost 
dependence on phospholipids for GTP binding (Kahn et al. 1992) and is therefore 
functional even in the absence of membranes. GST-ARNO Sec7 was active at nanomolar 
concentration, as shown in Figure 30.  
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Figure 30: GST-ARNO Sec7 fluorescence-based GDP-GTP exchange assay on N∆17Arf1 
GST-ARNO Sec7 (0 nM, 10 nM or 15 nM) was incubated with GDP preloaded Arf1. The reaction was 
started upon addition of GTP. The GDP-GTP exchange was monitored via the tryptophan fluorescence 
(excitation 280 nm; emission 340 nm). a) Measure of tryptophan fluorescence upon GTP addition. b) The 
curves were fitted with the linear regression model and the slope were reported as bar chart, N=3. 
IV.2.1.2.1.3 GST-pull-down assay  
After confirming functionality of purified GST-ARNO Sec7, and the purification 
of EGFR, the interaction between the JM segment of EGFR and GST-ARNO Sec7 was 
evaluating using a GST-pull-down assay. For a detailed protocol see Section VII.2.9.3.  
Micelles containing the TM domain and JM region of EGFR were pre-incubated 
with GST-ARNO Sec7 and subsequently with glutathione beads. Upon interaction, co-
elution between ARNO and TMJM-micelles was expected. Samples of the loaded 
fraction, supernatant after bead incubation, eluate, and the beads were analyzed by SDS-
PAGE (Figure 31). 
a) 
b) 
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Figure 31: GST-pull-down of HST-EGFR-TMJM in micelles in presence of GST-ARNO 
Sec7 
15 % SDS-PAGE stained with Coomassie Brilliant Blue. The protein pull-down was performed with 
glutathione beads in the presence (with: w/) or absence (without: w/o) of 30 µM GST-ARNO Sec7. HST-
EGFR-TMJM embedded in sodium cholate micelles was used at the concentration of 10 µM. The beads 
were incubated with GST-ARNO Sec7 and EGFR-TMJM, or only with EGFR-TMJM as control. The total 
protein (T), supernatant after bead incubation (S), pull-down (PD) and bead (B) fractions were collected. 
Only GST-ARNO Sec7 is visible in the pulled down fraction, no EGFR-TMJM is co-eluted. The TMJM 
peptide may interact unspecific with the GST-beads, since it is present in the bead fraction of the reactions 
with or without Sec7. 
From the pull-down assay no interaction between ARNO and EGFR-TMJM was 
detected. In the bead fraction, HST-EGFR-TMSM was visible indicating an unspecific 
interaction with the glutathione beads.  
To avoid this problem, a reverse pull-down was performed, using strep-tactin 
beads instead of glutathione beads. Strep-tatctin beads bind to the SBP-tag at the N-
terminus of HST-EGFR-TS construct. Also in this case, the elution of EGFR construct 
was not possible, as the protein remains attached to the beads (data not shown). Since it 
was not possible to observe EGFR-TMJM construct in the eluted fraction of both pull-
down assays, other approaches were used to assay ARNO-EGFR interaction. 
IV.2.1.2.2 Crosslinking assay in micelles 
IV.2.1.2.2.1 Expression and purification of His-EGFR-TMJM-SBP 
Due to the difficulties in obtaining the desired purity of the HST-EGFR-TMJM 
construct, another TMJM construct was expressed and purified for the following 
experiments. The new construct contained the SBP-tag at the C-terminal part instead of at 
the N-terminus which bears a 6xHis-tag (Figure 32). The SBP-tag contains 38 amino acid 
residues and its presence close to the His-tag in the previously used HST-EGFR-TMJM 
construct, could interfere with the proper binding of the His-tag to the Ni-NTA beads for 
the purification. The construct was expressed in E. coli in a pET28 expression system as 
reported in Section VII.2.1.8.1.  
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Figure 32: Schematic representation of His-EGFR-TMJM-SBP construct 
The construct contains a 6xHis-tag (green) at the N-terminal part, followed by the TM (purple) and JM 
(yellow) regions. The SBP-tag (green) is present at the C-terminal part. 
The construct has a molecular weight of ~14 kDa. The final His-EGFR-TMJM-
SBP had a greater purity and yield than HST-EGFR-TMJM; nevertheless contaminant 
traces were still visible. Purification steps of His-EGFR-TMJM-SBP are illustrated in 
Figure 33. 
 
Figure 33: His-EGFR-TMJM-SBP expression and purification from inclusion bodies 
15 % SDS-PAGE stained with Coomassie Brilliant Blue. Prestained molecular weight marker was loaded 
on lane 1. The induction of protein expression is observed comparing the cell lysate before (lane 2) and 
after induction (lane 3). His-EGFR-TMJM-SBP is visible at ~14 kDa. Lane 4 shows the cell lysate. Lane 5, 
6, 7 and 8 shows the wash steps 1 to 4 respectively. Lane 9 shows the cellular extract after incubation with 
8 M urea. Lane 10 shows cellular debris after centrifugation Lane 11 shows the supernatant after incubation 
with Ni-NTA (nickel-nitrilotriacetic acid) beads. Lane 12 illustrates the wash step 5. In lane 13 the eluted 
protein is visible. Contaminant traces are visible at ~55 kDa, 35 kDa, and 25 kDa. In lane 14 the 
supernatant after overnight dialysis in MSP standard buffer with 0.2 % sodium cholate is visible. In lane 15 
no precipitate after dialysis is visible. 
IV.2.1.2.2.2 Expression and purification of HT-ARNOΔPBR 
ARNOΔPBR is an almost full-length ARNO construct, lacking the C-terminal 
polybasic region (PBR). The protein was expressed in E. coli as an N-terminal Histidine 
(H) fused construct in a pIBA101 vector, followed by a TEV (T) cleavage site. For the 
purification protocol see Paragraph VII.2.1. Samples, before and after protein induction, 
were collected and analyzed by SDS-PAGE (Figure 34). HT-ARNOΔPBR has a 
molecular weight of 47 kDa. The construct was expressed a basal level upon induction. 
Ni-NTA agarose beads were used for the purification. A high proportion of protein 
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remained insoluble, and was found in the precipitated fraction. Three separate elution 
steps were performed. The elution fractions were pooled together and a further gel 
filtration step was used to remove impurities (data not shown).  
 
Figure 34: HT-ARNOΔPBR expression and purification 
12.5 % SDS-PAGE stained with Coomassie Brilliant Blue. Prestained molecular weight marker was loaded 
on lane 1. HT-ARNOΔPBR has a molecular weight of 47 kDa. Before IPTG induction in lane 2, a basal 
expression level of the protein is visible. Upon IPTG addition, protein expression becomes stronger (lane 
3). The total cell lysate is visible in lane 4. Cellular debris containing unfolded protein is visible in lane 5. 
The total cell lysate after bead incubation (lane 6) still shows protein traces. HT-ARNOΔPBR was washed 
(lane 7) one time before elution. Three different elutions were performed (from lane 8 to 10). The final 
protein product was gel filtrated to remove contaminants (not shown on the gel). 
IV.2.1.2.2.3 Crosslinking  
Crosslinking is a technique to stabilize molecular interactions. Protein-protein 
binding can be transient and difficult to detect. “Freezing" the moment of the interaction 
with a chemical crosslinker can allow the detection of weak and transient interactions 
(Thermo Scientific Pierce 2010). Crosslinking reagents are bi-functional compounds and 
covalently bind particular groups on the molecules (Peters, Richards 1977). The 
crosslinking reaction forms monomer, dimer, trimer, tetramer or high molecular weight 
complexes. The crosslinker concentration, the concentration of the interacting partners, 
and the reaction time should be carefully evaluated to avoid the formation of high 
molecular aggregates that cannot be analyzed by SDS-PAGE. Crosslinking between the 
same protein and unspecific crosslinking can also occur. 
To analyze the interaction of ARNO with the His-EGFR-TMJM-SPB construct in 
sodium cholate micelles, the crosslinker bis(sulfosuccinimidyl)suberate (BS3, 
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ThermoFisher Scientific) was used. BS3 is a water-soluble crosslinker, with a spacer arm 
of 11.4 Å. BS3 reacts with primary amines at pH 7-9 (Thermo Scientific Pierce 2010).  
Previous experiment in Famulok’s group (personal communication from 
Benjamin Weiche, Anton Schmitz and Michael Famulok) provides support to the theory 
that the JM-A segment is responsible for binding to ARNO Sec7. As a proof of principle, 
only the JM peptide (kindly provided by Doctor Benjamin Weiche) was crosslinked with 
HT-ARNOΔPBR. For a detailed protocol see Section VII.2.10.1. Two different 
concentrations of crosslinker were initially used: 1.5 mM and 0.5 mM. The JM peptide 
has a molecular weight of 11 kDa, while HT-ARNOΔPBR has a molecular weight of 47 
kDa. The crosslinked band between one ARNO monomer and one JM monomer was 
expected at ~55 kDa. Samples, before and after crosslinking, were collected and analyzed 
by SDS-PAGE (Figure 35).  
 
Figure 35: Crosslinking between ARNOΔPBR and JM peptide with different BS3 
concentrations 
15 % SDS-PAGE stained with Coomassie Brilliant Blue. The BS3 was used at two different concentrations: 
1.5 mM (++) and 0.5 mM (+). HT-ARNOΔPBR concentration was 30 µM, while the JM peptide 
concentration was 10 µM. An additional band at ~55 kDa appears upon BS3 incubation only when ARNO 
and JM are present together. The ARNO-JM crosslinked complex was visibly stronger at the lower BS3 
concentration. The crosslinked band size corresponds to a 1:1 interaction between the two proteins. 
ARNOΔPBR formed dimers at ~90 kDa and higher molecular aggregates. JM crosslinking was not visible. 
It is possible that the peptide formed larger aggregates that were not able to enter the gel matrix at the given 
percentage. 
For the JM peptide no crosslinked band was visible in the gel, but the band 
intensity became weaker upon crosslinker addition. One possible explanation is that JM 
forms high molecular weight aggregates upon crosslinking. The aggregates were not able 
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to enter this percentage of gel during the run. ARNOΔPBR crosslinks formed dimers at 
~90 kDa, and higher molecular weight complexes were also visible. JM crosslinks with 
ARNOΔPBR, and formed a 1:1 complex at ~55 kDa. This band interestingly showed a 
stronger intensity with lower BS3 concentration, while it became weaker when the 
concentration of the crosslinker was increased.  
The same experiment was repeated with His-EGFR-TMJM-SBP construct 
embedded in sodium cholate micelles. The TM region and the JM domain of the insulin 
receptor (IR) in micelles were used as negative control. Hafner et al. (2006) reported that 
cytohesins play a role in the downstream signaling of IR, and no direct interaction 
between IR-JM and cytohesin seems to be necessary for this effect. The IR-TMJM 
construct provides a feasible negative control for interactions for evaluating the specific 
versus non-specific interactions between JM and ARNO. 
The BS3 crosslinker was again used at the concentrations of 1.5 mM (Figure 36a) 
and 0.5 mM (Figure 36b). No crosslinking was visible between EGFR-TMJM and 
ARNO. Also EGFR-TMJM:EGFR-TMJM complexes, upon BS3 addition, were not 
visible. The band intensity of the EGFR-TMJM after crosslinking became weaker. 
Probably higher molecular weight structures were not able to enter the gel matrix. For the 
IR-TMJM construct, high molecular weight aggregates were present.  
 
Figure 36 : Crosslinking between ARNOΔPBR and TMJM constructs in micelles  
12.5 % SDS-PAGE stained with Coomassie Brilliant Blue. The BS3 was used at two different 
concentrations: a) 1.5 mM (++) and b) 0.5 mM (+). ARNOΔPBR concentration was 30 µM, while for the 
TMJM constructs was 10 µM. His-EGFR-TMJM-SBP did not crosslink with ARNO in micelles. Also for 
the EGFR-TMJM construct, upon BS3 addition, no crosslinking band was visible. For the IR-TMJM 
construct a high molecular weight aggregate was visible upon BS3 addition and, as expected, no 
crosslinked band with ARNOΔPBR. 
a) b) 
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From these results, micelles are not a suitable model for studying ARNO-EGFR 
interaction. It is probable that high concentrations of detergent that are necessary to keep 
the transmembrane protein in a soluble state represent an obstacle for the interaction 
itself. For this reason, other membrane systems were tested. 
IV.2.2 Bicelles  
Bicelles are often used as a membrane model system for the study of membrane 
proteins. Bicelles are discoidal phospholipids aggregates formed by long chain 
phospholipids, usually DMPC (1,2-dimyristoyl-sn-glycero-3-phosphocholine) or DPPC 
(1,2-dipalmitoyl-sn-glycero-3-phosphocholine), and short-chain lipid, such as DHPC 
(1,2-dihexanoyl-sn-glycero-3-phosphocholine) or detergent (CHAPSO) (Dürr et al. 2012; 
Glover et al. 2001). Previous studies used bicelles for solid-state NMR and have 
suggested that the bicelle formation is temperature, lipid concentration (cL) and long-
chain:short-chain lipid ratio (q) dependent. The central structure of bicelles is formed by 
the long chain phospholipids and their fatty acid chains, which are protected from contact 
with the water by a ring of short-chain lipid or detergent molecules (Ram, Prestegard 
1988; Whiles et al. 2002) 
Transmembrane proteins can be reconstituted into bicelles upon lyophilization. 
Bicelles were used as a membrane-like system to test the interaction between ARNO 
Sec7 and EGFR-TMJM. No phosphorylation studies were possible using the bicelles, due 
to the inability of recovering the kinase activity of EGFR after lyophilization (Rey L., 
May J. C. 2010).  
IV.2.2.1 Bicelles assembly 
DMPC/DHPC bicelles with q=0.25 and cL=46 mM were prepared. For a detailed 
protocol see Section VII.2.4.1. The protocol was modified from Avanti Polar Lipid 
(Avanti Polar Lipids Website a). DMPC and DHPC were provided as a powder, and were 
solubilized in buffer. Subsequently heating and cooling down steps were performed until 
a homogenous solution was formed. 
IV.2.2.1.1 Dynamic Light Scattering (DLS) of bicelles 
Bicelles assembly was assayed with DLS (Figure 37) and the measured diameter 
was around 6 nm, comparable with the data reported in literature (Glover et al. 2001). 
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Dilutions of bicelles were only possible if the DHPC concentration was kept at 10 mM to 
ensure bicelle integrity.  
 
Figure 37: DLS to control the formation of bicelles 
DLS was performed in the laboratory of Professor Gerd Bendas (University of Bonn). The x-axis indicates 
the hydrodynamic diameter (d) of the particles in nanometers. Qr indicates the distribution function of the 
particle size in percentage. qIr indicates the frequency distribution of the particle size in percentage. The 
measured diameter for DMPC/DHPC bicelles was 5.65 nm with a 99 % volume distribution. 
Lyophilized His-EGFR-TMJM-SBP protein was reconstituted at the concentration 
of 300 µM in a solution of previously formed bicelles. The size of bicelles containing the 
transmembrane protein was analyzed with DLS (Figure 38). No change in the diameter of 
bicelles upon the reconstitution of the transmembrane protein was observed. 
 
Figure 38: DLS of bicelles containing His-EGFR-TMJM-SBP 
DLS was performed in the laboratory of Professor Gerd Bendas (University of Bonn). The x-axis indicates 
the hydrodynamic diameter (d) of the particles in nanometers. Qr indicates the distribution function of the 
particle size in percentage. qIr indicates the frequency distribution of the particle size in percentage. The 
measured diameter for DMPC/DHPC bicelles containing His-EGFR-TMJM-SBP was 5.66 nm with a 96.9 
% volume distribution 
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To test if the peptide was embedded into the bicelles, fractions were taken during 
the assembly with lyophilized EGFR-TMJM and analyzed by centrifugation. As a 
control, EGFR-TMJM peptide was dissolved in buffer only and samples of supernatant 
and precipitate were analyzed by SDS-PAGE (Figure 39). 
 
Figure 39: Control of His-EGFR-TMJM-SBP assembly into bicelles 
15 % SDS-PAGE stained with Coomassie Brilliant Blue. Lyophilized His-EGFR-TMJM-SBP peptide at the 
concentration of 300 µM was mixed with 46 mM DMPC/DHPC bicelles or solubilized in 10 mM 
Phosphate Buffer pH 7.2. Fractions of both mixtures were taken as loading controls. Cycles of cooling and 
heating were performed and the final products were centrifuged. Samples of the supernatant and precipitate 
were collected and analyzed. No EGFR-TMJM band was visible in the supernatant where no bicelles were 
present, while the EGFR-TMJM band was visible in the supernatant of the bicelles sample. The precipitate 
fraction of the bicelle sample showed a lower amount of EGFR-TMJM peptide than the buffer fraction. 
The same concentration of EGFR-TMJM was used for both mixtures. The peptide 
remains in solution only when bicelles are present; no traces of peptide in the buffer 
supernatant are visible. Precipitate is visible for both mixtures, but in lower amounts in 
the bicelle fraction. 
IV.2.2.2 EGFR-ARNO interaction in bicelles 
IV.2.2.2.1 Crosslinking in bicelles 
Bicelles containing the TMJM region of EGFR were crosslinked with 
ARNOΔPBR (for a detailed protocol see Section VII.2.10.2). In Figure 40 the 
crosslinking experiment between the two proteins using BS3 as a crosslinker is evaluated. 
The SBP-tag of the EGFR-TMJM peptide was detected with a streptavidin-conjugated 
dye Western Blot, while ARNO was detected using an anti-ARNO antibody. The TMJM 
has a molecular weight of ~14 kDa, while HT-ARNOΔPBR is approximately 47 kDa. 
The same crosslinking band at ~60 kDa was detected using both antibodies, but the 
intensity was very weak. Dimeric EGFR-TMJM was visible from the streptavidin 
Western Blot also before BS3 addition (confirmed with Mass Analysis, data not shown) 
at ~25 kDa. In the anti-ARNO Western Blot a large quantity of unspecific bands were 
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visible, this complicated the identification of the crosslinking between the two proteins. 
Nevertheless, the crosslinked band size indicated in Figure 40 corresponds to a 1:1 
interaction of ARNO with EGFR TMJM. 
 
 
 
 
Figure 40: Crosslinking between ARNOΔPBR and EGFR-TMJM embedded into bicelles 
BS3 crosslinking agent was incubated with two different HT-ARNOΔPBR concentrations, 10 µM (+) and 
50 µM (++) respectively, and bicelles containing His-EGFR-TMJM-SBP. Analysis was performed by SDS-
PAGE and a) Streptavidin Western Blot detecting the SBP-labeled EGFR-TMJM or b) anti-ARNO 
Western Blot. An additional band appeared upon BS3 incubation, only where ARNO and EGFR-TMJM 
were present together at ~60 kDa. The same band was detected in the streptavidin and anti-ARNO Western 
Blot. The crosslinked band indicates the interaction of one ARNO monomer with one EGFR-TMJM 
monomer. 
To understand if ARNO Sec7 domain was responsible for the interaction with the 
JM domain, BS3 crosslinking was repeated with this construct. The Sec7 domain did not 
have an additional tag, and for this reason only a streptavidin Western Blot was 
performed. ARNO Sec7 has a molecular weight of 22 kDa, while EGFR-TMJM has a 
a) 
b) 
Streptavidin Western Blot 
Anti-ARNO Western Blot 
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molecular weight of 14 kDa. The expected crosslinking between one monomer of TMJM 
and Sec7 is ~35 kDa. 
 
Figure 41: Crosslinking between ARNO Sec7 and EGFR-TMJM embedded into bicelles 
BS3 was incubated with two different ARNO Sec7 concentrations, 10 µM (+) and 50 µM (++) respectively, 
and bicelles containing HT-EGFR-TMJM-SBP. Analysis was performed with SDS-PAGE and streptavidin 
Western Blot detecting the SBP-tagged EGFR-TMJM. An additional band appeared at 35 kDa upon BS3 
incubation only where ARNO and EGFR-TMJM were present together. The crosslinking band indicates the 
interaction of one ARNO monomer with one EGFR-TMJM monomer. 
The crosslinking between ARNO Sec7 and EGFR-TMJM is indicated in Figure 41 
at around 35 kDa. The crosslinked band intensity increased with increasing ARNO 
concentration. The visible band size corresponds to a 1:1 complex between ARNO Sec7 
and EGFR-TMJM. High molecular weight aggregates were also visible upon BS3 
addition, but only in the presence of both proteins. The Sec7 domain appears to be 
sufficient for the interaction with the JM region.  
To test whether the interaction between ARNO and JM is specific, two scrambled 
versions of the EGFR JM domains were produced. The JM domain can be further divided 
into two sub-regions: JM-A (residues 645-663) and JM-B (residues 664-682) (Jura et al. 
2009a). The JM-A region is rich in arginine residues, and is necessary for the 
dimerization and stabilization of the asymmetric dimer. The JM-B segment is referred to 
as “juxtamembrane latch” and it wraps around the kinase domain to stabilize it (Jura et al. 
2009a; Red Brewer et al. 2009).  
NMR studies (not published yet) performed in collaboration with Dr. Manuel 
Etzkorn, from the University of Düsseldorf, provide additional support to the interaction 
between ARNO Sec7 and EGFR-JM. The JM-A is important for dimerization, by forming 
a coiled-coil structure. According to the program for the prediction of coiled-coil regions 
in proteins (COILs), in the JM-A scrambled version 1 (sc1), the coiled-coil motif is 
Streptavidin Western Blot 
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partially conserved, while in the JM-A scrambled version 2 (sc2) there is no tendency to 
form the coiled-coil structure. In Table 1, the sequence of the JM wild-type and the two 
scrambled versions are reported.  
Table 1: Sequences of JM domain wild-type and scrambled versions (sc) 1 and 2  
 JM-A (residues 645-663) JM-B (residues 664-682) 
JM wild-type RRRHIVRKRTLRRLLQERE LVEPLTPSGEAPNQALLRI 
JM sc1 PRQTEINRVLEITRRRLEL LKLVASPALERQGRRPHRL 
JM sc2 RELKHIQVRLRTERQLEPL EIRAVNRSRLTPRLAGLPR 
To reduce unspecific interactions during crosslinking, 10 µM BSA was added to 
the reaction. In Figure 42 it is possible to observe the streptavidin Western Blot 
crosslinking using BS3 of EGFR-TMJM wild type and the two scrambled versions, 
named scrambled version 1 (sc1) and scrambled version 2 (sc2), respectively. From the 
Western Blot, it was possible to identify the crosslinked band between ARNO Sec7 and 
wild-type EGFR-TMJM at ~35 kDa. However a weak interaction for EGFR-TMJM sc1 
was observed and no crosslinking was visible for the EGFR-TMJM sc2.  
 
Figure 42: Crosslinking between ARNO Sec7 and EGFR-TMJM wild-type, sc1 and sc2 
embedded into bicelles 
Crosslinking agent BS3 was incubated with 10 µM ARNO Sec7 and bicelles containing His-EGFR-TMJM-
SBP wild-type, scrambled version 1 (sc1), or 2 (sc2). The TMJM domain concentrations contained within 
the bicelles was 5 µM. Analysis was performed by SDS-PAGE and streptavidin Western Blot, detecting the 
SBP-labeled EGFR-TMJMs. A weak band at ~35 kDa was observed between the wild-type TMJM 
appeared upon incubation with BS3. Almost no interaction was detected upon incubation of the TMJM sc1 
with the Sec7 domain, while no crosslinking was visible for TMJM sc2. 
The interaction between ARNO Sec7 and the wild-type JM domain was once 
again visualized by the crosslinked band size at ~35 kDa, nevertheless the band intensity 
Streptavidin Western Blot 
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was weak and hard to detect. Only a weaker crosslinked band size between Sec7 and 
TMJM sc1 was detected. In the TMJM sc1, the coiled-coil motif on the JM-A is partially 
conserved and probably for this reason, it was possible to observe a weak crosslinked 
band with ARNO Sec7. No crosslinking was detected with TMJM sc-2, in which both 
JM-A and JM-B segments were completely modified.  
Multiple crosslinking conditions were tested to try to increase the efficiency of the 
reaction, but were without success. Mineev et al. (2015) recently observed the structure of 
the JM-A segment in DMPC/DHPC bicelles. Mineev et al. (2015) showed with NMR 
studies that the JM-A region in bicelles shows an unstructured random-coil conformation 
that forms a transient helix. These data are in agreement with the work by Endres et al. 
(2013). The JM in bicelles is solvent exposed and can interact with protein in solution. 
The unstructured JM domain could be more flexible and this could explain the weak 
nature of the interaction detected. 
Furthermore, to support the theory that Sec7 is sufficient for the interaction, the 
PH domain of ARNO was used as negative control (Figure 43). The PH domain of 
ARNO contained a Flag-tag at the N-terminal part in order to perform a Flag Western 
Blot. The crosslinking was performed as before.   
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Figure 43: Crosslinking between ARNO PH and EGFR-TMJM wild-type, sc1 and sc2 
embedded into bicelles  
BS3 was incubated with 10 µM Flag ARNO PH and bicelles containing His-EGFR-TMJM-SBP wild-type 
and scrambled version 1 (sc1) and 2 (sc2). The TMJM domains contained within bicelles had a 
concentration of 5 µM. Analysis was performed by SDS-PAGE and a) anti-Flag Western Blot detecting the 
N-terminal part of ARNO PH domain and b) streptavidin Western Blot detecting the SBP-labeled EGFR-
TMJMs. In figure a) no crosslinking between TMJM domains and ARNO PH is visible. Only monomeric, 
dimeric, and trimeric structures of ARNO PH were visible. In figure b) different TMJM concentrations 
were loaded on to the gel. For this reason, different intensities of TMJM dimers were visible from the 
Western Blot. Nevertheless, no interaction of ARNO PH with TMJM domains was detected. 
ARNO PH as described before is necessary for the membrane recruitment and 
interaction with PIPns. The PH domain of ARNO does not seem to be directly involved in 
the interaction with the JM domain of the EGFR. 
a) 
b) 
Flag Western Blot 
Streptavidin Western Blot 
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IV.2.3 Nanodiscs  
IV.2.3.1 Nanodiscs production with synthetic phospholipids 
To increase nanodiscs stability and avoid rapid degradation of phospholipids due 
to oxidation processes, synthetic phospholipids were used, such as DMPC (1,2-
dimyristoyl-sn-glycero-3-phosphocholine) or DPPC (1,2-dipalmitoyl-sn-glycero-3-
phosphocholine). DMPC has a 14:0 fatty chain, while DPPC has a 16:0 fatty chain. 
Nanodiscs assembly was performed as reported in Section VII.2.5.1.2. Since new 
phospholipids were used, a further lipid to MSP1D1 titration was necessary. The final 
MSP:lipid molar ratio used is 1:60 for DMPC and 1:70 for DPPC. Controls for nanodiscs 
assembly were performed. 
IV.2.3.1.1 Analytical gel filtration to verify nanodiscs formation with 
synthetic phospholipids 
FPLC (fast protein liquid chromatography) gel filtration was performed on a 
Superdex 200 10/300 GL (GE Healtcare) column in MSP standard buffer with a flow rate 
of 0.4 ml/min. Column calibration was performed using a gel filtration standard from 
Bio-rad. Catalase, used as control for nanodiscs assembly from Sligar and co-workers 
(Sligar’s Laboratory Website), and γ-globulin present almost the same Stokes diameter, at 
10.4 nm and 10.2 nm respectively (Le Maire et al. 2008). 
Table 2: Gel filtration protein standards 
Protein Standard Stokes Diameter (nm) Elution volume (mL) 
Thyroglobulin (bovine) 17 8.76 
γ-globulin (bovine) 10.2 12.24 
Ovalbumin (chicken) 5.6 15.05 
Myoglobin (horse) 3.8 17.42 
DMPC- and DPPC-nanodisc chromatograms are visible in Figure 44 and 45, respectively. 
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Figure 44: FPLC analytical gel filtration of DMPC-nanodiscs 
Gel filtration was performed on Superdex 200 10/300 GL column in MSP standard buffer with a 0.4 ml/min 
flow rate. The aggregate peak elutes at 11.19 ml. Nanodiscs elute as mainly product at 12.96 ml.  
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Figure 45: FPLC analytical gel filtration of DPPC-nanodiscs 
Gel filtration was performed on Superdex 200 10/300 GL column in MSP standard buffer with a 0.4 ml/min 
flow rate. The aggregate peak elutes at 11.93 ml. Nanodiscs elute as mainly product at 12.78 ml.  
DMPC- and DPPC-nanodiscs presented almost the same elution volume as γ-
globulin, with a Stokes diameter of circa 10 nm, as reported in literature (Bayburt, Sligar 
2010). A small aggregate peak was eluted at around 12 ml. 
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IV.2.3.1.2 Dynamic light scattering (DLS) to verify nanodiscs assembly 
with synthetic phospholipids 
Nanodisc assembly was also confirmed via DLS, as reported in Section 
VII.2.5.3.1 DLS was performed in the group of Professor Gerd Bendas. The measured 
diameter for DMPC-nanodiscs was 9.87 nm, while DPPC of 11.07 nm. Synthetic 
nanodiscs show comparable dimensions to the one reported in literature (Bayburt et al. 
2002). 
 
Figure 46: DLS analysis of nanodiscs with synthetic phospholipids 
DLS is performed in the laboratory of Professor Gerd Bendas (University of Bonn). The x axis indicates the 
hydrodynamic diameters of the particles in nanometers. Qr indicates the particle size distribution function 
in percentage. qIr indicates the frequency distribution of particle size in percentage. a) The measured 
diameter for DMPC-nanodiscs was 9.87 nm with a 79.7 % volume distribution. Aggregate traces were 
detected at higher molecular range (3.880 µm). b) The measured diameter for DPPC-nanodiscs was 11.07 
nm with a 100 % volume distribution.  
IV.2.3.1.3 Negative Staining Electron Microscopy to verify nanodiscs 
assembly with synthetic phospholipids 
Negative staining electron microscopy was performed in collaboration with Dr. 
Elmar Behrmann (Center of advanced European studies and research, Bonn) as a further 
control to confirm the correct nanodisc assembly and to control nanodisc dimensions 
(Figure 47). For the sample preparation see Section VII.2.5.3.4. Highly diluted nanodisc 
samples after gel filtration were analyzed in a low salt buffer. The diameter of single 
nanodisc particles were measured and resulted to be around 10 nm. Nanodiscs of bigger 
dimensions were measured around 18 nm, probably due to degradative processes 
occurring during sample preparation. Stacking effects and formation of long nanodisc 
chains were also observed. This phenomenon was probably caused by the air dryer effect 
during the sample preparation.  
DMPC-nanodiscs DPPC-nanodiscs 
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Figure 47: Negative Staining electron microscopy of nanodiscs 
Nanodisc assembly was analyzed with negative staining electron microscopy. After gel filtration the 
samples were stained with uranylformate in low salt buffer. Scale bars indicate 70 nm. Single nanodiscs are 
indicated with black arrows, while nanodisc chains are indicated with red arrows.  
IV.2.3.2 EGFR activity in nanodiscs 
IV.2.3.2.1 Insertion of lz-EGFR-TS into nanodiscs 
For the preparation of nanodiscs containing lz-EGFR-TS, the protocol reported in 
Section VII.2.5.2.1 was used. The receptor concentration 1 µM was used for the 
assembly. To confirm the assembly of the protein within the nanodiscs, an indirect 
control experiment was performed. Phospholipids and MSP protein with or without lz-
EGFR-TS, and the receptor alone were incubated with Amberlite beads. Amberlite beads 
are used commonly during the nanodiscs formation to remove detergents. Lz-EGFR-TS 
precipitates if no detergent of lipid environment are present. Nanodiscs, nanodiscs 
containing lz-EGFR-TS, and lz-EGFR-TS alone were analyzed before and after 
Amberlite bead incubation and then centrifuged and run on a SDS-PAGE gel (Figure 48). 
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Figure 48: Control of lz-EGFR-TS assembly into nanodiscs 
12.5 % SDS-PAGE stained with Coomassie Brilliant Blue. Empty nanodiscs (1), nanodiscs containing lz-
EGFR-TS (2) or lz-EGFR-TS alone (3) were incubated overnight with Amberlite beads. Samples of the 
total mixtures (T) before incubation were taken. After overnight incubation, beads were removed and 
samples of the supernatant (S) and precipitates (P) were collected. The lz-EGFR-TS remains in solution 
only when nanodiscs are formed. The protein alone cannot stay in solution without detergent and it is 
visible in the precipitated fraction. 
The lz-EGFR-TS was visible in the precipitated fraction, when no lipids were 
present. Transmembrane proteins, due to the presence of the hydrophobic domain, cannot 
stay in solution without detergent or lipids.  
Nanodiscs provide a membrane-like environment, allowing the receptor to remain 
soluble even if the detergent is removed.  
Analytical gel filtration was also performed to check the formation of the nanodiscs with 
lz-EGFR. Samples after gel filtration were collected and analyzed by SDS-PAGE and 
Coomassie Staining. Due to the high dilution of the samples during the assay and the 
already low concentration of the receptor used, no protein was detected on the gel (data 
not shown).  
IV.2.3.2.2 Phosphorylation assay in nanodiscs 
To test whether nanodiscs were a suitable model for the in vitro reconstitution of 
EGFR, the catalytic activity of lz-EGFR-TS was assayed with a phosphorylation assay. 
For a detailed protocol see Section VII.2.7.2. The reaction was started by the addition of 1 
mM ATP and the activation was measured for 1 min, 3 min, 5 min and 10 min. The 
reaction was stopped by the addition of 6x SDS-PAGE Sample Buffer. Samples before 
and after ATP addition were collected and analyzed by SDS-PAGE and Western Blot 
using an anti-EGFR antibody and an anti-pTyr (phosphor-Tyrosine) antibody (Figure 49). 
In the pTyr Western Blot, upon ATP addition, it is possible to see a double band, due to 
the phosphorylation of the receptor.  
Results 
 
64 
 
Figure 49: Phosphorylation of lz-EGFR-TS into nanodiscs 
Western Blot analysis with anti-EGFR sc03 antibody (upper panel) and pTyr antibody (lower panel). At 
time 0, the receptor is visible before stimulation. The receptor phosphorylation level increases upon ATP 
addition after 30 seconds, 1 minute, 5 minutes and 10 minutes of stimulation. The total amount of receptor 
seemed to decrease upon ATP addition, but the anti-EGFR sc03 antibody binding is inhibited by 
phosphorylation.  
Lz-EGFR-TS after purification exhibited a basal phosphorylation level. For this 
reason, receptor was dephosphorylated with YopH for further experiments. The kinetics 
of phosphorylation in nanodiscs seemed to be very slow and weak, compared to the one 
in micelles.  
IV.2.3.2.3 Influence of ARNO on EGFR Phosphorylation in nanodiscs 
The ARNO Sec7 influence on EGFR phosphorylation level into nanodiscs was 
assayed. Bill (2011) reported that ARNO Sec7 enhances lz-EGFR phosphorylation in 
living cells. To test whether this result is obtained also in nanodiscs, Lz-EGFR-TS was 
incubated with ARNO Sec7, or Flag-tagged ARNO Sec7, or Flag-tagged ARNO PH as 
negative control, in presence of 1 mM ATP for 1 minute or 3 minutes (Figure 50).   
Results 
 
65 
 
Figure 50: Phosphorylation of lz-EGFR-TS in nanodiscs in presence of ARNO Sec7, or Flag-
ARNO Sec7, or Flag-ARNO PH 
Western Blot with anti-pTyr antibody (upper panel) and 12.5 % SDS-PAGE stained with Coomassie 
Brilliant Blue (lower panel). Nanodiscs containing lz-EGFR-TS were incubated with 600 µM ARNO Sec7 
(no tag), or 600 µM Flag-ARNO Sec7, or 600 µM Flag-ARNO PH or Buffer in presence of 200 nM YopH. 
Samples before stimulation (time 0) were taken. The stimulation starts upon 1 mM ATP addition and 
samples after 1 minute and 3 minutes were taken. No increase of the phosphorylation level in the presence 
of ARNO Sec7 or Flag-ARNO Sec7 was observed. Proteins are visible from the Coomassie staining. The 
presence of nanodiscs is indicated by the staining of the membrane scaffold protein. 
Samples before and after ATP addition were collected and analyzed with anti-
pTyr antibody. Protein presence is indicated with Coomassie staining. Two different Sec7 
constructs were used, to exclude any tag influence on the experiment. As expected, 
ARNO PH has no effect on EGFR phosphorylation. However, an increase of EGFR 
phosphorylation was not observed after Sec7 addition too.  
IV.2.3.3 EGFR-ARNO interaction in nanodiscs 
To study if nanodiscs are a suitable model to study protein-protein interactions, 
the TM domain and the JM segment of the EGFR were embedded into the disc bilayer. 
The idea was to investigate the interaction between ARNO Sec7 and the JM domain, to 
elucidate the activation mechanism of EGFR.  
IV.2.3.3.1 Insertion of EGFR-TMJM into nanodiscs 
For the preparation of nanodiscs containing the transmembrane region of EGFR 
and the JM domain, a MSP:TMJM molar ratio of 3:1 was used. Nanodiscs containing the 
peptide were assembled as reported Section VII.2.5.2.2. Due to the small size of the His-
EGFR-TMJM-SBP peptide inserted into nanodiscs, no shift in gel filtration 
chromatogram and no change in the DLS diameter of nanodiscs were observed.  
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To confirm the correct nanodiscs-peptide assembly, an indirect control experiment 
was established. The EGFR-TMJM peptide was mixed only with the phospholipids, but 
no membrane scaffold protein was added to the mixtures. The same steps for nanodisc 
assembly were performed. After overnight incubation, Amberlite beads were removed 
and the mixtures were centrifuged for some minutes. Precipitate and supernatant were 
used for SDS-PAGE (Figure 51a) and streptavidin Western Blot (Figure 51b), 
recognizing the SBP-tag at the C-terminal part of the EGFR-TMJM construct.  
 
 
 
  
Figure 51: Control of EGFR-TMJM assembly into nanodiscs 
A phospholipids-MSP1D1 mixture or phospholipids only were mixed with His-EGFR-TMJM-SBP. DMPC 
phospholipids were used. Fractions of both mixtures were taken as a loading control. The nanodiscs-TMJM 
mixture and phospholipids-TMJM mixture were incubated with Amberlite beads overnight. Fractions of the 
precipitate after centrifugation and of the supernatant were collected. N: Nanodiscs; PL: Phospholipids. a) 
15 % SDS-PAGE stained with Coomassie Brilliant Blue. Smearing effects were due to phospholipids. The 
presence of the nanodiscs is highlighted by the membrane scaffold protein. No EGFR-TMJM band was 
visible in the supernatant of the lipid fraction. The EGFR-TMJM was not clearly visible in the supernatant 
of the nanodiscs sample. b) Western Blot performed using streptavidin-800 conjugated dye, recognizing the 
SBP-tag at the C-terminus of the TMJM peptide. The EGFR-TMJM was present only in the supernatant of 
the formed nanodiscs. Precipitation of the peptide was visible for nanodiscs and phospholipids fractions. No 
TMJM peptide was visible in the supernatant of the lipid mixture. 
TMJM peptide was added in larger amount to be sure that the majority of 
nanodiscs contained the protein. Precipitation phenomena were visible for both mixtures. 
a) 
b) 
SDS-PAGE 
Streptavidin Western Blot 
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The TMJM peptide stayed in solution only when nanodiscs were properly formed, while 
no peptide was visible in the Western Blot of the lipid-protein mixture. 
IV.2.3.3.2 Pull-down assay to analyze the interaction of ARNO Sec7 with 
the JM domain of EGFR 
IV.2.3.3.2.1 GST pull-down with nanodiscs 
DMPC-nanodiscs containing the TM domain and JM region of EGFR were pre-
incubated with GST-ARNO Sec7 and subsequently with glutathione beads. A sample of 
the loaded fraction, supernatant, eluate, and the beads were analyzed by SDS-PAGE and 
Western-Blot. To increase the binding capacity between nanodiscs containing TMJM and 
ARNO Sec7, a pull-down assay at 25 °C was performed (Figure 52). The protocol is 
reported in Section VII.2.9.4. 
Lipid motility is increased at temperatures closer to the transition temperature. The 
transition temperature is defined as the temperature at which the lipids change physical 
state, from a structured gel phase to a fluid crystalline phase (Avanti Polar Lipids Website 
b). Close to the transition temperature, the membrane fluidity increases and therefore the 
interaction between membrane proteins and cytosolic proteins can be influenced (Simons, 
Vaz 2004). For DMPC, the transition temperature is 24 °C, for this reason the experiment 
was performed at room temperature. 
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Figure 52: GST pull-down at 25 °C with DMPC-nanodiscs to analyze TMJM-Sec7 
interaction 
The pull down assay was performed with catalytically active GST-ARNO Sec7 and His-EGFR-TMJM-SBP 
containing nanodiscs (NDs+TMJM). Empty nanodiscs (NDs) were used as a control. Glutathione beads 
were incubated with nanodiscs with (+) or without (-) the TMJM domain and GST-ARNO Sec7 at 25 °C 
for 1 hour. The total protein (T), supernatant after beads incubation (S), pull-down (PD) and beads (B) 
fractions were collected and analyzed. a) 15 % SDS-PAGE stained with Coomassie Brilliant Blue. GST-
ARNO Sec7, the scaffold protein of nanodiscs and the TMJM domain were visible. b) Western Blot 
performed with streptavidin-800 conjugated dye, recognizing the SBP-tag at the C-terminus of TMJM 
peptide. The TMJM domain was visible in the pull-down fraction. c) Western Blot performed with anti-His 
antibody detecting the N-terminal part of MSP1D1 protein and the N-terminal part of His-EGFR-TMJM-
SBP construct. MSP1D1 was detected only in the total fraction and supernatant. 
From the Coomassie staining (Figure 52a), GST beads showed low binding 
capacity, because almost the same band intensity was visible before and after beads 
incubation. In the pull-down fraction, a very weak band was visible for the TMJM 
a) 
b) 
SDS-PAGE 
Streptavidin Western Blot 
His Western Blot 
c) 
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domain. No MSP1D1 band was visible in neither the pull-down fraction and in the bead 
fractions.  
In the streptavidin Western Blot (Figure 52b) the TMJM co-eluted with Sec7. 
Unspecific binding of the EGFR-TMJM was visible in the bead fraction.  
Also a Western Blot analysis using an anti-His antibody recognizing the N-
terminal part of the membrane scaffold protein and the N-terminal part of the EGFR-
TMJM was performed (Figure 52c). MSP1D1 was present only in the total fraction and in 
the supernatant. EGFR-TMJM was not detected, due to the low antibody sensitivity.  
Furthermore, no MSP1D1 was detected in the pull-down and beads fraction in 
neither the SDS-PAGE and in the anti-His Western Blot. However, the TMJM was 
visible in the pull-down fraction of the streptavidin Western Blot, suggesting that the 
TMJM domain could be pulled out from the nanodiscs during the binding. The interaction 
might be sufficient to pull out the peptide form the lipid bilayer. 
To understand if this problem could be due to the fact that DMPC-bilayer was not 
thick enough to allow the proper insertion of TMJM, DPPC-nanodiscs were used. DPPC, 
as previously mentioned, has a longer fatty acid chain of 16:0, compared to the 14:0 chain 
of DMPC. DPPC-nanodiscs with or without EGFR-TMJM, were incubated with GST-
ARNO Sec7 or GST protein as a negative control at 37 °C (Figure 53). This temperature 
was chosen for two reasons: first, the lipid motility at this temperature is comparable to 
the physiologic one; second, DPPC has a transition temperature of 41 °C and the 
membrane fluidity should be high enough to allow a better interaction, but since it is not 
above the transition temperature, the peptide removal from the bilayer via Sec7 is 
avoided. 
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Figure 53: GST pull-down at 37 °C with DPPC-nanodiscs to analyze TMJM-Sec7 
interaction 
Glutathione beads were incubated with nanodiscs with (NDs+TMJM) or without (NDs) the TMJM domain 
and GST-ARNO Sec7 or GST protein as negative control at 37 °C for 1 hour. The total protein (T), 
supernatant after bead incubation (S) and pull-down (PD) fractions were collected and analyzed. a) 15 % 
SDS-PAGE stained with Coomassie Brilliant Blue. Four different proteins are visible in the total protein 
fractions: GST-ARNO Sec7, GST protein and nanodiscs scaffold protein, running at the same molecular 
weight, and EGFR-TMJM-SBP protein. In the pull-down fraction, TMJM peptide was visible only where 
DPPC-nanodiscs were incubated with ARNO-Sec7. The last lane, in which GST and nanodiscs with TMJM 
were loaded, was broken and part of the fraction was lost. b) Streptavidin Western Blot was performed with 
streptavidin-800 conjugated dye, recognizing the SBP-tag at the C-terminus of TMJM peptide. TMJM 
domain was visible in the pull-down fraction only in presence of ARNO Sec7. No unspecific binding 
between GST and TMJM was detected.  
With DPPC-nanodiscs at 37 °C, the interaction between ARNO Sec7 and TMJM 
was weak but specific. No interaction of TMJM with GST protein was detected.  
Comparing the pull-down assays performed at 25 °C and 37 °C, the co-elution 
between ARNO Sec7 and TMJM was higher at 37 °C with DPPC-nanodiscs. Since the 
membrane scaffold protein is an N-terminal truncated form of the human Apolipoprotein 
A-1 (Apo A-1), to verify the presence of MSP1D1 in the pull down fraction, a Western 
Blot using anti-Apo A-1 antibody was performed (data not shown). The antibody showed 
high unspecific binding and it was not possible to confirm the presence of the scaffold 
protein in the pulled down fractions. Since no other antibody was commercially available 
for MSP1D1 and the anti-His antibody previously used was unspecific, the detection of 
the protein in the pulled down fraction was not possible. 
a) 
b) 
SDS-PAGE 
Streptavidin Western Blot 
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IV.2.3.3.2.2 Ni-NTA pull-down with nanodiscs 
In order to test if the weak interaction shown in the GST-pull down was due to the 
low elution capacity, other beads for the pull-down were tested. Furthermore, to avoid the 
possibility that the TMJM was pulled out of the nanodiscs during the interaction with 
ARNO Sec7, the His-tag at the N-terminal part of the His-EGFR-TMJM-SBP was 
anchored to the Ni-NTA agarose beads for the pull-down. The His-tag of MSP1D1 was 
previously removed by TEV cleavage. A detailed protocol is reported in Section 
VII.2.9.5. DPPC-nanodiscs with or without the TMJM peptide were pre-incubated at 37 
°C with the beads. After the pre-incubation, GST-ARNO Sec7 was added. In Figure 54, 
the SDS-PAGE and the GST Western Blot of the fractions are shown.  
 
 
 
 
Figure 54: Ni-NTA Agarose beads pull-down at 37 °C to analyze TMJM-Sec7 interaction 
The pull down assay was performed with catalytically active GST-ARNO Sec7 and His-EGFR-TMJM-SBP 
containing nanodiscs (NDs+TMJM). Empty nanodiscs (NDs) were used as control. MSP1D1 had no His-
tag (w/o His-tag). This experiment was performed by the student Kevin Baβler, under my direct 
supervision. Ni-NTA Agarose beads were incubated with nanodiscs with or without the TMJM domain and 
GST-ARNO Sec7 at 37 °C for 1 hour. The total protein (T), supernatant after beads incubation (S), the pull-
down (PD) and bead (B) fractions were collected and analyzed. a) 15 % SDS-PAGE stained with 
Coomassie Brilliant Blue. Three different proteins are visible in the total protein fractions: GST-ARNO 
Sec7, the nanodiscs scaffold protein, and His-EGFR-TMJM-SBP protein. ARNO Sec7 co-eluted only 
where TMJM was present. b) A Western Blot using an anti-GST antibody was performed. A higher GST-
ARNO Sec7 amount was eluting in presence of the TMJM domain.  
a) 
b) 
SDS-PAGE 
GST Western Blot 
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GST-ARNO Sec7 eluted in higher amounts in presence of the EGFR-TMJM 
domain. Unspecific interactions of ARNO Sec7 with the nanodiscs or the Ni-NTA beads 
were visible in the pulled down fraction. From the Coomassie staining, it was visible that 
MSP1D1 was co-eluting with TMJM, indicating that the peptide was not removed from 
the bilayer upon interaction. 
The same experiment was repeated at 25 °C, but no specific co-elution between 
ARNO and EGFR was detectable (data not shown). These findings support the idea that 
the temperature has a high contribution on the interaction and membrane fluidity. These 
preliminary results support the theory that the JM region interacts specifically but in a 
weaker and transient way with ARNO Sec7.  
Due to challenges in increasing the pull-down efficiency and in reproducing the 
experiment using other types of Ni-NTA beads, other approaches were used to verify the 
interaction between ARNO Sec7 and the JM domain of EGFR. 
IV.2.3.3.3 Crosslinking to analyze the interaction of ARNO Sec7 with 
the JM domain of EGFR 
Nanodiscs containing the TMJM region of the EGFR were crosslinked with 
ARNOΔPBR (for a detailed protocol see Section VII.2.10.3). BS3 was used at the 
concentration of 0.5 mM for 5 minutes to crosslink ARNOΔPBR and EGFR-TMJM 
embedded into nanodiscs (Figure 55).  
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Figure 55: BS3 crosslinking with nanodiscs containing EGFR-TMJM and ARNOΔPBR 
BS3 crosslinker at the concentration of 0.5 mM was incubated with 30 µM ARNOΔPBR and 20 µM 
nanodiscs containing His-EGFR-TMJM-SBP or HT-IR-TMJM-SBP (negative control). Samples before and 
after addition of the crosslinker were collected and analyzed by a) 15 % SDS-PAGE stained with 
Coomassie Brilliant Blue and b) Western blot using a streptavidin-800 conjugated dye. No crosslinking 
between ARNO and EGFR-TMJM was visible using BS3 crosslinker. 
After BS3 addition, the gel analysis was complicated by the presence of a variety 
of different crosslinked bands. Nanodiscs containing HT-IR-TMJM-SBP were used as a 
negative control. The EGFR-TMJM was visible at 14 kDa. Before crosslinker addition, 
EGFR-TMJM as a dimer was present at around 25 kDa. A similar behavior was already 
seen for TMJM-micelles. MSP1D1 of nanodiscs has a molecular weight of 24 kDa. Upon 
BS3 addition, the crosslinking band of MSP1D1 was visible around 45 kDa. 
SDS-PAGE 
Streptavidin Western Blot 
b) 
a) 
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ARNOΔPBR crosslinked at ~100 kDa. For a 1:1 complex between ARNO and EGFR-
TMJM, it was expected a crosslinked band around 60 kDa, as already seen in bicelles (see 
Section IV.2.2.2.1), but no interaction was visible. HT-IR-TMJM-SBP had a similar 
molecular weight of EGFR-TMJM, and also for this peptide, there was already a 
dimerized construct at ~25 kDa. High molecular aggregates were also visible on the upper 
part of the gel. As expected, no crosslinking was observed between HT-IR-TMJM-SBP 
and ARNOΔPBR.  
In order to understand if the difficulty in observing the interaction in nanodiscs 
with BS3 crosslinker was due to the fact that the JM region was inserted too deeply inside 
the phospholipid bilayer, a membrane permeable crosslinker was used. DSS (dissucimidyl 
suberate) is the membrane permeable analogue of BS3. DSS at a concentration of 0.5 mM 
was incubated for 5 minutes in the presence of 30 µM ARNOΔPBR and nanodiscs 
containing His-EGFR-TMJM-SBP or HT-IR-TMJM-SBP as a negative control.   
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Figure 56: DSS crosslinking of nanodiscs containing EGFR-TMJM and ARNOΔPBR 
DSS crosslinker at the concentration of 0.5 mM was incubated with 30 µM ARNOΔPBR and 20 µM 
nanodiscs containing His-EGFR-TMJM-SBP or HT-IR-TMJM-SBP (negative control). Samples before and 
after addition of the crosslinker were collected and analyzed with a) 15 % SDS-PAGE stained with 
Coomassie Brilliant Blue and b) Western blot using a Streptavidin-800 conjugated dye. No crosslinking 
between ARNO and EGFR-TMJM was visible using a membrane permeable crosslinker. 
As previously reported, the expected crosslinked band for a 1:1 complex should be 
visible at around 60 kDa. Also using a membrane permeable crosslinker, no interaction 
between EGFR-TMJM and ARNO was visible. The same crosslinking behavior of BS3 
was observed as well for the non-water soluble analogue DSS. The crosslinking in 
nanodiscs is not a suitable method to analyze ARNO-EGFR interactions. 
SDS-PAGE 
Streptavidin Western Blot 
b) 
a) 
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IV.2.3.3.4 Microscale Thermophoresis (MST) to analyze the interaction 
of ARNO Sec7 with the JM domain of EGFR 
Another technique, microscale thermophoresis (MST), was used to verify the 
interaction between ARNO Sec7 and the JM domain of the EGFR into nanodiscs.  
MST measures the motion of molecules in solution when a temperature gradient is 
generated. Different parameters are important to determine thermophoretic movement: 
hydration shells, charge, and size of the molecules (Duhr, Braun 2006). Molecules to be 
detected have to be labeled with florescent dyes. The intrinsic tryptophan fluorescence 
can also be used. The interaction between one or more molecules affect the 
thermophoretic movements and a change in the fluorescence intensity can be detected 
(Jerabek-Willemsen et al. 2011). MST has the advantage that a small amount of protein 
and low concentrations of the interacting partners are required.  
To perform MST, the MSP1D1 of nanodiscs was expressed and purified as a C-
terminal fusion construct with the monomeric enhanced green fluorescence protein 
(MSP1D1-mEGFP). A further gel filtration step on a Superdex 200 10/300 GL column 
was necessary to remove the aggregates formed during nanodisc production. To estimate 
the labeled moiety, a dilution series of nanodiscs after gel filtration was analyzed with 
MST. The eluted nanodiscs were diluted 20 times in buffer and directly used to perform 
MST experiments. DPPC-nanodiscs containing the TMJM domain of EGFR or empty 
discs used as a negative control were incubated with different ARNO Sec7 concentrations 
from 50 µM to 1.5 nM. Three different MST powers (20 %, 40 % and 60 %) with a 20 % 
LED (Light Emitting Diode) power were used. In Figure 57 the typical thermophoresis 
(with temperature jump) results are reported. Exactly the same thermophoresis behavior 
was observed for the empty nanodiscs and for the nanodiscs containing the TMJM 
domain. No specific interaction between Sec7 and JM was detected. The same 
thermophoresis behavior is probably due to unspecific binding. To reduce the unspecific 
interaction, the measurement was repeated in presence of 1.5 mg/mL BSA, but no 
variation in the curves was visible (data not shown).  
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Figure 57: MST analysis of DPPC NDs containing EGFR TMJM and ARNO Sec7 
MST analysis was performed in MSP standard buffer at 25 °C with 20 % LED power and 40 % MST 
power. Gel filtrated DPPC nanodiscs (NDs) labeled with GFP were used. Serial dilutions of nanodiscs after 
gel filtration were performed to establish the fluorescence moiety. NDs were diluted 1:20 after gel filtration. 
The thermophoresis with temperature-jump is shown as normalized fluorescence (ΔFnorm) and is plotted 
against the logarithmic ARNO Sec7 concentration. The data of two independent experiments are shown as 
mean±SEM. Almost the same behavior was observed for empty DPPC NDs (blue curve) and TMJM 
containing NDs (black curve), probably due to unspecific interactions.  
Due to the difficulties in studying the interaction of JM domain with ARNO Sec7 
in nanodiscs, other membrane model systems were used. 
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IV.2.4 Membrane Sheets  
Membrane sheets are native plasma membranes adherent to a glass support. Cells 
which adhered to coverslips, are then subjected to a short ultrasound pulse and only the 
basal membrane remains attached to the support (Zilly et al. 2011). The following 
experiments were performed with the collaboration of Professor Thorsten Lang (Life and 
Medical Sciences Institute, University of Bonn).  
Membrane sheets constitute the most complex in vitro membrane system to study 
protein clustering, protein-protein, and protein-lipid interactions. Membrane sheets were 
used to test the activity of EGFR upon the addition of ARNO and the interaction between 
the two proteins. For all the following experiments 20-35 membrane sheets for each 
coverslips were analyzed. 
IV.2.4.1 EGFR activity on membrane sheets incubated with 
ARNO 
EGFR activity was assayed using membrane sheets. HeLa membrane sheets were 
prepared as reported in Paragraph VII.2.6. Different experimental approaches were tested 
for assay optimization. Initially, the membrane sheets were pre-incubated for 5 minutes 
with buffer containing 1 mM Na-orthovanadate, a phosphatase inhibitor. The reaction 
was started by adding 1 mM ATP in the presence of 12.5 ng/ml, 25 ng/ml or 50 ng/ml 
EGF and stopped after 1 minute (Figure 58). Phosphorylated EGFR was measured with 
anti-pTyr1086 antibody. Samples were imaged by fluorescence microscopy. 
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Figure 58: EGFR phosphorylation on HeLa membrane sheets with pre-incubation and 
stimulation with different EGF concentrations for 1 minute (n=3) 
HeLa membrane sheets were pre-incubated for 5 minutes in buffer in presence of 1 mM of phosphatase 
inhibitor (Na-othovanadate). Then, the membrane sheets were stimulated for 1 minute with 1 mM ATP and 
three different EGF concentrations: 12.5 ng/ml, 25 ng/ml and 50 ng/ml, respectively. The phosphorylation 
of EGFR was measured with anti-pTyr1086 antibody. The bar chart shows the mean±SEM. Significance is 
calculated with one way ANOVA on Rank analysis. There is a statistically significant difference (p=0.006). 
The columns were compared with Dunn’s Method. The comparison between the column 1 and column 2, 
column 1 and 3, and column 1 and 4 are reported (ns: not significant; **:p<0.01). No relevant increase of 
EGFR phosphorylation was observed.  
The receptor was already in a highly active state prior to stimulation. For this 
reason no EGF-dependent EGFR stimulation was observable. EGFR activity was 
completely maximized during the pre-incubation time.  
The experiment was repeated stimulating the receptor in the presence of 50 ng/ml 
EGF and 1 mM ATP for 1 minute, without pre-incubation (Figure 59). Furthermore, the 
influence of ARNO on the phosphorylation level of the EGFR was observed. HeLa 
membrane sheets were incubated with 100 nM ARNO full-length and stimulated with 50 
ng/ml EGF and 1 mM ATP for 1 minute. 
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Figure 59: EGFR phosphorylation on HeLa membrane sheets without pre-incubation, in 
presence of 100 nM of ARNO (n=3) 
HeLa membrane sheets were stimulated for 1 minute with 1 mM ATP and 50 ng/ml EGF with or without 
100 nM ARNO. The phosphorylation of EGFR was measured with anti-pTyr1086 antibody. The bar chart 
shows the mean±SEM. Upon EGF addition, there was a three times increase of the phosphorylation level of 
the EGFR. No ARNO-dependent EGFR phosphorylation was observed. Significance is calculated with one 
way ANOVA on Rank analysis. There is a statistically significant difference (p<0.001). The columns were 
compared with Dunn’s Method. The comparison between the column 1 and column 2, column 1 and 3, 
column 2 and 3, are reported (***: p<0.001; ns: not significant). 
The receptor on membrane sheets was active, and upon EGF addition, gave a 
twofold increase in phosphorylation. The results showed that ARNO has no influence on 
EGFR phosphorylation on HeLa membrane sheets. 
To exclude the cell-type influence, the same experiment with H460 cells was 
repeated (Figure 60).  
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Figure 60: EGFR phosphorylation on H460 membrane sheets in presence of 100 nM of 
ARNO (n=2) 
H460 membrane sheets were stimulated for 1 minute with 1 mM ATP and 50 ng/ml EGF with or without 
100 nM ARNO. The phosphorylation of EGFR was measured with anti-pTyr1086 antibody. The bar chart 
shows the mean±SEM. No ARNO-dependent EGFR phosphorylation was observed. Significance is 
calculated with one way ANOVA on Rank analysis. There is a statistically significant difference (p<0.001). 
The columns were compared with Dunn’s Method. The comparison between the column 1 and column 2, 
column 1 and 3, column 2 and 3, are reported (***: p<0.001; ns: not significant). 
In H460, a similar increase in phosphorylation (nearly 100 %) was observed upon 
EGF addition. Nevertheless, ARNO has no effect on EGFR phosphorylation on 
membrane sheets. 
IV.2.4.2 EGFR-ARNO co-localization on membrane sheet 
Since ARNO had no effect on EGFR activation on membrane sheets, it was 
analyzed if ARNO co-localized at the plasma membrane with EGFR. HeLa cell line 
prepared membrane sheets were used for this purpose. Flag-ARNO at the concentration 
of 1 µM was incubated on membrane sheets for 5 minutes. Membrane sheets were stained 
with anti-EGFR antibody and anti-Flag antibody for ARNO detection. The Figure 61 
shows representative images for membrane sheets incubated with buffer as a negative 
control or with Flag-ARNO. EGFR was stained in green, while ARNO in red and imaged 
with fluorescence microscopy. When membrane sheets were incubated with buffer, no 
co-localization between EGFR and ARNO channel was visible. When ARNO was added, 
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merging images, the overlapping spots in the red (ARNO) and green (EGFR) channel 
appear yellow. The co-localization results are represented graphically with a scatterplot 
(Figure 62). In the diagram, the pixel intensity of the red channel (x-axis) is plotted 
against the green pixel intensity (y-axis) of the background corrected membrane mean 
intensities. In a scatterplot, if co-localization between two proteins is present, the points 
cluster around a straight line, as is seen with ARNO and EGFR. In the buffer control, the 
points were localized in a small group, with no influence from the red channel (ARNO) 
on distribution.  
 
Figure 61: Representative images for Flag-ARNO co-localization with EGFR on HeLa 
membrane sheets  
HeLa membrane sheets were incubated with 1 µM Flag-ARNO. ARNO was stained in red (using anti- Flag 
antibody to detect the N-terminal tag of ARNO), while EGFR was stained in green (using anti-EGFR sc03 
antibody). The overlap between the two channels is indicated as “merge”. In yellow is indicated the co-
localization between ARNO and EGFR. No co-localization was visible when the membrane sheets were 
incubated with buffer. All the pictures are shown with the same lookup tables (LUT). The scale bar 
indicates 7.5 µm. 
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Figure 62: Scatterplot of the EGFR mean pixel intensity (y-axis) and ARNO pixel intensity 
(x-axis) of Flag-ARNO of background subtracted mean membrane sheet (mean-BG) 
intensity (n=3) 
Scatterplot of three different experiments: day 1 in red, day 2 in blue and day 3 in black. 
a) When membrane sheets were incubated only with buffer, no influence of the ARNO channel is visible on 
the scatterplot. b) The scatterplot of the membrane sheets incubated with ARNO shows points clustering 
around a straight line, indicating an equal contribution from the two channels for the total intensity. 
To quantify the correlation between ARNO and EGFR, the Pearson’s correlation 
coefficient (PCC) was used. The PCC was calculated with the following formula:  
𝑃𝐶𝐶 =
∑ (𝑅𝑖 − ?̅?) ×  (𝐺𝑖 − ?̅?)𝑖
√∑ (𝑅𝑖 − ?̅?)2𝑖 ×  ∑ (𝐺𝑖 − ?̅?)2𝑖
 
𝑅 refers to the intensity of the pixel, i, of the red channel and 𝐺 to the pixel intensities of 
the green channel. 𝑅 ̅and ?̅? are the mean intensities of the red and green channel, 
respectively. PCC has values ranging from 1, for a perfect co-localization, to -1 for 
intensity inversely related. PCC values around 0 indicate no correlation between the two 
a) 
b) 
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intensities (Dunn et al. 2011). In Figure 63, the PCC for the co-localization of ARNO and 
EGFR in region of intersest (ROIs, 50x50 pixel) on the membrane, is reported.  
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Figure 63: Pearson’s correlation coefficient for ARNO and EGFR on HeLa membrane 
sheets within ROIs (n=3) 
The PCC is calculated with the formula reported above within defined region of interest, termed ROI 
(50x50 pixels). When ARNO was not incubated with the membrane sheets, the PCC had a value around 0, 
indicating no correlation between the two proteins. Upon ARNO incubation, the PCC reached a value of 
0.42, indicating a moderate degree of correlation between ARNO and EGFR. Significance calculated with 
Mann-Whitney test. (***: p<0.001 with p<0.0001). 
The PCC calculated for ARNO-EGFR was 0.42, indicating a moderate degree of 
correlation between the two proteins.  
IV.2.4.3 The effect of ARNO on EGFR clustering 
Many membrane proteins organize themselves at the plasma membrane in 
microdomains or clusters. Cluster formation is controlled by lipid-lipid, protein-lipid, and 
protein-protein interactions (Zilly et al. 2011). The mechanism of cluster formation 
currently is not entirely understood. A recent study shows that EGFR can cluster at the 
plasma membrane due to the interaction between the JM region and anionic 
phospholipids, such as PIP2 (Wang et al. 2014).  
During the co-localization analysis of ARNO with EGFR on membrane sheets, 
another phenomenon was observed. A preliminary way to analyze membrane clustering 
on membrane sheets, using fluorescence microscopy, is to calculate the relative standard 
deviation (RSD) of EGFR channel intensity. The RSD is calculated within 50x50 pixel 
ROIs with the following formula: 
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𝑅𝑆𝐷 =
𝑆𝐷𝑖
(𝑀𝑖 − 𝐵𝑖)
 
Where 𝑆𝐷 is the membrane standard deviation of the pixel intensity, 𝑖, of the channel. 𝑀 
is the intensity of the membrane ROI and 𝐵 the intensity of the background ROI. The 
RSD gives information about the degree of clustering. Low RSD values indicate a 
homogenous pixel intensity distribution within a ROI, while high RSD values indicate 
that the pixel intensity is concentrated in spots, representing the protein cluster areas. 
During the co-localization experiments, it was observed that the RSD of EGFR upon the 
addition of ARNO significantly decrease, while EGFR intensity increases. In Figure 64 
the RSD and EGFR intensity on membrane sheets incubated with buffer as a negative 
control or with Flag-ARNO is reported. 
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Figure 64: ARNO effect on the EGFR relative standard deviation on HeLa membrane 
sheets and on EGFR channel intensity (n=3) 
a) The RSD gives information about the clustering degree of EGFR on HeLa membrane sheets. The RSD 
was measured on membrane sheets incubated with buffer or with 1 µM Flag-ARNO. The RSD goes from 
0.63 to 0.45 upon ARNO addition. The RSD decreased and therefore, the degree of clustering of EGFR 
decreased too. b) Total EGFR channel intensity increased upon ARNO addition.  
Significance was calculated with Mann-Whitney test. (***: p<0.001 with p<0.0001). 
ARNO seemed to have an effect on the degree of clustering of EGFR. Upon 
ARNO addition, the degree of cluster decreased (since the RSD value decreased), going 
from 0.6 when the membrane sheets were incubated only with buffer, to 0.4. 
Different explanations for ARNO’s effect on the RSD are possible: ARNO 
decreases EGFR clustering at the plasma membrane. The binding of ARNO to EGFR 
makes EGFR more accessible to antibody staining by decreasing packing density in 
a) b) 
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clusters or by inducing conformation changes. In the latter case, the clusters may also 
become larger, which could be investigated in further studies employing super resolution 
microscopy. 
IV.2.4.4 A mutation on ARNO PH domain affects EGFR co-
localization and clustering 
To understand whether the PH domain contributed to ARNO/EGFR co-
localization and clustering, a Flag-tagged ARNO mutated construct, containing a single 
point mutation (R280C; R: Arginine; C: Cysteine) at the PH domain was developed. The 
PH domain, as described in Section II.4.1.1 is important for recruitment of proteins to the 
plasma membrane and interaction with PIPns. A single point mutation in the PH domain 
of ARNO was made to block the interaction with PIPns at the cell membrane.  
Firstly, the co-localization of the mutated construct versus the wild-type construct 
was measured. In Figure 65 representative HeLa membrane sheets are shown. The 
binding of ARNO to the membrane sheets was drastically reduced in the ARNO construct 
containing the point mutation. The co-localization results were represented graphically in 
a scatterplot (Figure 66). As expected, for the mutated ARNO, the points were randomly 
distributed showing no correlation between EGFR channel (green) and ARNO channel 
(red).  
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Figure 65: Representative images for mutant Flag-ARNO and wild-type Flag-ARNO co-
localization with EGFR on HeLa membrane sheets 
HeLa membrane sheets were incubated with 1 µM mutant Flag-ARNO or 1 µM wild-type Flag-ARNO. 
ARNO was stained in red, while EGFR was stained in green. The overlap between the two channels is 
indicated as “merge”. In yellow, is indicated the co-localization between wild-type Flag-ARNO and EGFR. 
No co-localization was visible when the membrane sheets were incubated with buffer, as well as for point 
mutant Flag-ARNO. All the pictures are shown with the same lookup tables (LUT). The scale bar indicates 
7.5 µm. 
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Figure 66: Scatterplot of EGFR mean pixel intensity (y-axis) and ARNO mean pixel 
intensity (x-axis) of wild-type Flag-ARNO vs. mutant Flag-ARNO of background subtracted 
mean membrane sheet (mean-BG) intensity (n=3) 
Scatterplot of three different experiments: day 1 in red, day 2 in blue and day 3 in black.  
a) When membrane sheets were incubated with wild-type Flag-ARNO, the points are clustering around a 
straight line. b) The scatterplot of the membrane sheets incubated with mutant Flag-ARNO shows a 
disordered distribution. Not an equal contribution from the two channels was visible. 
 
 
 
 
 
 
a) 
b) 
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The degree of co-localization was then calculated as the Pearson’s correlation 
coefficient (Figure 67). 
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Figure 67: Pearson’s correlation coefficient for wild-type ARNO or mutated ARNO and 
EGFR on HeLa membrane sheets (n=3) 
The PCC was calculated within defined ROI (50x50 pixel). Wild-type ARNO showed, as previously seen, a 
middle co-localization value of 0.4. ARNO containing a PH mutation is unable to bind the PIP2 and the co-
localization drastically drops to 0.17, comparable to the buffer control with a PCC value of 0.12. 
Significance was calculated with one way ANOVA on Rank analysis. There is a statistically significant 
difference (p<0.001). The columns were compared with Dunn’s Method. The comparison between the 
column 1 and column 2, column 1 and 3, column 2 and 3, are reported (***: p<0.001; **: p<0.01). 
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To understand if the effect observed for the wild-type ARNO on EGFR clustering 
was due only to the membrane interaction, the RSD for mutated ARNO was calculated. 
Also EGFR intensity was measured (Figure 68). 
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Figure 68: Different effect of ARNO constructs on EGFR relative standard deviation (RSD) 
and on EGFR intensity (n=3) 
a) The RSD gives information about the clustering degree of EGFR on HeLa membrane sheets. The RSD 
was measured on membrane sheets incubated with buffer or 1 µM wild-type Flag-ARNO or 1 µM Flag-
mutated ARNO. The RSD slightly decreased for the mutated ARNO (0.55) compared to the buffer RSD 
(0.64). For wild-type ARNO, the RSD had again a value around 0.4, meaning a decrease of EGFR 
clustering. b) Total EGFR channel intensity increased upon wild-type ARNO addition, and it was slight 
higher than the buffer control when the mutated ARNO was present. 
Significance was calculated with one way ANOVA on Rank analysis. There is a statistically significant 
difference (p<0.001). The columns were compared with Dunn’s Method. The comparison between the 
column 1 and column 2, column 1 and 3, column 2 and 3, are reported (***: p<0.001). 
Only a slight effect on the clustering degree of the EGFR was visible for ARNO with a 
mutant PH domain. 
In the light of these results, the PH domain is important to transport ARNO to the 
plasma membrane to increase its local concentration. ARNO could directly hinder tight 
EGFR clustering by binding or inducing conformational changes. Conformational 
changes alone may already be sufficient for increased accessibility. Alternatively, the 
PIP2 microenvironment may be altered via PH domain binding PIP2 at the plasma 
membrane. A point mutation of the PH domain of ARNO strongly reduces the membrane 
recruitment of ARNO. A small effect on the receptor clustering was still observed for this 
mutant, potentially due to the fact that the Sec7 domain still interacts with the JM region. 
Interaction of ARNO with the JM domain, which interacts with PIP2, may also alter 
EGFR clustering by altering EGFR-PIP2 interactions. Nevertheless, the effect is 
a) b) 
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drastically reduced if compared with wild-type ARNO, indicating a role of the PH 
domain in the receptor activation. Moreover, other cytosolic co-factors could also assist in 
the interaction between ARNO and EGFR in the living cell. 
Fluorescence microscopy is a useful tool to study the co-localization between 
proteins, but due to the resolution limits, it is not possible to assay if a direct interaction 
between ARNO and EGFR takes place or if additional factors are required. Furthermore, 
to understand which domains of ARNO are involved in the interaction, deletion studies 
are necessary.  
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V. Discussion 
V.1 Nanodiscs as a model system to study 
membrane-ARNO interactions 
The comprehension of protein-membrane interactions and the influence of 
phospholipid composition on protein recruitment and activation is a major goal of 
biochemical and biophysical research (Contreras et al. 2011). Nanodiscs are an useful tool 
to study membrane-protein interactions and protein-protein interactions (Schuler et al. 
2013). Cytohesins act as GEFs for Arf, in particular Arf1 and Arf6 (Cohen et al. 2007). 
Cytohesins are involved in membrane trafficking, vesicle formation and signal pathways 
important for cell growth and development (Casanova 2007). In Famulok’s research 
group, the role of cytohesin-2 (ARNO) PH domain has been investigated. The PH domain 
recruits cytohesins to the plasma membrane, due to the interaction with PIPns (Kolanus 
2007). In order to use an in vitro system to observe the interaction between ARNO PH 
domain and anionic lipids, nanodiscs containing PIP2 have been produced.  
V.1.1 Protein Expression and Purification 
The first steps for this part of the project were the expression and purification of 
the PH domain of ARNO and the membrane scaffold protein, necessary for nanodisc 
assembly. 
The PH domain was expressed in E. coli as an N-terminal SBP-tagged construct (Figure 
13). The SBP-tag was used for the purification. The purification was performed as 
described by Keefe et al. (2001). The SBP-tag contains 38 amino acids residues and it 
was selected to bind selectively to streptavidin with a Kd of 2.5 nM (Keefe et al. 2001). 
The SBP-tag binds to an improved version of streptavidin, termed strep-tactin.  
One liter of bacterial culture was cultivated overnight at 20 °C to increase protein yield 
and avoid protein aggregates formation. Cell lysate was applied to strep-tactin 
immobilized beads to allow the binding between the protein of interest and the conjugated 
matrix. After a wash step, performed to remove unspecific binding to the beads, ARNO 
PH was eluted using 2.5 mM desthiobiotin. Desthiobiotin is a modified form of biotin and 
binds with lower affinity to the strep-tactin matrix, allowing mild elution conditions and 
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bead recycling (Hirsch et al. 2002). After elution, a buffer exchange was performed in 
order to remove desthiobiotin for further experiments. The final protein yield for 1 liter 
culture was 2.8 mg.  
Nanodiscs are surrounded by two membrane scaffold proteins that keep the 
hydrophobic tails of the phospholipids protected from the aqueous environment. 
Membrane scaffold protein 1 deleted 1 (MSP1D1) is a modified form of the human 
Apolipoprotein A-1 (Apo A-1) (Bayburt et al. 2002). MSP1D1 was expressed as a His-
tagged construct followed by a TEV cleavage site in E. coli using the protocol reported by 
Sligar and co-workers available online (Sligar's Laboratory Website) (Figure 14). Two 
liters of bacterial culture were cultivated at 37 °C until the logarithmic phase of bacterial 
growth was reached (corresponding to an OD600 between 0.6 and 0.8). The protein was 
expressed for a maximum of 3 hours at 37 °C. Upon that time, proteolytic processes are 
started. Cell lysate was incubated with Ni-NTA agarose beads, which bind to the His-tag 
on the protein. In order to remove unspecific binding, several washing steps with different 
detergents were performed. MSP1D1 was eluted with buffer containing imidazole, and 
the protein was dialyzed overnight against MSP standard buffer for further nanodiscs 
assembly. Some precipitate was also present after dialysis. The final protein yield for 2 
liters of culture was 15 mg. 
V.1.2 Nanodiscs production with natural 
phospholipids 
PIP2 and PIP3 are anionic phospholipids constituting less than 1% of the cellular 
membrane lipids (Czech 2000). In order to visualize PIPns at the plasma membrane, PH 
domains are used (Kavran et al. 1998). Grp-1 (cytohesin-3) PH domain, was the first 
member of the cytohesins family identified to interact with PIP3 with high efficiency 
(Klarlund 1997). Subsequently, ARNO PH was identified to be recruited at the 
membrane, due to the interaction with PIPns (Venkateswarlu et al. 1998).  
In order to validate nanodiscs as a suitable model to study membrane-protein 
interaction, PIP2 was inserted into the phospholipid bilayer. Nanodiscs were assembled 
using natural phospholipids. Nanodiscs not containing PIP2 were used as a negative 
control. The assembly procedure was adapted from Bayburt et al. (2002).  
First, phospholipids and membrane scaffold protein were mixed in the appropriate 
amount, in order to achieve almost 100 % nanodisc formation, avoiding the presence of 
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free MSP1D1 or free lipids in the mixtures. For this reason, several different MSP to 
phospholipids ratios have been tested.  
Second, to assess the formation of nanodiscs, HPLC (high pressure liquid 
chromatography) analytical gel filtration was performed. Sligar and co-workers reported 
that formed nanodiscs have the same elution time of the reference protein catalase 
(Sligar’s Laboratory Website). Catalase is a globular protein with a Stokes diameter of 
10.2 nm and it eluted at 13.3 minutes (Figure 15). PCPE-nanodiscs and PIP2-nanodiscs 
were loaded on a Superdex 200 10/300 column and the elution time of the main peak was 
compared with the catalase peak. For PCPE-nanodiscs, three MSP to phospholipids ratio 
were analyzed with gel filtration: 1:60, 1:40 and 1:20 (Figure 16). In the 1:60 ratio, the 
nanodisc peak was visible at 12.8 minutes but an aggregate peak was eluting at the 
column void volume, at 9.4 minutes, due to the presence of a too high lipid amount. In the 
1:40 ratio, the nanodisc main peak eluted at 13.3 minutes, and was corresponding to the 
same elution time of catalase. Nevertheless, aggregate traces were visible at around 10 
minutes, indicating the presence of an excess of lipids. On the other side, when a 1:20 
MSP to phospholipid ratio was used, free MSP1D1 as a shoulder of the main nanodisc 
peak (13.7 minutes) was visible at around 16 minutes. For this reason, an intermediate 
ratio between 1:40 and 1:20 was chosen, to avoid aggregate formation and the presence of 
free-MSP in the mixtures. PCPE-nanodiscs were produced with a 1:30 MSP to 
phospholipids ratio.  
Also for PIP2-nanodiscs, three different MSP:phopsholipids were tested: 1:60, 
1:40 and 1:20 (Figure 17). After careful evaluation for PIP2-nanodiscs a 1:30 ratio was 
also chosen, because aggregates caused by lipid excess in the 1:60 and 1:40 ratios were 
visible. Furthermore, for the 1:20 ratio, after the nanodisc peak at 13.8 minutes, free MSP 
was eluting at 16 minutes.  
To evaluate nanodiscs formation, dynamic light scattering (DLS) was performed 
in the group of Professor Gerd Bendas (University of Bonn). DLS gives information 
about the size of the molecules in solution, according to their Brownian motion. The 
sample was irradiated with a monochromatic laser beam and the light was scattered in a 
time dependent manner according to the molecules movements. The intensity of the 
scattered light was then analyzed with an autocorrelation function, which gives 
information about the motion of the particle in solution, their diffusivity and the 
dimensions (Lorber et al. 2012). DLS was used to evaluate the polydispersity of 
nanodiscs and their dimensions in solution. DLS analysis of PCPE-nanodiscs (Figure 18a) 
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measured particles with a diameter of 16.18 nm and 94 % volume distribution, while the 
measured diameter for PIP2-nanodiscs (Figure 18b) was 15.34 nm with a 98 % volume 
distribution. These results indicated an almost 100 % monodispersed samples and 
complete nanodiscs formation. The DLS measurement revealed nanodisc dimensions 
circa 5 nm bigger than the dimensions reported by Bayburt et al. (2002; 2003). This can 
be due to the fact that natural phospholipids were used. Natural phospholipids are 
heterogeneous preparations, with different fatty acid chains distribution, if compared with 
synthetic phospholipids. The predominant fatty acid species for egg PC have a chain 
length of 16:0 (32.7 %) and 18:1 (32.0 %). PE contains 19.5 % of fatty acids with a chain 
length of 20:4. Brain PIP2, the chain length distribution is for 37 % 18:0, 36.8 % 20:4 and 
7.7 % is unknown. Therefore the final dimension of the nanodisc bilayer can be 
influenced by the presence of unsaturated fatty acids. Furthermore, the DLS measurement 
was performed at room temperature and not at 4 °C, as for gel filtration experiment. 
Unsaturated fatty acids and higher temperature could increase the membrane fluidity 
(Hagve 1988; Nicolson 2014). 
V.1.3 ARNO PH domain interacts with PIP2-
nanodiscs 
To prove that nanodiscs are a suitable system to study membrane-ARNO 
interaction, a pull-down assay with PIP2-nanodiscs and PCPE-nanodiscs was performed. 
ARNO PH fused at the N-terminal part with a SBP-tag was mixed with PCPE-nanodiscs 
or PIP2-nanodiscs and then incubated with strep-tactin magnetic beads (Figure 19). 
Magnetic beads presented several advantages, they are usually smaller than non-magnetic 
beads and therefore the binding surface increase and fewer beads are required. 
Furthermore, magnetic beads can be easily removed from the suspension, without time 
consuming processes (Sepmag 2010). The pull-down assay was performed on ice, to 
avoid protein denaturation. In order to remove unspecific binding, several washing steps 
were performed. To displace ARNO PH from its interaction site on the beads, 
desthiobiotin at the appropriate concentration was used. The pull-down assay (Figure 20) 
shows no co-elution between PCPE-nanodiscs and the PH domain, as expected. ARNO 
PH domain interacts selectively with nanodiscs containing PIP2. Two bands were visible 
in the pulled-down fraction: MSP1D1, indicating the presence of nanodiscs and ARNO 
PH domain. 
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V.1.4 Cyplecksins inhibit the binding of ARNO 
PH domain 
Cyplecksins covalently target the cytohesins-PH domains. Cyplecksins are 5-
bromo-pyrimidine-2,4,6-triones identified and synthetized by Doctor Mohammed 
Hussein, from Famulok’s group. Inactive analogues were also produced (Figure 21). To 
understand if cyplecksins inhibits the membrane recruitment of ARNO PH domain in 
membrane surrogate systems, PIP2-nanodiscs were used. A similar pull-down assay to the 
one previously described, with strep-tactin magnetic beads was performed. The 
compounds were pre-incubated with ARNO PH domains and subsequently nanodiscs 
were added to the mixtures. Also in this experiment, several washing steps were 
performed in order to remove unspecific binding. Cyplecksins inhibit the membrane 
recruitment of ARNO PH domain to the membrane but the inactive analogues have no 
effect (Figure 22). 
From these results, nanodiscs demonstrate the ability to be a reliable system to 
detect the PIP2 interaction and to test small-molecules inhibitors. 
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V.2 Different membrane-like environments to 
study EGFR-ARNO interaction and EGFR 
activation 
Cytohesins were identified as cytoplasmic activators for EGFR in Famulok’s 
research group. In particular, cytohesins work as enhancer for EGFR phosphorylation in 
living cells (Bill 2011). H460 cells treated with SecinH3, an inhibitor for cytohesins, 
showed a reduction of EGFR phosphorylation. On the other hand, the overexpression of 
cytohesin-2 in H460 cells led to an increase of EGFR activation level. From cell-free 
reconstitution experiments it was concluded that ARNO enhances EGFR phosphorylation 
by direct interaction, probably by enhancing the formation of the active asymmetric 
dimer.  
Starting from this point, the aim of this work was to gather further characterization 
on the activation mechanism of EGFR driven by cytohesins, in native-like membrane 
systems using phosphorylation as readout. During this work, the findings that cytohesins 
are directly involved in the activation of the EGFR were challenged (Anastasi et al. 
2016). Therefore, the key experiments of the earlier publication by Bill et al. (2010) 
involving EGFR activation by cytohesin-2 were repeated in our group. Whereas all the 
cellular data could be reproduced and the cytohesin-dependent stimulation of EGFR 
phosphorylation also be observed in HeLa cells, the cell-free reconstitution of the EGFR 
activation could not be reproduced. As a consequence, the publication was retracted by 
the authors (Bill et al. 2016). The discrepancy between the cellular and the cell-free data 
emphasizes further that deeper insight into the cytohesin-dependent activation of EGFR is 
needed. 
EGFR is not a prototypical RTK, because its activation is regulated not only from 
the binding of a ligand to the extracellular domain, but more complex mechanisms are 
involved. Peculiar to EGFR is the regulating function of the juxtamembrane (JM) domain 
(Lemmon et al. 2014). The JM domain is a short intracellular region sited directly after 
the transmembrane (TM) domain. The JM domain contributes to the stabilization of the 
kinase domain in the active conformation. Moreover, the JM domain seems to also 
contribute to the inactive state of the receptor, via a direct interaction between the 
positively charge residues of the receptor and the anionic lipids of the plasma membrane 
(Arkhipov et al. 2013; Endres et al. 2013). The TM domain consists of a single α-helix 
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spanning through the membrane bilayer, comprised between the amino acid residues 621 
to 644 (Jura et al. 2009a). Endres et al. (2013) recently identified the TM domain as 
another regulation motif for EGFR activation, underling the importance of a 
conformational change in the transmembrane segment to remove the JM domain from its 
inactive conformation at the plasma membrane and to keep the kinase domain in an active 
state. Moreover, recent studies in Famulok’s research group (personal communication 
from Benjamin Weiche, Anton Schmitz and Michael Famulok) suggested that the 
interaction site for ARNO on EGFR is located on the JM domain.  
To further investigate the regulation mechanism involved in EGFR-ARNO 
interaction, truncated EGFR constructs containing only the TM and the JM regions were 
embedded in membrane surrogates. Starting from simplified systems, like micelles and 
bicelles, and ending with more complex membrane-like environments, such as nanodiscs 
and membrane sheets, the interaction between cytohesin-2 and EGFR was studied.  
V.2.1 Micelles  
Detergent and phospholipids are amphiphilic molecules consisting of a 
hydrophilic head group and a lipophilic tail. In aqueous environments, they form 
micelles, spherical structures, to minimize the interaction of the hydrophobic tails with 
the solvent. Due to their nature, micelles constitute the most simplified membrane-like 
system and are a useful tool to solubilize membrane proteins.  
V.2.1.1 EGFR phosphorylation in micelles  
In order to study the activation of EGFR in micelles, a constitutively dimerized 
form of the receptor, namely lz-EGFR-TS, was used (Figure 23). In the lz-EGFR-TS 
construct, the extracellular domain was replaced by a leucine-zipper dimerization module. 
Since the construct is purified as already dimerized form, to evaluate receptor 
phosphorylation, no stimulation with an extracellular ligand was required. A Flag-tag was 
present at the N-terminal part, while the C-terminal part of the receptor had a SBP-tag 
used for purification. Lz-EGFR-TS was expressed in Sf9 insect cells by Yvonne 
Aschenbach, from Famulok’s group. For the purification, strep-tactin beads were used. 
Protein expression was not high and the final product contained a variety of contaminants 
(Figure 24). For this reason, only an approximate determination of the protein 
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concentration was possible. Since lz-EGFR-TS eluted as a double band, a Western Blot 
with an anti-Flag antibody, for the N-terminal part, and a streptavidin-conjugated dye, for 
the C-terminal part, was performed to understand if during the purification the receptor 
was subjected to protease cleavage. Both antibodies recognized the upper band at 76 kDa, 
indicated in Figure 24. 
Preliminary experiments were performed to understand if the receptor embedded 
in micelles was active and able to undergo phosphorylation. Since the receptor presented 
a basal phosphorylation level upon purification, the tyrosine-protein phosphatase YopH 
was used to dephosphorylate the protein. The addition of ATP led to an increase of the 
receptor phosphorylation level within 20 seconds (Figure 25). Interestingly, it was 
possible to observe that an upper band appeared after stimulation, due to the 
phosphorylation of several tyrosine residues on the C-terminal tail of the receptor. From 
these results, it is possible to assert that lz-EGFR-TS activity was conserved upon 
purification and micelles offer an easy solution to study EGFR activity in a native-like 
environment.  
As a second step, the influence of ARNO on lz-EGFR-TS phosphorylation in 
micelles was observed. Bill (2011) reported that the Sec7 domain is sufficient to enhance 
EGFR phosphorylation. For this reason, the micelles containing the receptor were 
incubated with ARNO Sec7 or GST as a negative control protein (Figure 26). GST was 
used as a control, since GST monomers have almost the same molecular weight of Sec7. 
No influence of ARNO Sec7 on in vitro activation of EGFR was observed. These results 
are in contrast to the study of Bill (2011). It has to be considered, however, that Bill 
(2011) examined the phosphorylation of lz-EGFR in intact cells. 
V.2.1.2 EGFR-ARNO interaction in micelles 
After determining that it was not possible to observe an influence of ARNO on 
EGFR activation in micelles, it was investigated whether the absence of the effect was 
due to micelles not being suitable for the interaction. Famulok’s research group has 
evidence that ARNO interacts with EGFR, directly binding to the JM domain (personal 
communication from Benjamin Weiche, Anton Schmitz and Michael Famulok). 
Furthermore, two recent studies highlighted the role of the JM domain on the regulation 
of EGFR activity (Arkhipov et al. 2013; Endres et al. 2013).  
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First, to verify if micelles were a suitable environment for the interaction, a 
truncated form of the receptor, i.e. HST-EGFR-TMJM, containing the TM domain and 
the JM domain of EGFR was expressed and purified in bacteria. Initially the construct 
was expressed with a His-tag and a SBP-tag at the N-terminal part (Figure 27). In 
bacteria, the construct was accumulated in inclusion bodies during the protein expression. 
The formation of inclusion bodies in bacteria remains not completely understood (Ramón 
et al. 2014). Protein purification from inclusion bodies requires harsh denaturing 
conditions. Urea at high concentration was used to extract the protein from the inclusion 
bodies. Since the HST-EGFR-TMJM is a short peptide containing only 120 amino acids 
residues, no complex renaturation processes were required. Urea was simply removed by 
dialysis overnight against the desired buffer containing detergents for micelle formation. 
The final purity of the protein was around 70 % due to its low expression (Figure 28).  
Second, a GST-tagged ARNO Sec7 construct was purified from E. coli. Protein 
expression was very high and the final protein yield was 50 mg starting from 2 liters of 
bacterial culture (Figure 29). To test if the Sec7 construct was correctly folded after 
purification, its catalytic activity was tested. For this purpose, a fluorescence-based 
nucleotide exchange assay was performed (Figure 30). An increase of tryptophan 
fluorescence was observed within 10 minutes, and the slope was calculated with a linear 
regression model. ARNO Sec7 was active at nanomolar concentration. The protein 
conserved its structure and activity upon purification.  
In order to analyze and characterize ARNO-EGFR interaction, a GST pull-down 
assay was performed (Figure 31). From the bead fraction, it was possible to observe an 
unspecific interaction of the peptide with the glutathione beads, in presence or absence of 
ARNO Sec7. For this reason, it was not possible to draw a clear conclusion about ARNO 
Sec7 and EGFR TMJM interaction with GST pull-down. To avoid unspecific binding of 
TMJM peptide to GST beads, a pull-down assay with strep-tactin beads, interacting with 
the N-terminal SBP-tag of HST-EGFR-TMJM, was performed. Nevertheless, no elution 
of the peptide was visible in the pulled down fraction, meaning that in this case unspecific 
interaction with the beads was also observed. Because of the infeasibility of performing a 
reliable pull-down assay, other biochemical assays to investigate the interaction were 
used.  
Crosslinking is used to “freeze” molecular interactions at a given point in time, 
and it is a useful tool to detect weak and transient binding events between proteins. To 
perform crosslinking, other constructs for EGFR and ARNO were expressed and purified. 
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A new EGFR-TMJM peptide was used, i.e. His-EGFR-TMJM-SBP. The construct 
contained a His-tag at the N-terminal part and a SBP-tag at the C-terminal (Figure 32). 
The presence of the SBP-tag at the C-terminal increased the yield (circa 13 mg from 2 
liters of bacterial culture) and the purity of the final product (Figure 33). This was 
probably due to the increased binding capacity of the His-tag to the beads, since no steric 
hindrance of the SBP-tag was present anymore. 
In addition to the Sec7 domain, an almost full-length form of the cytohesin-2 was used to 
increase the efficiency of crosslinking. The polybasic region (PBR) of ARNO is 
responsible for the interaction with acidic phospholipids at the plasma membrane (Nagel 
et al. 1998a). The construct, termed ARNOΔPBR, contained a 14 amino acids C-terminal 
deletion of the polybasic region. During the purification, degradation processes were 
occurring and degradation products were visible in the eluted fractions (Figure 34). Gel-
filtration was performed to remove contaminants and the final protein yield was 10 mg 
starting from 2 liters of bacterial culture.  
For the crosslinking assay, the crosslinker BS3 was used. Since BS3 interacts only 
with primary amine, and the polybasic region (PBR) of ARNO contains five lysine 
residues almost in succession, the ARNO domain was removed, to prevent the possibility 
that during the crosslinking only ARNO:ARNO complexes were formed.  
Previous crosslinking experiments performed in Famulok’s research group by Doctor 
Benjamin Weiche showed that the JM domain of EGFR is sufficient for ARNO binding. 
As a proof of principle, the experiment with JM domain and ARNOΔPBR was repeated 
(Figure 35). The JM domain does not required the presence of detergents to be soluble, 
and for this reason no micelles were formed. Two different concentrations of BS3 were 
used: 1.5 mM and 0.5 mM. The crosslinking experiment showed that the JM domain 
binds to ARNOΔPBR. Interestingly, the crosslinked band intensity between ARNO and 
the JM peptide became stronger when the lower BS3 concentration (0.5 mM) was used. 
Probably, high BS3 concentration (1.5 mM) shifts the reaction equilibrium to the 
formation of higher order ARNO and ARNO/JM complexes, which are not resolved in 
the gel. 
The crosslinking experiment was repeated with micelles containing His-EGFR-
TMJM-SBP and using as a negative control the TM and JM regions of the insulin 
receptor (IR). Insulin-receptor is a RTK, which regulates the glucose homeostasis, tissue 
growth and cellular metabolism (Kitamura et al. 2003). Cytohesins have an effect on 
insulin signaling. Hafner et al. (2006) have shown that the Sec7 antagonist, SecinH3, 
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blocked the insulin-dependent repression of the insulin-regulated gene for insulin-like 
growth factor binding protein (IGFBP1) in HepG2 cells. Furthermore, SecinH3 
diminished GTP-bound Arf6 membrane recruitment upon insulin stimulation. Similar 
results were obtained with the knock-down of cytohesins-2 and 3. Nevertheless, the IR 
density at the cell membrane and the receptor phosphorylation were not affected by 
SecinH3 treatment, indicating that cytohesins play a role in the downstream signaling of 
IR, probably facilitating the formation of the IR-IRS1 complex (Hafner et al. 2006). Lim 
et al. (2010) recently identified a scaffold protein termed connector enhancer of KSR1 
(CNK1) as a binding partner for cytohesins. The CNK1/cytohesin complex is necessary 
for the activation of the IR downstream signaling (Lim et al. 2010). Taking that into 
account, no direct binding between the IR-JM domain and ARNO seems to be involved in 
the receptor activation mechanism.  
The crosslinking experiments between EGFR-TMJM and ARNOΔPBR revealed no 
interaction between the two proteins (Figure 36). No crosslinking between ARNO and IR 
was observed, as expected.  
Since the crosslinking assay detected the interaction between the peptide JM and 
ARNO, but no interaction was observed between ARNO and EGFR-TMJM in micelles, 
two explanations are possible. First, micelles are not a suitable model to study the 
interaction. The detergent concentration required to maintain the protein in solution can 
be high enough to disrupt the protein-protein interaction. Second, the JM domain may 
interact with the detergent, and the interaction with ARNO is not strong enough to 
displace the detergent molecules. 
Taking that into account, other membrane model systems were evaluated. 
V.2.2 Bicelles  
Bicelles are phospholipids bilayer formed by long-chain and short-chain lipids. 
Bicelles were used to study EGFR-ARNO interactions. For bicelle formation, 
phospholipid powders were mixed together in phosphate buffer at pH 7.2, to increase 
long-term bicelle stability (Ottiger, Bax 1998). Bicelles formation was assayed by DLS 
(Figure 37) and the resulting diameter was around 6 nm, with almost 100 % sample 
homogeneity. During DLS analysis, the sample was diluted and DHPC was supplemented 
into the dilution buffer to keep the q ratio stable and avoid the disassembly of bicelles 
(Beaugrand et al. 2014).  
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For the reconstitution of membrane proteins into bicelles, the lyophilization of the 
protein is often necessary (Dürr et al. 2012). The insertion of transmembrane proteins into 
bicelles requires a high amount of protein, generally above 10 mg/ml (Ujwal, Bowie 
2011). Since the amount of lz-EGFR-TS purified was not enough to allow the insertion 
into bicelles, and lyophilization of the protein was not possible, only bicelles containing 
the TMJM peptide were produced. For this reason, the interaction between ARNO and 
EGFR, but not the phosphorylation in bicelles was studied.  
DLS was used to analyze bicelles containing His-EGFR-TMJM-SBP (Figure 38) 
but no variation in the diameters was observed. In order to analyze if the peptide was 
assembled into bicelles, an indirect control experiment was performed (Figure 39). From 
the SDS-PAGE gel, it was possible to observe that the TMJM was present only in the 
soluble fraction when the bicelles were formed. Protein precipitate was also visible, due 
to an incomplete protein solubilization during sample preparation. The bicelles containing 
His-EGFR-TMJM-SBP were used within a week, to avoid the degradation of the sample.  
V.2.2.1 EGFR-ARNO interaction in bicelles 
To analyze the interaction between ARNOΔPBR and His-EGFR-TMJM-SBP, 
BS3 crosslinking was performed (Figure 40). Two different ARNO concentrations were 
used for this experiment and upon BS3 addition a crosslinked band with the peptide was 
visible at ~60 kDa. This result indicated a weak but reliable interaction of the EGFR-
TMJM peptide with ARNO. 
In order to understand if the Sec7 domain alone was sufficient for the interaction, 
the crosslinking experiment was repeated with two different Sec7 concentrations (Figure 
41). ARNO Sec7 interacted with EGFR-TMJM in a concentration-dependent manner in 
bicelles. As mentioned before, studies in Famulok’s research group and in the group of 
Doctor Manuel Etzkorn, suggested that the interaction site with ARNO is located on the 
JM-A segment of EGFR. To provide evidence towards that, two different constructs of 
the His-EGFR-TMJM-SBP peptide were produced, in which the JM segment was 
scrambled (Table 1). The JM-A segment is important for protein dimerization, probably 
due to the tendency to form a coiled-coil structure. Generally, a coiled-coil motif can 
contain from two to five α-helices and it is a common domain in proteins, which act as 
transcription factors and are involved in cell growth and proliferation (Mason, Arndt 
2004). According to the program “prediction of coiled-coil regions in proteins” (COILs) 
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the motif is partially conserved in JM sc1, while no coiled-coil tendency was found for 
JM sc2. In the crosslinking experiments performed with wild-type EGFR-TMJM or the 
two scrambled versions (Figure 42), the interaction between wild-type EGFR-TMJM was 
observed. A weaker crosslinked band for the EGFR-TMJM sc1 and no interaction with 
the sc2 were detected. These data support the theory that for the interaction with ARNO is 
necessary an intact JM segment, in which a coiled-coil domain is formed.  
In addition to the above experiment, a control experiment with the PH domain was 
performed (Figure 43). No interaction with EGFR-TMJM was detected for the PH 
domain, providing further evidence that Sec7 is the binding site for the EGFR.  
Bicelles provide a reliable system to study protein-protein interactions. A recent 
publication of Mineev et al. (2015) reveals two different conformations of the EGFR-
TMJM peptide in micelles and bicelles. In micelles, the JM domain is embedded or 
attached to the surface of the micelles. For this reason, the JM domain could not be free to 
interact with proteins present in the surrounding environment. Furthermore, Mineev et al. 
(2015) reported that the JM domain in bicelles does not interact with the phospholipid 
bilayer. For this reasons, interactions with other proteins could easily take place.  
These findings could explain why no interaction between ARNO and EGFR-
TMJM was detected in micelles, but weak interactions were observed when bicelles were 
used. Moreover, it was observed that the JM domain in bicelles is more flexible than in 
micelles, in which it forms a compact α-helix structure. The flexibility of the JM domain 
in bicelles may also explain the weak nature of the interaction observed with ARNO 
(Mineev et al. 2015). 
V.2.3 Nanodiscs  
Going through the different membrane systems, nanodiscs were the next choice to 
study EGFR-ARNO interactions. Since there were difficulties with natural phospholipids 
for nanodiscs production and storage, synthetic phospholipids were used to reduce the 
variability of the fatty acid chain (Amin, Hazelbauer 2012).  
Nanodisc assembly was assayed with FPLC (fast protein liquid chromatography) 
analytical gel filtration and DLS. A Superdex 200 10/300 GL column was calibrated with 
gel filtration standard protein mixtures (Table 2). The protein γ-globulin, used for the 
calibration, has almost the same Stokes diameter of catalase, the reference protein used by 
Sligar and co-workers to assay the assembly of nanodiscs (Sligar’s Laboratory Website). 
Discussion 
 
105 
Nanodiscs, formed with synthetic phospholipids, eluted at almost the same volume as γ-
globulin, indicating a proper disc formation (Figures 44 and 45). The DLS analysis 
(Figure 46) confirmed that the nanodiscs were correctly assembled, with a diameter 
approximately of 10 nm. Further evidences on nanodisc shape and integrity were gathered 
with negative staining electron microscopy (Figure 47). Negative staining images of 
nanodiscs showed discoidal particles as single molecules or as chain aggregates. Since the 
nanodisc samples were gel filtered before electron microscopy analysis, the formation of 
nanodisc piles was probably caused by the under-vacuum drying phase necessary for the 
sample preparation. A 10 nm diameter was measured for the single nanodisc particles, 
although bigger particles with an 18 nm diameter were also found. Also in this case, the 
presence of bigger particles can be explained with sample degradation or with 
contaminants still present after purification of the nanodiscs. 
V.2.3.1 EGFR phosphorylation in nanodiscs 
In order to study EGFR activation in nanodiscs, the lz-EGFR-TS construct was 
reconstituted into nanodiscs membranes. The assembly protocol was adapted from Mi et 
al. (2008). To analyze if the receptor was properly inserted into the discs bilayer, an 
indirect control experiment was performed (Figure 48). The assembly process of 
nanodiscs starts when the detergent used to solubilize the lipids is removed with 
hydrophobic beads. Lz-EGFR-TS cannot stay in solution without detergent in the absence 
of nanodiscs. No traces of free lz-EGFR-TS were present in the supernatant upon 
detergent removal in the absence of nanodiscs. Only if nanodiscs were formed, lz-EGFR-
TS was observed in the supernatant fraction after bead incubation.  
Lz-EGFR-TS was then tested for phosphorylation into nanodiscs (Figure 49). 
Compared to the previously used micelles system, the kinetics of the receptor in 
nanodiscs were very slow and even after 10 minutes of stimulation the complete receptor 
activation was not reached. Seeing that the receptor already expressed a basal 
phosphorylation level after purification, the protein phosphatase YopH was then used. In 
presence of YopH, the receptor could reach a higher phosphorylation level, within 3 
minutes (Figure 50). Moreover, Flag-ARNO Sec7 or ARNO Sec7 without tag, in order to 
exclude the possibility that the presence of a tag may influence the protein activity, were 
added to the reaction mixture. No changes of EGFR phosphorylation was detected in 
presence of ARNO Sec7 constructs. 
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Nanodiscs showed a slower kinetic activation of EGFR compared to the micellar 
system. This is presumably due to membrane constriction and lipid-protein interactions, 
whereby the receptor cannot be easily phosphorylated, as compared with the detergent-
solubilized receptor. These data are in agreement with previous studied published by Mi 
et al. (2008) and He et al. (2015), in which EGFR activation in nanodiscs or 
nanolipoprotein particles was studied between 2 to 18 hours. As the focus of this thesis 
was about the early activation stages of EGFR, the activation kinetics were only evaluated 
for a short incubation. Bill (2011) reported that in living cells ARNO enhances EGFR 
phosphorylation in the early stimulation stages (5 minutes stimulation). Taking that into 
account, a difference on the phosphorylation level within the first stimulation minutes 
was expected.  
Nanodiscs and micelles provide only an artificial system in which transmembrane 
proteins can maintain their conformation but other regulatory factors are missing. For this 
reason, more complex membrane-like systems were used to evaluating ARNO effect on 
EGFR activity. 
V.2.3.2 EGFR-ARNO interaction in nanodiscs 
A series of different studies reported the use of nanodiscs to reconstitute 
transmembrane protein to study their structure, the conformation and the interaction with 
other associated factors (Alvarez et al. 2010; Bayburt, Sligar 2010; Denisov, Sligar 2011; 
Näsvik Öjemyr et al. 2012).  
The previously used His-EGFR-TMJM-SBP construct was inserted into nanodiscs 
to study the interaction with ARNO. The assembly of the peptide in the discs bilayer was 
assayed with an indirect control. The peptide was purified in micelles and subsequently 
incubated with lipids and the membrane scaffold protein for the nanodisc assembly. At 
the same time, another mixture containing only the peptide and lipids was prepared. Both 
mixtures were incubated with hydrophobic beads, and only if the peptide was correctly 
integrated into the nanodiscs, could it remain soluble (Figure 51).  
To test the interaction between His-EGFR-TMJM-SBP and ARNO, a GST pull-
down with DMPC-nanodiscs and DPPC-nanodiscs was performed. DMPC and DPPC 
differ in the length of the fatty acid chain, 14:0 and 16:0 respectively. Longer side chains 
increase the transient temperature of the lipids and therefore the membrane fluidity can be 
modulated, changing the experiment parameters. GST pull-down with DMPC-nanodiscs 
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containing His-EGFR-TMJM-SBP was performed at 25 °C, close at the transition 
temperature of DMPC phospholipids (Figure 52). At the transition temperature, the 
membrane motility increases and becomes more fluid. Protein-protein interaction can be 
favored in these conditions. From the pulled down fraction, it was possible to observe a 
co-elution between GST-Sec7 and EGFR-TMJM, but no MSP1D1 was eluted. It is 
possible that during the interaction, the TMJM peptide was pulled out from the nanodiscs 
bilayer.  
To verify this hypothesis, another pull-down experiment was performed at 37 °C 
with DPPC-nanodiscs (Figure 53). Two parameters were changed: lipid, and temperature. 
First, DPPC was used because the fatty acid chain is longer than DMPC chain. This may 
allow a better insertion of the peptide into the membrane. Additionally, DPPC has a 
transition temperature at 41 °C. The pull-down was performed at 37 °C to test the binding 
at a physiological temperature and to be close, but not above, the transition temperature of 
DPPC. In this way the membrane fluidity may be sufficient to facilitate the interaction, 
but since the bilayer is still in the gel phase, the peptide should not be removed from the 
nanodiscs. From the pulled down fraction it is possible to observe a co-elution between 
ARNO and nanodiscs containing His-EGFR-TMJM-SBP (Figure 53a). From the 
streptavidin Western Blot, the TMJM peptide was detected in the pulled down fraction 
only where Sec7, and not the control protein GST, was added (Figure 53b). Nevertheless, 
no MSP1D1 was detected in the pulled down fraction. For this reason, other approaches 
were used.  
Another pull-down experiment was performed with Ni-NTA Agarose beads. This 
was to anchor the His-tagged TMJM to the beads. In this way, during the interaction, the 
peptide cannot be easily removed from the discs bilayer. In the Ni-NTA pull-down assay 
(Figure 54), it was possible to observe the co-elution of GST-ARNO Sec7, the scaffold 
protein of the nanodiscs, and EGFR-TMJM. The peptide is interacting with Sec7, and it is 
not removed from the discs bilayer. The same experiment was repeated at 25 °C (data not 
shown), but no interaction between ARNO Sec7 and EGFR-TMJM was visible, 
suggesting a primary role of the membrane motility for the interaction. Clarifications of 
these data are necessary. Other pull-down experiments were performed to gather evidence 
for the interaction. Nevertheless, no further reliable results were obtained from the pull-
down experiments, underling the weak and transient nature of the interaction between 
ARNO and Sec7. 
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For this reason, crosslinking in nanodiscs was also performed. As was done for the 
bicelles experiments, BS3 was used to crosslink ARNOΔPBR with His-EGFR-TMJM-
SBP for nanodiscs. As a negative control, nanodiscs containing the IR-TMJM were used. 
No crosslinking was observed between EGFR-TMJM and ARNO (Figure 55).  
Endres et al. (2013) proposed that the JM domain, in its inactive state, is 
interacting with the plasma membrane, preventing the formation of the asymmetric dimer. 
To understand if the absence of protein interaction was due to the fact that BS3 
crosslinker is not able to enter the membrane, the DSS crosslinker was used, which is a 
membrane permeable analogue of BS3. Even using DSS, no crosslinking between ARNO 
and EGFR-TMJM was visible (Figure 56). 
It is interesting to observe that, the EGFR-TMJM construct embedded in 
nanodiscs, as well as the IR-TMJM construct, before crosslinker incubation, were almost 
only present in monomeric form. The proteins were visible at ~13 kDa, and almost no 
dimer was visible at ~25 kDa. After crosslinker addition, the dimer band became stronger 
for both constructs. For bicelles, the dimer was present before BS3 addition (see Figure 
40) and when incubated with ARNO, a crosslinking between the two proteins was visible. 
In micelles, no interaction between EGFR-TMJM and ARNO was detected and almost no 
dimeric form of the receptor was observed (see Figure 36). These observations suggest 
that the receptor presents as a pre-formed dimer in membrane surrogate systems, may 
easily interact with ARNO. These results highlight an important regulatory role of the TM 
region of EGFR. Further analysis and experiments to clarify this theory are necessary. 
As only weak interactions were detected with pull-down experiments, and no 
crosslinking was observed between ARNOΔPBR and EGFR-TMJM, another technique 
was used to investigate the interaction. Microscale thermophoresis (MST) is a useful 
technique to detect protein-protein interactions in a nanomolar range and without high 
protein consumption (Jerabek-Willemsen et al. 2011). DPPC-nanodiscs were directly 
produced with a MSP1D1-GFP labeled construct. Empty nanodiscs and nanodiscs 
containing TMJM presented the same thermophoretic pattern (Figure 57). The sigmoidal 
binding curves probably result from an unspecific interaction between the nanodiscs and 
Sec7. Since no reliable interactions between EGFR and ARNO were detected by using 
nanodiscs, other in vivo like membrane system were evaluated.  
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V.2.4 Membrane Sheets  
Membrane sheets were prepared starting from cells adhered to a glass support, 
termed a cover slip. Cells were subjected to an ultrasound pulse and the plasma 
membrane remained immobilized on the glass support. These membrane sheets allow the 
access to the intracellular leaflet, to study other membrane-associated proteins. 
Furthermore, since the cytosolic component is removed, membrane sheets are a useful 
tool to study membrane proteins via fluorescence imaging studies, without the problem of 
cell autofluorescence (Perez et al. 2006). Membrane sheets constitute a more complex 
surrogate system, as the composition of the plasma membrane is completely native. 
V.2.4.1 EGFR activity on membrane sheets stimulated with 
ARNO 
To analyze the activation of EGFR on membrane sheets, different concentrations 
of EGF were tested. After membrane sheet preparation, the cover slips were pre-
incubated with buffer and phosphatase inhibitor. The receptor phosphorylation was 
analyzed with pTyrosine antibody specific for a tyrosine residue on the C-terminal tail of 
the receptor (Tyr1086). Fluorescence microscopy was used to quantify the 
phosphorylation level on membrane sheets. No increase in phosphorylation level was 
observed upon EGF addition (Figure 58). This phenomenon was due to the fact that the 
receptor presented a high phosphorylation level, previous to EGF addition. During the 
pre-incubation time, the receptor almost completely recovered its activation level.  
The experiment was repeated without pre-incubating the membrane sheets and 
adding ARNO in the stimulation mixtures, to observe if the protein had an effect on 
receptor activation (Figure 59). The addition of EGF allowed a two-time increase of the 
phosphorylation level of EGFR. Nevertheless, EGFR stimulation in membrane sheets is 
lower than the one measured in cellular systems (Bill 2011). Moreover, no enhancement 
of EGFR activation was observed upon ARNO addition.  
Another cell line was used for membrane sheet preparation and evaluation of the 
effect of ARNO. H460 membrane sheets were treated as in the previous experiment 
(Figure 60). The phosphorylation of EGFR doubled upon EGF stimulation, but no effect 
was observed on membrane sheets incubated with ARNO. 
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In all membrane systems no ARNO-dependent EGFR phosphorylation was 
observed. These results are contradictory with the data reported by Bill (2011), although 
it has to be considered that in Bill (2011) the cell-free experiments were performed with a 
soluble form of EGFR lacking any membrane-like environment. There is evidence that 
ARNO has an effect on EGFR phosphorylation in cell systems, but cell-free results were 
not able to be reproduced. In the cell-free systems only a low level of EGFR 
phosphorylation and no effect of ARNO on EGFR activation were detected. This can be 
explained by different factors: First, EGFR necessitates a co-factor that helps the 
activation and the interaction with ARNO, resembling the role of CNK1/cytohesin 
interaction for the IR pathway (Lim et al. 2010). Second, in cell-free models important 
regulatory systems of EGFR activity are missing. Protein phosphatases and endocytosis 
processes can also down-regulate EGFR activity. The equilibrium between inhibitory 
mechanisms and kinase activity regulates receptor phosphorylation (Segatto et al. 2011). 
In the latter case, the receptor in cell-free systems could already be in the proper 
conformation for activation and no enhancers are required to reach the fully activated 
state. 
V.2.4.2 EGFR clustering and co-localization with ARNO on 
membrane sheets 
Since an interaction between ARNO and EGFR was observed, albeit weak and 
transient in the previously illustrated experiment, the question was asked if ARNO was 
co-localizing at the plasma membrane with EGFR. Bill (2011) observed 60 % co-
localization between the two endogenous proteins on H460 membrane sheets. HeLa 
membrane sheets were incubated with Flag-ARNO or with buffer as control. The plasma 
membrane sheets were immunostained for endogenous EGFR (green) and for the added 
ARNO (red) (Figure 61). The overlay between EGFR and ARNO spots, indicated as 
“merge”, appeared yellow. The results were also interpreted using a scatterplot (Figure 
62) of the each sheets mean EGFR and mean ARNO intensities. Only when ARNO was 
incubated with the plasma membrane sheets, was a distribution along a straight line 
observed, indicating that increased EGFR levels correlated with an increased amount of 
bound ARNO. A random distribution (at ARNO background levels) was present when the 
membrane sheets were incubated buffer only. This correlation was quantified using the 
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Pearson’s correlation coefficient (PCC) of ARNO and EGFR mean intensities, showing a 
medium-high correlation (Figure 63).  
Independent from co-localization, another interesting phenomenon was observed. 
ARNO has an effect on EGFR clustering degree (Figure 64a). The relative standard 
deviation (RSD) is an indicator for the degree of clustering of EGFR molecules. The RSD 
for EGFR fluorescence was calculated in dependency on Flag-ARNO. The RSD 
decreased from 0.63 before ARNO addition, to 0.45 upon ARNO addition, indicating a 
reduction in the degree of clustering for EGFR. Since the RSD is also inversely 
proportional to the fluorescence intensity, the decrease of the RSD value may simply be 
caused by an increased EGFR intensity. Indeed, upon ARNO addition, EGFR intensity 
was increased by two times (Figure 64b). Therefore, ARNO may or may not decrease 
EGFR clustering, but it appears to make EGFR more accessible thereby giving a brighter 
EGFR fluorescence signal. In turn, this may indicate a less dense packing within clusters 
or a conformational rearrangement. The formation of EGFR agglomerates at the plasma 
membrane influences receptor activation (Ichinose et al. 2004). It is reported that pre-
formed EGFR dimers are present at the plasma membrane, without EGF stimulation 
(Moriki et al. 2001). A recent study described that EGFR clusters at the plasma 
membrane, due to the interaction between the JM domain and negatively charged 
phospholipids, like PIP2 (Wang et al. 2014). Taking that into account, it was evaluated if 
a PH mutated form of ARNO was still able to co-localize with EGFR at the plasma 
membrane (Figure 65). In the PH mutated ARNO construct the arginine residue in 
position 280 is substituted with a cysteine residue to impair the binding to PIPns on the 
cell membrane (Nagel et al. 1998b). The PH domain point mutation ARNO construct 
cannot interact with PIP2 on the membrane, and the scatterplot revealed a random 
distribution between the ARNO and EGFR staining intensities, compared to the wild-type 
ARNO construct (Figure 66). Quantification with PCC confirmed a drastic decrease in 
the co-localization value with EGFR for the PH mutant compared to wild-type ARNO. 
Interestingly, the PCC value for the PH mutant ARNO is still slightly higher than for the 
buffer control (Figure 67). Then, EGFR clustering upon addition of the two constructs 
was assessed (Figure 68a). Furthermore, since the RSD can be influenced by the overall 
fluorescence intensity (see above), the mean EGFR channel intensities were also recorded 
(Figure 68b). In Figure 68a, EGFR staining shows a high RSD value (0.64) in the absence 
of added ARNO, a slightly lower value for the PH mutant ARNO (0.55) and the lowest 
value for wild-type ARNO (0.4). This indicates that wild-type ARNO decreases EGFR 
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clustering (as measured by RSD) strongly, while PH mutant ARNO has a less pronounced 
effect. However, as described above, these results may also be interpreted as an increased 
accessibility of EGFR receptor upon ARNO addition, with a weaker effect for the PH-
domain point mutation. 
If compared with the buffer control, the PH mutant ARNO exhibited a low co-localization 
with EGFR at the plasma membrane. This can be due to the fact that a weak interaction 
between the Sec7 domain of ARNO and EGFR was still taking place. As this interaction 
is probably happening with a very high Kd, the accumulation at the plasma membrane via 
the PH domain could be indispensable for the interaction with the Sec7 domain. Another 
hypothesis is that ARNO requires a co-factor for the interaction with the receptor. 
Summarizing, ARNO PH domain is required for the membrane recruitment and also for 
strong co-localization with EGFR at the plasma membrane. The PH domain mutation, 
which disrupts the interaction with PIP2, significantly decreases the co-localization degree 
between the two proteins. 
Since fluorescence microscopy presents resolution limits, other high-resolution 
microscopy techniques are necessary to further investigate this problem. In particular, 
using STED (stimulated emission depletion) microscopy it would be possible to measure 
co-localization at smaller scales. In addition, STED microscopy would allow to measure 
EGFR cluster dimensions directly before and after ARNO addition, shining light on the 
issue of decreased EGFR clustering. Using different ARNO truncated constructs, the role 
of different ARNO domains for co-localization, interaction and clustering can also be 
investigated. Another way around, in order to understand which domain(s) of EGFR 
is/are responsible for the interaction with ARNO, competition experiments with soluble 
EGFR functional regions could be performed.  
Intriguingly, this implies a potentially new function of ARNO. In particular, the 
degree of EGFR clustering decreases in the presence of ARNO, and this effect depends 
on the ARNO PH domain. Wang et al. (2014) published that EGFR clustering is due to 
the interaction with anionic lipids. Furthermore they reported the presence of larger 
EGFR clusters in lung cancer cells compared to normal lung cells. EGFR clusters can be 
disrupted by PIP2 depletion. ARNO might have an indirect effect on receptor clustering, 
binding to PIP2 in EGFR proximity. This theory is supported by the fact that EGFR, in 
presence of the PH mutant, had a RSD value comparable to base level. The remaining 
small differences can be due to the fact that the Sec7 domain is still able to interact with 
EGFR and slightly influence clustering. Wang et al. (2014) proposed that a direct 
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interaction between the EGFR JM domain and PIP2 at the plasma membrane leads to an 
increase of receptor cluster dimensions, while Endres et al. (2013) and the related paper 
of Arkhipov et al. (2013), highlighted a strong interaction between anionic lipids and 
positive residues on the JM domain in the receptor inhibited conformation. A hypothesis 
is that a mutually supportive interaction between PIP2-JM, JM-ARNO Sec7 and PIP2-
ARNO PH can regulate EGFR activation, initially creating a PIP2 microenvironment, 
then allowing the interaction between Sec7 and the JM domain to occur and helping the 
displacement of the JM from the plasma membrane for the formation of the active 
asymmetric dimer.  
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VI. Conclusion 
VI.1 Which is the right membrane system? 
Plasma membranes are extremely heterogenic systems and in vitro models, and 
while accurate, they can never reach the native complexity. On the other hand, having 
simplified systems in which transmembrane proteins can be studied, represent one of the 
major goals of biochemical research in the past twenty years. Micelles are usually the first 
choice to solubilize membrane proteins. The type of detergent is often crucial and 
particular attention should be paid to the CMC to ensure proper micelle formation. 
However, since detergents may disrupt weak hydrophobic and, for ionic detergents, ionic 
interactions, micelles are not suited to study transient protein-protein interactions (Catoire 
et al. 2014).  
As plasma membranes are constituted of two phospholipids layers, bicelles 
represent a more native-like system in which transmembrane proteins can be studied. 
Bicelles can be easily prepared and they can self-assemble. Transmembrane proteins can 
be inserted into the bilayer and used for structural studies and they are accessible from 
both sides of the membrane. A disadvantage of bicelles is that the protein amount 
required is very high and often the desired protein yield is not reached. Moreover, to 
reconstitute a transmembrane protein into bicelles, lyophilization processes can be 
necessary. For complex globular proteins, enzymes or proteins with kinase activity, 
reconstitution from a lyophilized powder is especially challenging. 
Further, nanodiscs were used to study protein-lipid and protein-protein 
interactions. Nanodiscs possess several advantages: modulation of the phospholipid 
composition, size control depending on the MSP type, and reconstitution of protein in 
oligomeric state (Borch, Hamann 2009). Nevertheless, finding the optimal ratio between 
phospholipids and membrane scaffold proteins for the proper nanodiscs assembly and for 
the membrane protein insertion can be very challenging. Also, the purification processes 
to obtain the desired nanodisc products can be tedious and time-consuming.  
The last membrane system analyzed was plasma membrane sheets. Membrane 
sheets are the most in vivo like systems, suitable for protein interaction studies and 
fluorescence imaging. Starting from whole cells, the endogenous transmembrane proteins 
are still present. Membrane sheets can be incubated with exogenous proteins, or co-
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transfection of two different proteins of interest can also be performed. As membrane 
sheets are adhered with their basal membrane to the glass support, the study of proteins 
from the extracellular side can be difficult. 
Taking all of these considerations together, it is possible to deduce that the choice 
of the membrane system depends on the biochemical and biophysical assays that are 
required to investigate one particular membrane protein. Multiple assays may be used to 
fully evaluate a particular interaction. Different parameters have to be considered: the 
capacity of the transmembrane protein to resist to harsh conditions, such as detergents. 
Second, bilayer model systems can be preferable since they resemble the structure of the 
native membranes. Third, phospholipid bilayers allow the study of transmembrane 
proteins from both sides of the membrane. Furthermore, the expression, purification and 
reconstitution of desired transmembrane proteins into surrogate membranes can be 
difficult and time consuming. In this latter case, membrane sheets can be the appropriate 
system. For this reason, careful considerations of protein characteristics and of the design 
of experiments are always necessary. 
VI.2 A new function for ARNO? 
As part of a large research project into the role of ARNO in EGFR activation, this 
PhD project aimed to develop and implement in vitro systems to investigate the effects of 
ARNO on a molecular basis. Bill (2011) showed that ARNO increases the 
phosphorylation level of EGFR in living cells and for the soluble intracellular domain of 
EGFR. They propose that ARNO helps the formation of the asymmetric dimer. In all the 
experiments with in vitro systems reported here, the enhancement of EGFR activation 
upon ARNO addition was not observed.  
Nevertheless, albeit weak and difficult to detect, observations were made 
regarding the interaction between the two proteins, with different limitations arising on 
the type of membrane system used. The current explanation for this interaction is based 
on Sec7 domain binding to the JM domain of EGFR, based on work in Famulok’s 
research group showing that the JM region plays a relevant role in ARNO-EGFR 
interaction (personal communication from Benjamin Weiche, Anton Schmitz and Michael 
Famulok). 
Furthermore, a new possible effect of ARNO on EGFR in membrane sheets was 
observed. ARNO either decreases EGFR clustering, or, more likely, increases EGFR 
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accessibility. A point mutation in the ARNO PH domain reduces membrane recruitment 
of ARNO, and the effect of ARNO on EGFR clustering. However, the remaining effects 
indicate interactions involving the Sec7 domain of ARNO and the JM domain of EGFR 
that may be significant. Nevertheless, the effect is drastically reduced if compared with 
wild-type ARNO, stressing the importance of the PH domain in the modulation of EGFR 
clustering. Moreover, the ARNO-EGFR interaction may be needed to induce 
conformational changes helping receptor activation, to alter the PIP2 microenvironment, 
or to recruit other cytosolic co-factors. 
These findings open the way to understanding the mechanism by which ARNO 
functions as activator for EGFR. As previously described, EGFR receptor is highly 
involved in different cancer types. Identifying the mechanism of activation of EGFR is 
crucial for developing new possible anti-EGFR treatments. Further experiments to 
elucidate the molecular details for the interaction are now even more necessary.  
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VII. Material and Methods 
VII.1 Material 
VII.1.1 Equipment 
Equipment, type Manufacturer 
Analytical Balance  Sartorius, BP 211D 
Autoclave Systec 
Blotting Chamber, semi-dry BioRad 
Centrifuges Beckmann; Eppendorf 
Christ Alpha 2-4 LD Freeze Dryers SciQuip 
Electrophoresis apparatus BioRad 
FPLC, ÄKTA GE Healthcare Life Science 
French Press Thermo Scientific 
Gel dryer BioRad, Model 583 
Heating blocks Bachofer 
HPLC, Agilent 1100 Agilent Technologies 
Incubator (bacteria) Innova4430 Eppendorf 
Incubator (mammalian cells)  Binder 
Infinite M1000 Pro Tecan 
Microscope Nikon Eclipse TS100 Nikon 
Microscope Olympus IX81-ZDC (AG Lang) Olympus 
Microwave Bosch 
MST-Monolith NT.115 Nano Temper 
Nanoqant Infinite M200  Tecan 
Odyssey Imager Licorn 
Over‐head‐tumbler Heidolph 
Peristaltic Pump Mettler Toledo  
pH-Meter Mettler Toledo  
Pipette‐boy  Brand GmbH + Co.  
Pipettes Eppendorf 
Plate reader, Enspire PerkinElmer 
Protino Ni-NTA Columns 5 ml Macherey Nagel 
Q1R column 1 ml (IEX) Amersham Biosciences 
SDS‐PAGE equipment and chambers BioRad 
Sonifier  Bandelin Sonoplus 
Sterile hood (bacteria) Infors HT 
Sterlie hood (mammalian cells) Heraeus 
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Superdex 200 HR 10/30 column GE Healthcare Life Science 
UV/Vis Spectrophotometer  Thermo Spectronic 
Vacuum-Pump AC500 HLC 
Vortex Zx3 Velp Scientifica 
Water bath GFL 
Water purification system TKA-Lab 
VII.1.2 Chemicals and Reagents 
Reagent Manufacturer 
Acetic acid Roth 
Acetone Roth 
Acrylamide-Bisacrylamide solution (37.5:1) Roth 
Agarose Bio-Budget Technologies 
Alexa647-NHS  Invitrogen 
Ammoniumperoxidisulfat (APS)  Roth 
Biotin Sigma-Aldrich 
Bis(sulfosuccinimidyl)suberate (BS3) Thermo Scientific 
β-mercaptoethanol  Roth 
Bradford Assay reagent  BioRad 
Bromophenol blue  Merck 
BSA Sigma-Aldrich 
Chloroform  VWR Chemical 
Coomassie Brilliant Blue R250  Biorad 
Desthiobiotin Sigma-Aldrich 
Dimethylsulphoxide (DMSO)  Fluka 
Disuccinimidyl suberate (DSS) Thermo Scientific 
Dithiothreitol (DTT) Roth 
Ethylendiaminetetraacetic acid (EDTA)  AppliChem 
Ethanol  Roth 
Gel filtration standard mix BioRad 
Glycerol Roth 
Glycine Roth 
HEPES  Roth 
Hydrochloric acid VWR Chemical 
Imidazole  Roth 
Isopropanol  Roth 
Magnesium chloride  Acros organics 
Methanol Roth 
N,N,N’,N’-Tetramethylendiamine (TEMED)  Merck 
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PAGE Ruler Prestained Plus Thermo Scientific 
Protease Inhibitor Cocktail Roche 
Sodium bicarbonate  Merck 
Sodium chloride Roth 
Sodium cholate  Sigma-Aldrich 
Sodium dodecyl sulphate (SDS)  Roth 
Sodium orthovanadate AppliChem 
TEMED Roth 
TetraSpeck beads 100 nm Thermo Scientific 
Thimerosal AppliChem 
TMA-DPH Thermo Scientific 
Trifluoroacetic acid Roth 
Tris  Roth 
Triton X-100  AppliChem 
Tween20  AppliChem 
Uranylformate  SPI-Chem 
Urea Roth 
VII.1.3 Consumables 
Reagent Manufacturer 
Amberlite XAD-2 Supleco Analytical 
Amicon Ultra Centrifugal Filters Millipore 
Blotting papers Macherey-Nagel  
Capillaries for MST NanoTemper 
Cell culture dishes  TPP 
Cell culture flasks  TPP 
Cell culture plates TPP 
Centrifugation tubes (15 ml and 50 ml) Falcons or TPP 
Dialysis membrane Spectra/Por 
Disposable columns BioRad 
Disposable cuvettes Roth 
Glutathione agarose beads Protino 
Glutathione magnetic beads Pierce 
Hamilton Syringes Sigma-Aldrich 
Membrane filters Sigma-Aldich 
NAP-5 and NAP- 10 columns GE healthcare 
Ni-NTA beads Qiagen 
Nitrocellulose papers Wathman 
Parafilm Roth 
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Petri dishes  Faust 
Pipette tips Eppendorf and Peske 
Reaction tubes (1.5 ml and 2 ml) Eppendorf or Sarstedt 
Serological pipettes (2 ml, 5 ml, 10 ml, 25 ml, 50 ml) Sarstedt 
Strep-tactin magnetic beads (MagStrep “type 2HC”)  Iba 
Strep-tactin superflow high capacity Iba 
Syringes Braun 
VII.1.4 Cell culture  
VII.1.4.1 Cell culture reagents  
Reagents Manufacturer 
Agar Roth 
Ampicillin  Sigma-Aldrich 
Chloramphenicol Sigma-Aldrich 
DMEM PAN 
EGF Peprotech 
Fetal Calf Serum (FCS) Biochrom 
Glutamine PAN 
Isopropyl β-1-thiogalactopyranoside (IPTG) Carbolution Chemicals 
Kanamycin  Sigma-Aldrich 
LB Medium Roth 
MEM PAN 
Metafecten Biontex 
NEAA (100x) PAN 
PBS Dulbecco’s (1x) pH 7.4 PAN 
Penicillin/Streptomycin  PAN 
RPMI PAN 
Trypsin/EDTA (10x) PAN 
VII.1.4.2 Bacterial strains 
Bacterial strains Supplier 
E. coli BL21DE3 Famulok’s group (V. Fieberg) 
E. coli BL21DE3 (RIL) Agilent technologies 
XL10-Gold Agilent technologies 
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VII.1.4.3 Mammalian cell lines 
Mammalian cell lines Supplier 
H460 (human lung cancer cell) - adherent ATCC 
HeLa (human cervix cancer cell) - adherent ATCC 
VII.1.5 Phospholipids 
Phospholipid Manufacturer 
1,2-diheptanoyl-sn-glycero-3-phosphocholine 07:0 
(DHPC) 
Avanti Polar Lipids 
1,2-dihexanoyl-sn-glycero-3-phosphocholine 06:0 
(DHPC) 
Avanti Polar Lipids 
1,2-dimyristoyl-sn-glycero-3-phosphocholine 14:0 
(DMPC) 
Avanti Polar Lipids 
1,2-dimyristoyl-sn-glycero-3-phospho-L-serine 14:0 
(DMPS) 
Avanti Polar Lipids 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine 16:0 
(DPPC) 
Avanti Polar Lipids 
L-α-phosphatidylcholine (PC, Egg, Chicken) Avanti Polar Lipids 
L-α-phosphatidylethanolamine (PE, Liver, Bovine) Avanti Polar Lipids 
L-α-phosphatidylinositol-4,5-bisphosphate (PIP2, Brain, 
Porcine) 
Avanti Polar Lipids 
VII.1.6 Antibodies 
VII.1.6.1 Primary antibodies 
Antibody target Dilution v/v Manufacturer 
Apo-A1 sc-13549 (mouse) 1:1,000 Santa Cruz 
Cytohesin 1/ARNO sc-9727 (goat) 1:1,000 Santa Cruz 
EGFR sc-03 (rabbit) 1:1,000 
(1:100 for 
microscopy) 
Santa Cruz 
FLAG M2 (mouse) 1:500 Sigma-Aldrich 
GST sc-138 (mouse) 1:1,000 Santa Cruz 
Penta-His (mouse) 1:500 Thermo Fisher 
Phospho-Tyrosine sc-7020 (rabbit) 1:1,000 Santa Cruz 
Phospho-Tyrosine 1086 EGFR (rabbit) 1:100 Cell Signaling  
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VII.1.6.2 Secondary antibodies 
Antibody target  Dilution v/v Manufacturer 
Anti-goat (594 nm)  1:200 Life Technologies 
Anti-mouse (594 nm)  1:200 Life Technologies 
Anti-mouse (800 nm)  1:20,000 Licor 
Anti-rabbit (488 nm) 1:200 Life Technologies 
Anti-rabbit (594 nm)  1:200 Life Technologies 
Anti-rabbit (800 nm) 1:20,000 Licor 
Streptavidin-cojugated dye (800 nm) 1:20,000 Santa Cruz 
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VII.2 Methods 
VII.2.1 Protein Expression and Purification 
VII.2.1.1 Transformation of E. coli competent cells 
The desired plasmids were introduced into BL21DE3 or BL21DE3 (RIL) E. coli 
strains. The RIL E. coli strain has the advantage of expressing extra tRNA genes for a few 
rare codons (R: arginine, I: isoleucine and L: leucine), increasing the expression 
efficiencies of heterologous proteins. 
100 µl of chemically competent E. coli were thawed on ice for 10 minutes. 10 ng of DNA 
plasmid were added directly with the cells. The cells were incubated for 20 minutes on 
ice. Then, the cells were heat shocked for 1 minute at 42 °C and subsequently flash 
cooled on ice for 2 minutes. 500 µl of LB medium was added to the cells and the culture 
was grown for 1 hour at 37 °C, 1,000 rpm (rounds per minute). 
Then the cells were centrifuged for 2 minutes at 3,500 rpm, and almost all the supernatant 
was discarded, the cell pellet was resuspended in the remaining 100 µl of LB (Luria 
Bertani) medium. The culture was plated on an Agar plate containing the appropriate 
antibiotic. The plate was incubated overnight at 37 °C in the incubator. The day after, the 
plate was removed from the incubator and stored for a maximum of 1 month at 4 °C. 
Table 3: Bacterial media 
Medium Components 
LB medium 20 g LB broth/1 L water 
LB-Agar medium LB medium supplemented with 15 g/L Agar 
VII.2.1.2 Large-scale culture and preparation of glycerol stock 
E. coli cells containing the plasmid of interest were growth overnight at 37 °C in 
100 mL of LB medium, supplemented with the corresponding antibiotic. The small-
volume culture was transferred into 1 L LB medium and grown at 37 °C until an OD 
(opticl density) at 600 nm between 0.6 and 0.8 was reached. A small aliquot of cell 
culture was removed and mixed with an equal volume of glycerol medium for the long-
term storage at -80 °C. 
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Table 4: Storage Buffer for bacteria 
Medium Components 
Glycerol medium 50 mM Tris-HCl pH 7.8 
300 mM NaCl 
40 % Glycerol 
VII.2.1.3 Induction of protein expression and cell harvest 
Protein expression was induced by the addition of 1 mM IPTG (isopropyl β-D-1-
thiogalactopyranoside) to the culture medium. IPTG is a non-hydrolysable molecular 
mimic of allolactose. IPTG releases the Lac-Repressor from the Lac-Operon located in 
the E. coli genome and the T7 RNA polymerase is expressed. IPTG also releases the Lac-
Repressor from the T7 promoter on the expression plasmid. Thus, the T7 RNA 
polymerase can bind to the T7 promoter and protein expression is induced. 
All the construct reported in Table 5 were cloned by Doctor Anton Schmitz from 
Famulok’s group. pMSP1D1 was a gift from Stephen Sligar (Addgene plasmid # 20061). 
Expression conditions were set up for each construct, as reported in Table 5. After 
expression, the cell culture was harvested at 5,000 rpm for 20 minutes at RT (Beckman 
Centrifuge, JLA 8.100 rotor). Cell pellets were stored at -80 °C until further processing. 
Table 5: Plasmids list for expression in E. coli. (o/n: overnight) 
Constructs Temperature Induction 
Time 
Antibiotic 
µg/ml 
E. coli 
Strain 
pET28-HT-ARNO-Sec7 37 °C 5 h Kanamycin 50  DE3 
pET28-HTF-ARNO 20 °C o/n Kanamycin 50  DE3 
pET28-HTF-ARNO-
R280C (PH mutant) 
20 °C o/n Kanamycin 50  DE3 
pET28-ST-ARNO-PH 20 °C o/n Kanamycin 50  DE3-RIL 
pGEX6P-ARNO-Sec7 37 °C 5 h Ampicillin 100  DE3 
pIBA101-HT-ARNO 20 °C o/n Ampicillin 100  DE3-RIL 
pIBA101-HT-ARNO-
ΔPBR 
20 °C o/n Ampicillin 100  DE3-RIL 
pMSP1D1 37 °C 3 h Kanamycin 50  DE3-RIL 
pMSP1D1-mEGFP 37 °C 3 h Kanamycin 50  DE3-RIL 
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VII.2.1.4 Cell lysis 
E. coli cell pellets were thawed and resuspended in the appropriated lysis buffer 
supplemented with 1x Protease Inhibitor Cocktail. 
The resuspended cells were disrupted using the French press for two cycles with a 
maximum pressure of 1,200 PSI (pound-force per square inch, 82 bar) for E. coli cells. 
Lysate was clarified via centrifugation at 2,0000 rpm for 20 minutes at 4 °C (Beckman 
Centrifuge, JA 25.50 rotor). The supernatant, containing the soluble protein, was used for 
further purification steps. 
Table 6: Lysis buffers 
 
 
 
 
VII.2.1.5 Affinity Chromatography 
Affinity chromatography is a technique to purify proteins through the reversible 
interaction between an affinity tag and a coupled matrix. A variety of different coupled 
matrix and affinity tags are commercially available. 
VII.2.1.5.1 Nickel-NTA Affinity Chromatography 
For the purification of the constructs reported in Table 5, containing a His-tag, a 
Ni-NTA Agarose matrix was used. His-tag interacts with Ni-NTA Agarose beads. 
Nitrilotriacetic acid (NTA) is a chelating agent and forms four coordination sites with 
Nickel molecules. Nickel molecules can form two reversible coordination sites with 
histidine residues of tagged proteins. Protein elution is achieved by adding a competitor, 
such as imidazole.  
The supernatant after cell lysis was incubated for 1 hour at 4 °C and overhead 
tumbled with the appropriate amount of Ni-NTA Agarose beads. The amount of beads 
used were set on a case to case basis (generally 1 mL beads was used).  
Buffer Components 
ARNO constructs - Lysis buffer 50 mM Tris-HCl pH 7.8 at 4 °C 
300 mM NaCl 
5 % v/v Glycerol 
MSP constructs - Lysis buffer 40 mM Tris-HCl pH 8.0 at 4 °C  
300 mM NaCl 
1% v/v Triton X-100 
20 mM Imidazole  
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After incubation, the beads coupled with the protein of interest were separated 
from the supernatant by centrifugation at 1,500 rpm for 10 min at 4 °C. The beads were 
washed with washing buffer, and transferred to a disposable column. Three washing steps 
were performed. The protein was eluted by adding one beads-volume of elution buffer to 
the beads. The elution buffer was incubated with the beads for 10 minutes. The flow-
through was then collected from the disposable column using a peristaltic pump. Three 
elution steps were generally performed. Samples from each purification steps were 
collected for SDS-PAGE analysis. 
Table 7: Purification buffers for His-tagged constructs 
 
 
 
 
 
 
 
 
VII.2.1.5.2 Strep-tactin Affinity Chromatography 
Strep-tactin is a derivate of streptavidin and binds to the streptavidin binding 
peptide (SBP)-tag. 600 µL strep-tactin beads were equilibrated with 25 mL lysis buffer. 
The supernatant containing the protein was then incubated with the beads for 1 hour at 4 
°C. After incubation, the beads were sedimented at 1,500 rpm for 10 minutes at 4 °C. 
Buffer Components 
ARNO constructs - Washing buffer 50 mM Tris-HCl pH 7.8 
300 mM NaCl 
20 mM Imidazole 
5 % v/v Glycerol 
ARNO constructs - Elution buffer 50 mM Tris-HCl pH 7.8 
300 mM NaCl 
350 mM Imidazole 
5 % v/v Glycerol 
MSP constructs - Washing buffer I 40 mM Tris-HCl pH 8.0 at 4 °C  
300 mM NaCl 
1% v/v Triton X-100 
20 mM Imidazole 
MSP constructs - Washing buffer II 40 mM Tris-HCl pH 8.0 at 4 °C 
300 mM NaCl 
50 mM cholate 
20 mM Imidazole 
MSP constructs - Washing buffer III 40 mM Tris-HCl pH 8.0 at 4 °C 
300 mM NaCl 
50 mM Imidazole 
MSP constructs - Elution buffer 40 mM Tris-HCl pH 8.0 at 4 °C 
300 mM NaCl 
500 mM Imidazole 
Material and Methods 
 
127 
Supernatant was discarded and the beads were transferred into a disposable column. The 
beads were washed with the wash buffer. One beads-volume of elution buffer was used. 
Elution buffer was incubated with the beads for 10 minutes on ice. The eluate was 
collected with the help of a peristaltic pump. Three elution steps were performed. 
Purification fractions were analyzed by SDS-PAGE and Western Blot. 
Table 8: Purification buffers for SBP-tagged constructs 
 
 
 
VII.2.1.5.3 Glutathione Affinity Chromatography 
Glutathione agarose beads were used for the purification of GST-ARNO Sec7 
construct. Glutathione beads bind to the GST-tag present at the N-terminal part of the 
construct. Glutathione-S-transferase Glutathione S-transferase (GST) is a dimeric protein. 
The GST-tag is composed of 220 amino acid residues, and it is often used to increase 
protein solubility. 2 mL of glutathione beads were incubated with the cell lysate for 1 
hour at 4 °C. The same steps reported in Section VII.2.1.5.1 were performed to purify the 
protein. 
Table 9: Purification buffers for GST-tagged construct 
Buffer Components 
Wash buffer 50 mM Tris-HCl pH 7.8 at 4 °C 
300 mM NaCl 
5 % v/v Glycerol 
Elution buffer 50 mM Tris-HCl pH 7.8 at 4 °C 
300 mM NaCl 
5 % v/v Glycerol 
10 mM glutathione 
Buffer Components 
Wash buffer 50 mM Tris-HCl pH 7.8 at 4 °C 
300 mM NaCl 
5 % v/v Glycerol 
Elution buffer  50 mM Tris-HCl pH 7.8 at 4 °C 
300 mM NaCl 
5 % v/v Glycerol 
2.5 mM desthiobiotin 
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VII.2.1.6 TEV digestion  
For certain experimental applications, the affinity tag of the purified proteins was 
removed. The constructs reported in Table 5 contain a tobacco etch virus (TEV) cleavage 
site between the affinity tag and the protein of interest. A molar ratio of TEV to protein of 
1 to 50 was used. The TEV digestion was performed overnight in the dialysis buffer. 
After overnight dialysis, the protein was centrifuged at 5,000 rpm, for 10 minutes 
at 4 °C to remove the precipitate. The supernatant was applied onto a Ni-NTA matrix to 
remove the uncleaved protein and the His-tagged TEV protease. 
Fractions of the flow-through containing the cleaved protein, the wash and elution 
fractions were collected and analyzed by SDS-PAGE. The fractions containing the 
cleaved protein were pooled together, divided into aliquots and stored at -80 °C. 
Table 10: Dialysis buffers 
 
 
 
 
VII.2.1.7 FPLC-gel filtration chromatography 
A final purification step via FPLC-gel filtration is often necessary to remove 
impurities from the final protein product. Gel filtration is a technique that allows the 
separation of molecules according to their hydrodynamic volume. Generally Superdex or 
Sepharose matrix are used. These matrixes contain pores of different size. Small 
molecules can pass through the pores, while bigger molecules are excluded. In this way, it 
is possible to separate high molecular weight molecules, that are eluted earlier, from 
small size molecules. HiLoadTM 16/600 SuperdexTM 200 (GE Healtcare) column or 
HiLoadTM 16/600 SuperdexTM 75 (GE Healtcare) were used. Gel filtration columns were 
equilibrated with 3 column volumes of gel filtration buffer. 1 mL protein sample was 
applied onto the column. Elution fractions were collected and analyzed by SDS-PAGE 
and protein concentration was measured with UV-Absorption at 280 nm. Only the most 
pure fractions and with the highest protein concentrations were pooled together, further 
Buffer Components 
ARNO constructs - Dialysis buffer 20 mM Tris-HCl pH 7.8 at 4 °C 
150 mM NaCl 
5 % Glycerol 
MSP constructs - Dialysis buffer 20 mM Tris-HCl pH 7.4 at 4°C 
100 mM NaCl 
0.5 mM EDTA 
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concentrated with Vivaspin concentrators (Sartorius) or Amicon concentrators 
(Millipore), aliquoted and stored at -80 °C. 
Table 11: Gel filtration buffers 
 
VII.2.1.8 Expression and Purification of protein from inclusion 
bodies 
Inclusion bodies are insoluble protein aggregates that accumulate in the cytoplasm 
of the host cell. The expression of hydrophobic heterologous protein in E. coli often leads 
to the formation of inclusion bodies, especially if the amount of expressed protein is high. 
For the purification of the proteins from inclusion bodies, the use of high concentration of 
denaturants, such as urea, is necessary (Singh et al. 2015).  
VII.2.1.8.1 Purification of EGFR-TMJM constructs 
The constructs reported in Table 12 were cloned by Doctor Anton Schmitz from 
Famulok’s group. 
  
Buffer Components 
ARNO constructs - gel filtration buffer 20 mM Tris-HCl pH 7.8 at 4 °C 
150 mM NaCl 
5 % Glycerol 
MSP constructs - gel filtration buffer 20 mM Tris-HCl pH 7.4 at 4°C 
100 mM NaCl 
0.5 mM EDTA 
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Table 12: Plasmids list for expression in E. coli as unsoluble proteins. (o/n: overnight) 
 2 L of culture which was made into a cell pellet was resuspended in 20 mL lysis buffer 
on ice. Cells were made into a lysate form with French Press for three times at maximum 
1,200 psi. Cell lysate was clarified with centrifugation for 20 minutes, 20,000 rpm at 4 °C 
(Beckman Centrifuge, JA 25.50 rotor). The supernatant was discarded and the cell pellet 
was washed three times with 20 mL washing buffer. Between each washing step, the cell 
pellet was resuspended and centrifuged again. 
Cell pellet was then stirred for 1 hour at room temperature (RT) with the extraction 
buffer. The cell suspension was centrifuged for 20 minutes, 20,000 rpm at RT (Beckman 
Centrifuge, JA 25.50 rotor). The supernatant was incubated for 1 hour with Ni-NTA 
beads at RT. The protein was eluted three times in the elution buffer. Urea was removed 
overnight via dialysis against water. Protein precipitate was collected and lyophilized 
(Christ Alpha 2-4 LD Freeze Dryers). Lyophilized protein was stored at -20 °C. 
  
Constructs Temperature Induction 
Time 
Antibiotic 
µg/ml 
E. coli 
Strain 
pET28-6H2W-EGFR-
TMJM-SBP 
37 °C o/n Kanamycin 50  DE3 
pET28-6H2W-EGFR-
TMJM-sc1-SBP 
37 °C o/n Kanamycin 50  DE3 
pET28-6H2W-EGFR-
TMJM-sc2-SBP 
37 °C o/n Kanamycin 50  DE3 
pET28-HT-IR-TMJM-
SBP 
37 °C o/n Kanamycin 50  DE3 
pET28-HST-EGFR-
TMJM 
37 °C o/n Kanamycin 50  DE3 
pET28-HST-IR-TMJM 37 °C o/n Kanamycin 50  DE3 
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Table 13: Buffers for protein purification form inclusion bodies 
Buffer Components 
Lysis buffer 50 mM Tris-HCl pH 8.0 at 4 °C 
100 mM NaCl 
Wash buffer 50 mM Tris-HCl pH 8.0 at 4 °C 
100 mM NaCl 
1 M Urea 
0.5 % Triton X-100 
Extraction buffer 50 mM Tris-HCl pH 8.0 at RT 
300 mM NaCl 
8 M Urea 
0.2 % SDS 
Purification buffer 50 mM Tris-HCl pH 8.0 at RT 
300 mM NaCl 
8 M Urea 
0.2 % Sodium Cholate 
20 mM Imidazole 
Elution buffer 50 mM Tris-HCl pH 8.0 at RT 
300 mM NaCl 
8 M Urea 
0.2 % Sodium Cholate 
350 mM Imidazole 
Dialysis buffer 20 mM HEPES pH 8.0 at 4 °C 
100 mM NaCl 
0.5 mM EDTA 
0.2 % Sodium Cholate 
VII.2.1.9 Protein purification from Sf9 insect cells 
VII.2.1.9.1 Expression of lz-EGFR-TS and cell harvest 
pFB-lzEGFR-TS was expressed in baculovirus-infected Sf9 (Spodoptera 
frugiperda) insect cells from Yvonne Aschenbach (Famulok’s group). The construct was 
designed by Dr. Anton Schmitz. Infection was performed for three days at 21 °C. Insect 
cells were harvested at 2,000 rpm for 15 minutes at 4 °C (Beckman Centrifuge, JLA 
8.100 rotor). 
VII.2.1.9.2 Purification of lz-EGFR-TS 
1.5 L cell pellet was resuspended in 25 mL lysis buffer supplemented with 1x 
Protease Inhibitor Cocktail. Cell lysate was incubated for 30 minutes on ice. Cells were 
passed through the French Press for two cycle at maximum 1,000 PSI (69 bar). Cell lysate 
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was centrifuged at 14,000 rpm for 20 minutes at 4 °C (Beckman Centrifuge, JA 25.50 
rotor). Supernatant was incubated with 2 mL Strep-tactin beads. The purification was 
performed as reported in Section VII.2.1.5.2.  
The construct has a C-terminal SBP-tag that was used for the purification. 2 mL Strep-
tactin beads were equilibrated with 25 mL lysis buffer. The supernatant containing lz-
EGFR-TS protein was then incubated with the beads for 1 hour at 4 °C. After incubation, 
the beads were sedimented at 1,500 rpm for 10 minutes at 4 °C. Supernatant was 
discarded and the beads were transferred into a disposable column. The beads were 
washed three times with the wash buffer. 2 mL elution buffer was incubated with the 
beads for 10 minutes on ice. The eluate was collected with the help of a peristaltic pump. 
Three elution steps were performed. Purification fractions were analyzed by SDS-PAGE 
and Western Blot. 
Table 14: Purification buffers for protein expressed in Sf9 cells 
Buffer Components 
Lysis buffer 20 mM Tris-HCl pH 8.0 at 4 °C 
400 mM NaCl 
10% v/v Glycerol 
0.1 % v/v Triton X-100 
1 mM EDTA 
Wash buffer 20 mM Tris-HCl pH 8.0 at 4 °C 
400 mM NaCl 
10% v/v Glycerol 
0.1 % v/v Triton X-100 
1 mM EDTA 
Elution buffer 20 mM Tris-HCl pH 8.0 at 4 °C 
400 mM NaCl 
10% v/v Glycerol 
0.1 % v/v Triton X-100 
1 mM EDTA 
2.5 mM desthiobiotin 
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VII.2.2 Determination of protein concentration 
VII.2.2.1 Absorption 
Protein concentration can be calculated using the absorption at 280 nm of amino 
acids containing an aromatic ring. The concentration was calculated using the Lambert-
Beer Law: 
 𝐴280 =  ɛ × c ×  l 
ɛ = extinction coefficient (mol-1 * cm-1) 
c = protein concentration (mol/L) 
l = path length (cm) 
VII.2.2.2 Bradford Assay 
The Bradford assay was performed using the BioRad Bradford reagent. The assay 
is based on the color shift of the Coomassie Brilliant Blue G-250 dye from 465 nm to 595 
nm upon protein binding. 
BioRad Bradford reagent was diluted 1:5 in water. Different BSA concentrations were 
used as standards. 2 µl of protein were mixed with 150 µl of diluted Breadford reagent. 
Absoption at 595 nm was measured using Varioskan plate reader. 
VII.2.3 Analysis of purified proteins 
VII.2.3.1 SDS-PAGE 
SDS-polyacrylamide gel electrophoresis (PAGE) was performed according the 
protocol of Laemmli (Laemmli 1970). SDS (sodium dodecyl sulphate) is an anionic 
detergent used to confer a negative net charge to the proteins. Proteins can be separate 
according to their size, moving from the negative to the positive pole, when an 
appropriate voltage is applied. Biphasic gels with a thickness of 1 mm were used. A 4 % 
stacking gel was casted on the upper part of the gel and a separating gel on the lower part. 
Different percentage of bis-acrylamide were used to cast the separating gel, depending on 
the molecular weight of the analyzed proteins. The gel mixture was prepared according to 
Material and Methods 
 
134 
Table 16. Polymerization was started upon addition of APS (ammonium persulfate) and 
TEMED (tetramethylethylenediamine). 
Protein samples were mixed with 1x sample buffer and boiled at 95 °C for 5 minutes. 5 µl 
samples and a molecular weight pre-stained protein standard were loaded onto the gel. 
Gels were run in BioRad gel chambers at 200 Volt in 1x running buffer. Gels were run 
until the bromophenol blue contained in the sample buffer had reached the lower part of 
the gel. Gels were further analyze by Coomassie staining or used for Western Blot. 
Table 15: Buffers for gel and sample preparation for SDS-PAGE 
 
 
 
 
 
 
Table 16: Recipe for SDS-PAGE preparation 
1 gel Separating  
Gel 
Stacking 
Gel 
 6 % 7.5 % 8 % 10 % 12.5 % 15 % 4 % 
acrylamide 1000 
µL 
1250 
µL 
1333 
µL 
1667 
µL 
2083 
µL 
2500 
µL 
213 µL 
water 2712 
µL 
2462 
µL 
2379 
µL 
2045 
µL 
1629 
µL 
1212 
µL 
975 µL 
4x separating gel 
buffer 
1250 µL - 
4x stacking gel 
buffer 
- 400 µL 
TEMED 8 µL 2 µL 
APS 30 µL 10.4 µL 
VII.2.3.2 Coomassie Staining 
SDS-PAGE gels were covered with Coomassie staining solution and incubated at 
room temperature for at least 30 minutes. Coomassie staining solution was then removed, 
Buffer Components 
4x Stacking Gel buffer 60.6 g/L Tris-HCl pH 6.8 
4 g/L SDS 
4x Separating Gel buffer 181.7 g/L Tris-HCl pH 8.8 
4 g/l SDS 
6x Sample buffer 50 mM Tris pH 6.8 
30 % Glycerol 
15 % w/v SDS 
600 mM DTT 
Bromophenol blue 
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and the gel was destained overnight in the destaining solution. Gels were scanned using 
Odyssey Image Scanner (Licor). 
Table 17: Buffers for protein gel staining  
 
 
VII.2.3.3 Western Blot 
After SDS-PAGE, proteins were transferred onto a nitrocellulose membrane 
according to the Kyhse-Andersen protocol (Kyhse-Andersen 1984). A semi-dried blot 
was performed. The nitrocellulose membrane was equilibrated in anode II buffer, while 
the gel was equilibrated in cathode buffer. The gel and the nitrocellulose membrane were 
then piled with filter papers (Machery-Nagel) as reported in Figure 69. The transfer was 
performed applying 2 mA/cm2 of gel for 45 minutes. 
 
Figure 69: Western Blot transfer schema 
Then, the nitrocellulose paper was incubated for 1 hour at room temperature with 
the blocking solution. The primary antibody was then applied onto the membrane for 1 
hour at room temperature. The membrane was washed 3 times for 5 minutes with TBS-T 
and incubated overnight with the secondary antibody at 4 °C. Primary antibodies were 
diluted in 5 % BSA/TBS-T with 1:500 Thimerosal. Antibody dilutions are reported in 
Section VII.1.6. The secondary antibodies anti-mouse (800 nm) and anti-rabbit (800 nm) 
were diluted 1:20,000 in in 5 % BSA/TBS-T with 1:500 Thimerosal. 
Buffer Components 
Coomassie staining 30 % v/v methanol 
10 % v/v acetic acid 
700 mg/L Coomassie Brilliant Blue G-250 
Coomassie destaining 30 % v/v methanol 
10 % v/v acetic acid 
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Table 18: Western Blot buffers 
Buffer Components 
Anode buffer I 300 mM Tris-HCl pH 10.4 
Anode buffer II 25 mM Tris-HCl pH 10.4 
Cathode buffer 25 mM Tris-HCl pH 9.4 
40 mM glycine 
TBS-T 20 mM Tris-HCl pH 7.6 
136 mM NaCl 
Tween20 0.1 % v/v 
Blocking buffer 5 % w/v BSA in TBS-T 
VII.2.4 Bicelles 
Bicelles are mixtures of short-chain and long-chain phospholipids. Bicelles 
arrange in solution to form phospholipids bilayers and are suitable for the insertion of 
membrane proteins. 
VII.2.4.1 Bicelles assembly 
DMPC (1,2-dimyristoyl-sn-glycero-3-phosphocholine) or DPPC (1,2-dipalmitoyl-
sn-glycero-3-phosphocholine) were mixed with DHPC (1,2-dihexanoyl-sn-glycero-3-
phosphocholine). One of the most important parameters for bicelles assembly is the q 
factor. The q factor is the molar ratio between DMPC or DPPC and DHPC.  
DMPC/DHPC or DPPC/DHPC were mixed together as a powder in a round-shaped glass 
vial. The q factor was set at 0.25. A pH around 7 is recommended to reduce oxidation 
processes. The final concentration of phospholipids was 46 mM in 10 mM phosphate 
buffer pH 7.2. The phospholipids were vortexed for 1 minute at room temperature and 
then incubated at 4 °C for 15 minutes. The mixture was warmed up in a water bath at 38 
°C for 20 minutes and vortexed again for 5 minutes. This cool-warm process was 
repeated for three cycles, until the mixture appeared clear. Bicelles formation was 
controlled with DLS.  
VII.2.4.2 Dynamic Light Scattering (DLS) 
DLS was performed in the group of Professor Gerd Bendas, University of Bonn. 
A Nanotrac Ultra (Microtrac) dynamic light scattering system was used. Prior to DLS 
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analysis, samples were centrifuged at 14,000 rpm for 10 minutes at 4 °C in a table top 
centrifuge, to remove aggregates. For the sample preparation for DLS measurement, the 
final concentration of DHPC has to be above 7 mM, otherwise bicelles are not stable and 
disassemble. DHPC was supplemented into the dilution buffer. Diameters and the percent 
of monodisperse populations in solution were calculated using FLEX Software. 
VII.2.4.3 Incorporation of EGFR-TMJM constructs in bicelles 
His-EGFR-TMJM-SBP and the scrambled version 1 and 2 were added as 
lyophilized powder (3 mg) to the already formed bicelles. Upon protein addition, the 
mixture was incubated for 15 min at 4 °C. Subsequently, the mixture was incubated in 
water bath at 38 °C for 20 minutes, vortexed and centrifuged in a table-top centrifuge for 
10 minutes at 14,000 rpm at room temperature. The supernatant with the protein 
incorporated in bicelles was stored at 4 °C and used within a week. To calculate the 
amount of protein incorporated in bicelles, absorption at 280 nm was measured. Empty 
bicelles were used as blank. Bicelles formation was controlled with DLS. Incorporation of 
His-EGFR-TMJM-SBP into bicelles was controlled by SDS-PAGE. 
VII.2.5 Nanodiscs  
Nanodiscs are phospholipids bilayers surrounded by two amphiphilic helical 
molecules, termed membrane scaffold proteins (Bayburt et al. 2002; Bayburt, Sligar 
2003). Different phospholipids were used for the assembly of nanodiscs, as reported in 
Section VII.1.5. Membrane scaffold protein was purified as described in Paragraph 
VII.2.1. 
VII.2.5.1 Preparation of nanodiscs reconstitution mixture 
VII.2.5.1.1 PCPE- and PIP2-nanodiscs preparation 
For the preparation of nanodiscs L-α-phosphatidylcholine (PC, egg, chicken), L-α-
phosphatidylethanolamine (PE, liver, bovine), and L-α-phosphatidylinositol-4,5-
bisphosphate (PIP2, brain, porcine) were used. Two different nanodisc compositions were 
prepared, as reported in Table 19. 
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Table 19: PCPE- and PIP2-nanodiscs composition 
Nanodiscs were prepared following the Sligar’s protocol (Bayburt, Sligar 2010). 
Phospholipids were dissolved in chloroform: PC at 20 mM and PE at 10 mM 
respectively. PIP2 was dissolved in chloroform/methanol/water (20:9:1, 1 mM). Hamilton 
syringes were used to take the desired volume of phospholipids. Phospholipids were 
transferred in round-bottom vials and chloroform was dried under-vacuum overnight. A 
lipid thin layer was formed by rotating the vial during the drying process. For PIP2-
containing mixture, during the evaporation process the vial was immersed in a water bath 
at 34 °C for 5 minutes to increase PIP2 homogenization. Phospholipid film was 
solubilized at the final concentration of 50 mM in 100 mM sodium cholate buffer.  
Table 20: Buffers for the preparation of nanodiscs containing natural phosholipids 
 
 
 
 
 
The sodium cholate concentration was twice the concentration of lipid. The 
phospholipid thin layer was vortexed, warmed up and sonicated until the mixture 
appeared clear.  
The appropriate amount of cholate-solubilized phospholipids and membrane 
scaffold protein were mixed. Typically a 1:30 MSP1D1:phospholipids molar ratio for 
PCPE-nanodiscs and PIP2-nanodiscs was used. The sodium cholate in the final mixture 
had to be above the critical micellar concentration (CMC), between 12 mM and 40 mM. 
The MSP:phospholipids ratio is critical for the properly nanodiscs formation. 
The nanodisc reaction mixtures were incubated for at least 15 minutes at 4 °C. The 
assembly process took place upon detergent removal. Amberlite XAD-2 beads (Sigma) 
Nanodisc Phospholipid MSP1D1:phospholipids  
molar ratio 
PCPE-
nanodiscs 
80 mol % L-α-phosphatidylcholine 
20 mol% L-α-phosphatidylethanolamine 
1:30 
PIP2-
nanodiscs 
75 mol % L-α-phosphatidylcholine 
20 mol % L-α-phosphatidylethanolamine 
5 mol % L-α-phosphatidylinositol-4,5-
bisphosphate 
1:30 
Buffer Components 
MSP standard buffer 20 mM Tris-HCl pH 7.4 at 4°C 
100 mM NaCl 
0.5 mM EDTA 
Sodium cholate buffer 100 mM Sodium cholate  
in MSP standard buffer 
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were used. Typically 0.5-0.8 g damp beads per ml mixture were used. Beads were washed 
twice with 1 ml methanol, water and MSP standard buffer. Phospholipids-cholate-
MSP1D1 mixture was incubated overnight with the Amberlite beads at 4 °C and overhead 
tumbled. 
Beads were then removed with two centrifugation steps in a table-top centrifuge at 
maximum speed at 4 °C. Nanodiscs formation was confirmed by gel filtration analysis on 
a Superdex 200 10/300 GL column (GE Healthcare) and with dynamic light scattering 
(DLS, Nanotrac, Microtrac). Nanodiscs were stored at 4 °C and used within a week. 
VII.2.5.1.2 DMPC- and DPPC-nanodiscs preparation 
For the preparation of nanodiscs with synthetic lipids 1,2-dimyristoyl-sn-glycero-
3-phosphocholine (DMPC) or 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) were 
used. DMPC and DPPC were dissolved in chloroform at 50-100 mM for storage. Two 
different nanodiscs compositions were prepared, as reported in Table 21. 
Table 21: DMPC- and DPPC-nanodiscs composition 
For the preparation of DMPC- and DPPC-nanodiscs the same steps as reported in Section 
VII.2.5.1.1 were performed. Briefly, the desired amount of phospholipids was dried for 3 
hours under vacuum. The phospholipid film was rehydrated in phospholipid rehydration 
buffer at the final concentration of 10 mM. The MSP1D1:phospholipids molar ratio was 
set to 1:60 for DMPC and 1:70 for DPPC. In 200 µL assembly reaction, 10 µM MSP1D1 
was incubated with 600 µM DMPC or 700 µM DPPC in the assembly buffer. 
  
Nanodisc Phospholipid MSP1D1:phospholipids  
molar ratio 
DMPC-
nanodiscs 
1,2-dimyristoyl-sn-glycero-3-
phosphocholine 
1:60 
DPPC-nanodiscs 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine 
1:70 
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Table 22: Buffers for the preparation of nanodiscs containing synthetic phosholipids 
Buffer Components 
Phospholipid rehydration buffer 10 mM Tris-HCl pH 7.4 at RT 
100 mM NaCl 
20 mM Triton X-100 
Assembly buffer 10 mM Tris-HCl pH 7.4 at RT 
100 mM NaCl 
1 mM Triton X-100 
The phospholipids-detergent-MSP1D1 mixtures were incubated for 1 hour at 25 °C for 
DMPC and 37 °C for DPPC, respectively. The mixtures were incubated overnight with 
Amberlite beads at 4 °C and overhead tumbled. Beads were removed and nanodiscs 
assembly was checked with gel filtration and DLS. Nanodiscs were stored at 4 °C and 
used within a week. 
VII.2.5.2 Incorporation of membrane proteins into nanodiscs 
For the incorporation of membrane proteins into nanodiscs the MSP to target 
protein ratio, the detergent and the assembly temperature are important parameters. It is 
suggested to establish the conditions to assembly “empty” discs and then to proceed with 
the insertion of membrane proteins.  
VII.2.5.2.1 Insertion of lz-EGFR-TS in nanodiscs 
Lz-EGFR-TS (for purification see Section VII.2.1.9.2) was incorporated into 
DPPC-nanodiscs. The MSP1D1 to phospholipids ratio was set to 1:70. The protocol was 
adapted from Mi et al. (2008). In 200 µL assembly reactions, 10 µM MSP1D1, 700 µM 
DPPC and 1 µM lz-EGFR-TS were mixed together at 45 °C for 1 hour. The final Triton 
X-100 concentration was kept between 2.0 mM and 2.5 mM. The final assembly steps 
were performed as reported in Section VII.2.5.1.2. To verify the insertion of the 
transmembrane protein, a negative control preparation was mixed. 200 µL mixtures 
containing 700 µM DPPC and 1 µM lz-EGFR-TS or 10 µM MSP1D1 and 1 µM lz-
EGFR-TS were prepared. The same steps as for the nanodiscs assembly were repeated. 
Proper nanodiscs formation was checked by analytical SDS-PAGE. 
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VII.2.5.2.2 Insertion of His-EGFR-TMJM-SBP in nanodiscs 
For the incorporation of His-EGFR-TMJM-SBP into nanodiscs, DMPC or DPPC 
were used. The phospholipid films were rehydrated in sodium cholate buffer at the final 
concentration of 50 mM. The volumes of solubilized phospholipids, MSP1D1, 
transemembrane protein and buffer for the reconstitution mixtures were calculated. The 
MSP:phopholipids ratios reported in Table 21 were used. The molecular ratio of MSP1D1 
to His-EGFR-TMJM-SBP was set to 3:1. The same assembly protocol reported in Section 
VII.2.5.2.1 was used.  
VII.2.5.3 Analysis of nanodiscs assembly 
VII.2.5.3.1 Dynamic Light Scattering (DLS)  
DLS was performed in the group of Professor Gerd Bendas, University of Bonn. 
A Nanotrac Ultra (Microtrac) dynamic light scattering system was used. DLS was 
performed as reported in Section VII.2.4.2. Samples were diluted 1:10 in MSP standard 
buffer and applied into the sample cell.  
VII.2.5.3.2 Analytical FPLC-gel filtration chromatography 
Analytical gel filtration was performed on a Superdex 200 10/300 GL column (GE 
Healthcare) in MSP standard buffer with a flow rate of 0.4 mL/min. 100 µL nanodisc 
sample was injected. BioRad protein standard was used as a molecular weight reference. 
Nanodisc fractions of 0.2 mL were collected and analyzed by 12.5 % SDS-PAGE. 
VII.2.5.3.3 Analytical SDS-PAGE 
SDS-PAGE was performed as reported in Section VII.2.3.1. To evaluate the 
incorporation of lz-EGFR-TS into nanodiscs an analytical 12.5% SDS-PAGE was 
performed. To calculate the amount of transmembrane protein embedded into nanodiscs, 
a titration gel was performed. 10 µL of purified lz-EGFR-TS protein was loaded onto the 
gel. The following protein concentrations were used: 1 µM, 750 nM, 500 nM, 200 nM 
and 100 nM. 
VII.2.5.3.4 Negative Staining Electron Microscopy (EM) 
For the preparation of the samples for negative staining, a modified protocol from 
Ohi et al. (2004) was used. Briefly, a 0.75% uranylformate staining solution was prepared 
dissolving 0.0375 g uranylformate in 5 ml boiling ddH2O by stirring for 5 minutes in the 
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dark. Subsequently, 6 µl of 5 M NaOH solution were added to the mixture and it was 
stirred again for 5 minutes in the dark. The prepared solution was then filtered through a 
0.22 µm filter to remove insoluble particles. A glow-discharged carbon-coated electron 
microscopy (EM) grid was prepared using a plasma cleaner (Diener, Femto). Then, the 
sample was adsorbed on the grid and washed with two drops of double deionized H2O 
and two drops of the heavy metal solution. The excess of fluid was removed with filter 
paper. The sample was completely dried using a suction pump. Samples can be stored dry 
for at least one year. 
Nanodiscs after gel filtration in EM Buffer were let adhere on the EM grid. 
Nanodiscs were imaged with a JEM-2200 FS (JEOL) Microscope. Images were taken 
with a TemCam-F416 (TVIPS) camera. 
Table 23: Electron Microscopy buffer 
Buffer Components 
EM buffer 10 mM Tris-HCl pH 7.4 at 4 °C 
25 mM KCl 
0.5 mM EDTA 
VII.2.6 Membrane Sheets  
VII.2.6.1 Cell culture 
Cells were grown at 37 °C with 5 % CO2 in 75 cm
2 flasks. Cells were split every 3 
days or when a confluence of 70-90 % was reached. HeLa cells were cultivated in MEM 
medium supplemented with 10 % FCS and 4 mM glutamine. H460 cells were cultivated 
in RPMI medium supplemented with 10 % FCS and 4 mM glutamine. 
Penicillin/Streptomycin was added to the medium at a final concentration of 60 U/ml 
each.  
Cell medium was removed and the cells were rinsed once with Dulbecco´s PBS (calcium- 
and magnesium-free). Cells were deatached from the flask by incubation with Trypsin-
EDTA for 3 minutes at 37 °C followed by addition of MEM medium. Cells were pelleted 
for 3 minutes at 1,000 rpm. The supernatant was removed and the cell pellet was 
resuspended in the desired volume of complete medium. The appropriate cell amount was 
further cultivated. 
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VII.2.6.2 Coverslip cleaning and coating  
Round glass coverslips (Ø 25 mm, thickness 1.0) were rinsed with water, ethanol, 
and water. Directly afterwards, coverslips were washed with 1 M HCl for ~2 hours and 
subsequently washed with water. Another 2 hours incubation step was performed in 1 M 
NaOH. Coverslips were then washed with water and rinsed in ethanol overnight. The day 
after, ethanol was removed and coverslips were sterilized at 150 °C. 
For the coating, coverslips were transferred into six-well plates. Poly-L-lysine at 
the concentration of 0.1 mg/mL was added to the coverslips (500 µL for each coverslip) 
and incubated for 30-45 minutes at room temperature. Then, the liquid was removed and 
the coverslips were dried for 1 hour and directly sterilized for 20 minutes using UV lamp. 
Coverslips were stored at 4 °C and used within a month. 
VII.2.6.3 Preparation of membrane sheets 
1.5x105 HeLa cells or H460 cells were plated onto poly-L-lysine coated 
coverslips. Cells were cultivated as reported in Section VII.2.6.1. Cells were left to adhere 
for 5 hours and then starved overnight. For the preparation of membrane sheets, the 
procedure was adapted from previously described protocols (Avery 2000; Lang 2001). 
Coverslips were immersed in ice-cold sonication buffer (composition depending on the 
experimental requirements, see Table 24) and treated with ultrasound for 100 ms. 
Membrane sheets were used to investigate the effect of ARNO on EGFR phosphorylation 
and the EGFR-ARNO co-localization at the plasma membrane. 
Table 24: Sonication buffers 
 
 
 
 
 
Buffer Components 
Sonication buffer (phosphorylation assay) 20 mM HEPES pH 7.2  
150 mM NaCl 
Sonication buffer (co-localization) 20 mM HEPES pH 7.2  
120 mM potassium glutamate 
20 mM potassium acetate 
10 mM EGTA 
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VII.2.7 Phosphorylation Assay 
To evaluate the activity of EGFR reconstituted in artificial membrane systems, in 
vitro phosphorylation assays were performed.  
VII.2.7.1 Phosphorylation Assay in micelles 
Triton X-100 micelles containing 100 nM lz-EGFR-TS were incubated in 
presence of 200 nM YopH (Tyrosine-protein phosphatase from Yersinia 
pseudotuberculosis), and 10 µM BSA in 1x Phosphorylation Buffer. The mixture was 
incubated for 5 minutes at room temperature. Subsequently, 600 nM ARNO Sec7, 600 
nM GST or reaction buffer were added. Samples before stimulation were taken. The 
reaction was started by the addition of 1 mM ATP. The receptor was stimulated for 10 
and 20 seconds and then stopped by ETDA addition at the concentration of 20 mM. 
Samples were analyzed by SDS-PAGE and anti-pTyr Western Blot. The antibody was 
diluted 1:10,000 in 5 % BSA/TBS-T with 1:500 Thimerosal. 
Table 25: Buffers for EGFR-phosphorylation assay 
 
 
 
 
 
VII.2.7.2 Phosphorylation Assay in nanodiscs 
Briefly, in 100 µL reaction mixtures 100 nM lz-EGFR-TS-containing nanodiscs, 
1x Phosphatase Inhibitors, and Phosphorylation Buffer were mixed together. Eventually, 
different ARNO constructs at the concentration of 600 nM were added: ARNO Sec7, 
Flag-ARNO Sec7, Flag-ARNO PH or reaction buffer. The mixtures were incubated for 
10 minutes at room temperature. Samples before stimulation were taken. The reaction 
was started by the addition of 1 mM ATP. The receptor was stimulated for 1 and 3 
Buffer Components 
Phosphorylation Buffer 10 mM Tris-HCl pH 7.4  
100 mM NaCl 
5 mM MgCl2 
0.1 % Triton X-100 
10x Phosphatase Inhibitor  25 mM NaO7P2 
10 mM β-Glycerophosphate 
10 mM Na3VO4 
Reaction Buffer 10 mM Tris-HCl pH 7.4  
100 mM NaCl 
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minutes and then stopped by addition of 20 mM ETDA. Samples were analyzed by SDS-
PAGE and anti-pTyr or anti-EGFR sc03 Western Blot. Both antibodies were diluted 
1:10,000 in 5 % BSA/TBS-T with 1:500 Thimerosal. 
VII.2.7.3 Phosphorylation Assay in membrane sheets 
Coverslips were removed from sonication buffer and were incubated upside-down 
on different reaction mixture drops on parafilm. Sonication buffer was supplemented with 
5 mM MgCl2 and 1 mM Na-orthovanadate. The coverslips were pre-incubated for 5 
minutes at room temperature. Coverslips were stimulated in presence of 1 mM ATP and 
three different EGF concentrations, 50 ng/mL, 25 ng/mL and 12.5 ng/mL respectively, for 
1 minute.  
In another experiment, 50 ng/ml EGF or 50 ng/ml EGF and 100 nM ARNO without His-
tag were incubated for 5 minutes in presence of 1 mM ATP. No pre-incubation was 
performed. Samples were directly fixed after stimulation and further analyzed as reported 
in Section VII.2.13.1. 
VII.2.8 Nucleotide Exchange Assay 
To measure the catalytic activity of GST-ARNO Sec7 a tryptophan fluorescence 
assay on NΔ17Arf1 was performed. A 500 µM GTP mixture in PBS pH 7.4 and 3 mM 
MgCl2 was prepared. NΔ17Arf1 at the concentration of 2.8 µM was then pre-incubated 
for 15 minutes at 37 °C with 80 µM GDP in PBS pH 7.4 and 2 mM EDTA. The GDP-
bound Arf1 was stabilized by adding 3 mM MgCl2 to the mixture and it was incubated for 
5 minutes at 37 °C. Different ARNO Sec7 concentrations (0 nM, 10 nM, 15 nM) were 
incubated with 700 nM GDP-Arf1 in PBS pH 7.4 and 3 mM MgCl2 (total volume 80 µL). 
The reaction was started by adding 10 µl GTP (50 nM). The tryptophan fluorescence was 
measured a 280 nm excitation and 340 nm emission for 600 seconds in a black 96-well 
plate. The fluorescence signal was detected every 5 seconds. The measurement was 
performed on an Infinite 200 Pro Tecan Reader (Tecan). The GraphPadPrism Software 
was used for the line fitting by linear regression. 
Material and Methods 
 
146 
VII.2.9 Pull-down Assay 
Pull-down is a technique to measure biochemical interactions between two or 
more proteins. Similarly to affinity chromatography, pull-down used tag-conjugated 
beads. The affinity tag binds to the “bait” protein contained in the solution. Washing steps 
are performed to remove the unbound proteins. Then, the “pray” protein is added to the 
mixture and binds to the “bait” protein. After a washing step, the protein-protein complex 
is eluted. Analysis was performed by SDS-PAGE. 
VII.2.9.1 Pull-down Assay of nanodiscs and ARNO PH domain 
20 µL Strep-tactin magnetic beads were equilibrated in 200 µL wash buffer for 
two times. 8 µM PCPE-nanodiscs or PIP2-nanodiscs were mixed with 16 µM ST-ARNO-
PH in wash buffer in the presence of 2 % v/v DMSO. The reaction mixture was incubated 
with the beads for 30 minutes on ice and vortexed every 5 minutes. The mixtures and the 
beads were put on a magnetic rack. The supernatant was removed and the beads were 
washed 3 times with 100 µL of wash buffer. 25 µL elution buffer was incubated for 10 
minutes with the beads. Loaded samples and eluted samples were analyzed by 12.5 % 
SDS-PAGE. 
Table 26: Buffers for nanodiscs-ARNO PH pull-down 
Buffer Components 
Wash buffer 50 mM Tris-HCl pH 7.8 at 4°C 
150 mM NaCl 
5 % Glycerol 
Elution buffer 50 mM Tris-HCl pH 7.8 at 4°C 
150 mM NaCl 
5 % Glycerol 
10 mM biotin 
VII.2.9.2 Pull-down Assay of nanodiscs and ARNO PH domain 
in presence of Cyplecksins 
Cyplecksins are barbiturate derivatives that inhibit the membrane recruitment of 
the PH domain of ARNO. Cyplecksins were synthetized and kindly provided by Doctor 
Mohammed Hussein, from Famulok’s group. ST-ARNO-PH was incubated for 15 
minutes on ice in the presence of 100 µM cyplecksins 1-3 or 100 µM of cyplecksins 
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inactive analogues (MH 40 A and MH 40 B). The final concentration of DMSO was 2 % 
v/v. Subsequently, 8 µM PIP2-nanodiscs were added and further incubated for 15 minutes 
on ice. Pull-down assay was performed as reported in Section VII.2.9.1. 
VII.2.9.3 GST Pull-down Assay of micelles and GST-ARNO 
Sec7 
HST-EGFR-TMJM in 0.2 % sodium cholate micelles at the concentration of 10 
µM was pre-incubated with 30 µM GST-ARNO Sec7 in wash buffer for 30 minutes at 4 
°C. 20 µL GST magnetic beads were pre-equilibrated in 200 µL wash buffer for two 
times. The mixtures and the beads were incubated for 1 hour at 4 °C. The supernatant 
after beads incubation was removed and the beads were washed for 3 times with 100 µL 
wash buffer. 20 µL elution buffer was incubated for 10 minutes with the beads at 4 °C. 
Total fraction, the supernatant and the pull down fraction were analyzed by 15 % SDS-
PAGE. 
Table 27: GST pull-down with micelles 
Buffer Components 
Wash buffer 50 mM Tris-HCl pH 7.8 at 4°C 
100 mM NaCl 
5 % Glycerol 
0.2 % sodium cholate 
Elution buffer 50 mM Tris-HCl pH 7.8 at 4°C 
100 mM NaCl 
5 % Glycerol 
10 mM glutathione 
VII.2.9.4 GST Pull-down Assay of nanodiscs and GST-ARNO 
Sec7  
15 µM empty DPPC-nanodiscs or 15 µM DPPC-nanodiscs containing 10 µM 
EGFR-TMJM peptide were preincubated with 30 µM GST-ARNO Sec7 (or 30 µM GST 
protein as a negative contriol) in wash buffer for 30 minutes at 25 °C or 37 °C. 20 µL 
GST magnetic beads were pre-equilibrated in 200 µL wash buffer for two times. The 
mixtures and the beads were incubated for 1 hour at 25 °C or 37 °C. The supernatant after 
beads incubation was removed and the beads were washed for 3 times with 100 µL of 
wash buffer. 20 µL elution buffer were incubated for 10 minutes with the beads at the 
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respective temperatures. Total fraction, the supernatant and the pull down fraction were 
analyzed by 15 % SDS-PAGE and streptavidin or anti-His Western Blot. Strevtavidin 
conjugated-dye was diluted 1:10,000 in 5 % BSA/TBS-T with 1:500 Thimerosal. Anti-
His antibody was diluted 1:500 in 5 % BSA/TBS-T with 1:500 Thimerosal. 
Table 28: GST pull-down in nanodiscs 
Buffer Components 
Wash buffer 50 mM Tris-HCl pH 7.8 at 4°C 
100 mM NaCl 
5 % Glycerol 
Elution buffer 50 mM Tris-HCl pH 7.8 at 4°C 
100 mM NaCl 
5 % Glycerol 
VII.2.9.5 Ni-NTA Pull-down Assay of nanodiscs and GST-
ARNO Sec7  
40 µL Ni-NTA Agarose beads were pre-equilibrated in 400 µL wash buffer for 
three times. 20 µM empty DPPC-nanodiscs or 20 µM DPPC-nanodiscs containing 13 µM 
EGFR-TMJM peptide were pre-incubated with the beads in wash buffer for 30 minutes at 
37 °C. Then, 30 µM GST-ARNO Sec7 was incubated with nanodiscs and beas for 30 
minutes at 37 °C. The supernatant after beads incubation was removed and the beads 
were washed three-time with 400 µL wash buffer. 25 µL elution buffer was incubated for 
10 minutes with the beads at 37 °C. Total fraction, the supernatant and the pulled down 
fraction were analyzed by 15 % SDS-PAGE and GST Western Blot. Anti-GST antibody 
was diluted 1:1,000 in in 5 % BSA/TBS-T with 1:500 Thimerosal. 
Table 29: Ni-NTA pull-down in nanodiscs 
 
 
 
 
Buffer Components 
Wash buffer 20 mM Tris-HCl pH 7.4 at RT 
100 mM NaCl 
0.5 mM EDTA 
20 mM Imidazole 
Elution buffer 20 mM Tris-HCl pH 7.4 at RT 
100 mM NaCl 
0.5 Mm EDTA 
300 mM Imidazole 
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VII.2.10 Crosslinking 
Chemical crosslinking was performed with bis(sulfosuccinimidyl)suberate (BS3) 
or with the water insoluble analogue disuccinimidyl suberate (DSS). BS3 in an 
homobifunctional, water-soluble noncleavable crosslinker, with a spacer arm of 11.4 Å. 
BS3 contains an N-hydroxysulfosuccinimide (NHS) ester that reacts with primary amines 
at pH 7-9, contained in the side chain of lysine residues or at the N-terminal part of 
polypeptides (Thermo Scientific Pierce 2010). The chemical structure of BS3 is reported 
in Figure 70.  
 
Figure 70: BS3 crosslinker structure (from Thermo Fisher Website) 
 DSS is a lipophilic noncleavable crosslinker. DSS is the membrane permeable 
analogue of BS3. The crosslinker structure is reported in Figure 71. 
 
Figure 71: DSS crosslinker structure (from Thermo Fisher Website) 
VII.2.10.1 Crosslinking in micelles 
A 50 µL reaction mixture containing 10 µM JM peptide or 10 µM His-EGFR-
TMJM-SBP or 10 µM HT-IR-TMJM-SBP was incubated in presence or absence of 30 
µM ARNOΔPBR for 30 minutes at 20 °C. Samples before crosslinker addition were 
taken. BS3 crosslinker at the concentration of 1.5 mM or 0.5 mM was added and 
incubated for 10 minutes at room temperature. Reaction was stopped by the addition of 
50 mM Tris-HCl at pH 7.5. Samples were analyzed by SDS-PAGE. 
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Table 30: Crosslinking buffers for micelles 
Buffer Components 
Crosslinking buffer for JM peptide 20 mM HEPES pH 8.0 at RT 
150 mM NaCl 
Crosslinking buffer for TMJM constructs 20 mM HEPES pH 8.0 at RT 
150 mM NaCl 
0.4 % sodium cholate 
VII.2.10.2 Crosslinking in bicelles 
Different ARNO constructs at the concentrations of 10 µM and 50 µM 
respectively, were pre-incubated with 46 mM bicelles containing His-EGFR-TMJM-SBP 
for 30 minutes at 38 °C. Samples before crosslinker addition were taken. BS3 at the 
concentration of 2.0 mM was added to the mixtures and incubated for 10 minutes at room 
temperature. The reaction was stopped by the addition of 6x sample buffer (see Table 15). 
Samples were analyzed by SDS-PAGE and streptavidin, anti-ARNO and anti-Flag 
Western Blot. See Section VII.1.6.1 and VII.1.6.2 for primary and secondary antibody 
dilutions, respectivly. 
Table 31: Crosslinking buffer for bicelles 
Buffer Components 
Crosslinking buffer  7 mM DHPC  
10 μM BSA  
in 10 mM Phosphate Buffer pH 7.2 at RT 
VII.2.10.3 Crosslinking in nanodiscs 
Nanodiscs containing His-EGFR-TMJM-SBP or HT-IR-TMJM-SBP at the 
concentration of 20 µM were pre-incubated with 30 µM ARNOΔPBR for 30 minutes at 
20 °C. BS3 or DSS crosslinker at the concentration of 0.5 mM was added to the mixture 
and incubated for 5 minutes. The reaction was stopped by the addition of 6x sample 
buffer (see Table 15). Samples were analyzed by SDS-PAGE and streptavidin Western 
Blot. 
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Table 32: Crosslinking buffer for nanodiscs 
Buffer Components 
Crosslinking buffer  20 mM HEPES pH 8.0 at RT 
150 mM NaCl 
VII.2.11 MembraneScale Thermophoresis (MST) 
To perform the MST analysis the Monolith NT.115 instrument (NanoTemper) was 
used. DPPC-nanodiscs with or without His-EGFR-TMJM-SBP were assembled with a 
MSP1D1-mEGFP fusion construct. Nanodiscs after gel filtration were diluted 20 times 
and incubated with a serial dilution of ARNO Sec7 (from 50 µM to 1.5 nM) in MSP 
standard buffer. Standard capillaries were used. The MST measurement was performed 
with 20 % LED power and 40 % MST power. The same experiment was repeated also in 
presence of 1.5 mg/mL BSA to reduce unspecific interactions. The thermophoresis with 
the temperature jump is calculated as a change in the normalized fluorescence (ΔFnorm), 
which is defined as the ratio between the hot and cold fluorescence in a defined area 
(Figure 72) (Jerabek-Willemsen et al. 2014).  
 
Figure 72: Typical MST binding experiment  
The fluorescent molecule trace (in black) changes upon ligand binding (in red). The analysis is performed 
calculating the normalized fluorescence difference (ΔFnorm). The fluorescence is defined as the Fhot/Fcold 
ratio. Different ligand concentrations are used to obtain a binding curve (Jerabek-Willemsen et al. 2014). 
VII.2.12 Co-localization in membrane sheets 
Coverslips were removed from sonication buffer and were incubated upside-down 
on different reaction mixture drops on parafilm. Wild-type Flag-ARNO or PH mutant 
(R280C; R: arginine, C: cysteine) Flag-ARNO at the concentration of 1 µM were 
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incubated on the membrane sheets for 5 minutes at room temperature. Samples were 
directly fixed after incubation and further analyzed as reported in Section VII.2.13. 
VII.2.13 Microscopy 
VII.2.13.1 Immunofluorescence on membrane sheets  
After incubation with the different reaction mixtures, membrane sheets were fixed 
for 30 minutes at room temperature with 4 % PFA (paraformaldehyde) in PBS. 
Eventually 20 mM EDTA were added to stop the reaction after the phosphorylation assay. 
Coverslips were quenched with 50 mM NH4Cl in PBS for 20 minutes. Membrane sheets 
were rinsed with PBS three times for 5 minutes each. Coverslips were then incubated for 
1 hour at room temperature with 3 % BSA in PBS.  
For the phosphorylation assay analysis, phospho-tyrosine 1086 EGFR (rabbit) 
antibody was diluted 1:100 in PBS containing 3 % of BSA. Coverslips were incubated for 
1 hour at room temperature with the primary antibody. Membrane sheets were washed 
three times for 10 minutes each in PBS. The secondary antibody anti-rabbit Alexa 594 
was diluted 1:200 in PBS containing 1 % BSA in PBS and centrifuged for 2 minutes at 
14,000 rpm at room temperature. Coverslips were incubated with the secondary antibody 
for 1 hour at room temperature in the dark. After incubation, coverslips were washed 
again for three times for 10 minutes each in PBS. Samples were then prepared for 
imaging. 
For the co-localization analysis, FLAG M2 (mouse) antibody for Flag-ARNO 
constructs detection was diluted 1:500 in PBS containing 3 % of BSA. Coverslips were 
washed three times in PBS for 5 minutes each. Subsequently, the secondary antibody 
donkey anti-mouse Alexa 594 was incubated for 1 hour at room temperature in the dark. 
The same coverslips were subsequently incubated with an anti-EGFR sc-03 (rabbit) 
antibody 1:100 diluted in PBS containing 3 % of BSA for EGFR detection. The 
coverslips were incubated for 1 hour at room temperature with the primary antibody. 
Membrane sheets were washed three times for 5 minutes each in PBS. The secondary 
antibody donkey anti-rabbit Alexa 488 was diluted 1:200 in PBS containing 3 % BSA. 
The antibody was incubated for 1 hour at room temperature in the dark. After incubation, 
coverslips were washed again for three times for 5 minutes each in PBS. Samples were 
then prepared for imaging. 
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VII.2.13.2 Fluorescence Microscopy 
Membrane sheets were imaged in 500 µL of a 10 % saturated TMA-DPH 
(trimethylammonium diphenylhexatriene) solution in PBS. For colocalization 
experiments, 80 µl of a 1:1,000 dilution of fluorescent beads (TetraSpeck beads, 100 nm 
size) were added for image alignment purposes (see below). Membrane sheets were 
imaged with an Olympus IX81-ZDC Microscope, with a 60x 1.49 NA Apochromat 
objective applying 1.6x and a 2x magnifying lenses (Olympus). Images were taken with a 
digital 16bit EM-CCD camera (ImagEM Enhanced C9100-13, 16 µm pixel size, 
Hamamatsu Photonics, Hamamatsu) at 100 % EM gain. An MT20E illumination system 
(Olympus) equipped with a 150 W Xenon lamp was used for illumination. Alexa 488 was 
imaged with the filter set F36-525 EGFP. Alexa 594 was imaged with the filter set F36-
503 TRITC HC. TMA-DPH fluorescence was imaged using filter set F36-500 DAPI HC. 
Fluorescent microspheres were imaged using the filter set F46-009 Cy5 ET narrow 
bandpass (AHF Analysentechnik). Images were analyzed with ImageJ Software (version 
1.48 or higher).  
For unbiased quantification of the fluorescence intensity, regions of interest 
(ROIs) were selected in TMA-DPH channel. The ROIs dimension was set to 50x50 
pixels. The ROI was transferred to the Alexa 594 channel image to measure the mean 
pixel intensity within the ROI. Similarly, the mean background intensity in the Alexa 594 
channel was determined using a ROI placed outside the membrane sheet area and 
subtracted from the mean sheet intensity. This procedure was repeated for all quantified 
image channels. For each coverslips 20-35 membrane sheets were analyzed and the 
background-corrected intensities were averaged. Values are given as mean ± SEM. 
For co-localization experiments, different image channels were aligned by shifting 
images laterally using the ImageJ plugin AlignSlice. Correct alignment was verified using 
the positions of added fluorescent beads (see above) as a reference. 
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VIII. Appendix 
VIII.1 Original gel figures 
 
Supporting Figure 1: Original SDS-PAGE of ST-ARNO PH expression and purification (see 
Figure 13) 
15 % SDS-PAGE stained with Coomassie Brilliant Blue. Lane 11 shows the elution 4 and the lane 12 
shows the beads fraction. ST-ARNO PH is indicated with an arrow.  
 
Supporting Figure 2: Original SDS-PAGE of MSP1D1 expression and purification (see 
Figure 14)  
12.5 % SDS-PAGE stained with Coomassie Brilliant Blue. In lanes 10, 11, 12 and 13 there are protein 
samples evaluated for Volkmar Fieberg from Famulok’s group and they were not used in this PhD Thesis. 
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Supporting Figure 3: Original SDS-PAGE of Figures 20 and 22 
Pull-down assay of ARNO PH incubated with PCPE-NDs (nanodiscs) or PIP2-NDs in presence of 2 % 
DMSO. PIP2-NDs and ARNO PH were incubated with 100 μM Cyplecksins (Cyp.) 1, 2 or 3 or the inactive 
analogues MH 40 A (4) or MH 40 B (5). The input or total (T) fractions and the pull-down (PD) fractions 
were analyzed by SDS-PAGE and visualized by Coomassie staining. The prestained molecular weight 
marker (M) was loaded in the first lane. 
 
Supporting Figure 4: Original SDS-PAGE of the purification of lz-EGFR-TS from Sf9 cells 
(see Figure 24) 
10 % SDS-PAGE stained with Coomassie Brilliant Blue. 
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Supporting Figure 5: Original Western Blot of lz-EGFR-TS phosphorylation in micelles (see 
Figure 25) 
Western Blot analysis is performed with anti-pTyr antibody. The receptor was incubated only with Buffer.  
 
Supporting Figure 6: Original Western Blot of the Influence of ARNO Sec7 on lz-EGFR-TS 
phosphorylation in micelles (see Figure 26) 
Western Blot analysis is performed with anti-pTyr antibody. Influence of ARNO Sec7 on lz-EGFR-TS 
phosphorylation in micelles.  
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Supporting Figure 7: Original SDS-PAGE of HST-EGFR-TMJM expression and 
purification from inclusion bodies (see Figure 28) 
15 % SDS-PAGE stained with Coomassie Brilliant Blue. 
 
Supporting Figure 8: Original SDS-PAGE of GST-ARNO Sec7 expression and purification 
(see Figure 29) 
12.5 % SDS-PAGE stained with Coomassie Brilliant Blue. 
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Supporting Figure 9: Original SDS-PAGE of GST-pull-down of HST-EGFR-TMJM in 
micelles in presence of GST-ARNO Sec7 (see Figure 31) 
15 % SDS-PAGE stained with Coomassie Brilliant Blue. The protein pull-down was performed with 
glutathione beads in the presence (with: w/) or absence (without: w/o) of GST-ARNO Sec7. T: Total 
protein; S: Supernatant after bead incubation; P: Pulled-down fraction; B: Bead fraction. 
 
Supporting Figure 10: Original SDS-PAGE of His-EGFR-TMJM-SBP expression and 
purification from inclusion bodies (see Figure 33) 
15 % SDS-PAGE stained with Coomassie Brilliant Blue. 
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Supporting Figure 11: Original SDS-PAGE of HT-ARNOΔPBR expression and purification 
(see Figure 34) 
12.5 % SDS-PAGE stained with Coomassie Brilliant Blue. 
 
Supporting Figure 12: Original SDS-PAGE of the crosslinking between ARNOΔPBR and 
JM peptide with different BS3 concentrations (see Figure 35) 
15 % SDS-PAGE stained with Coomassie Brilliant Blue. 
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Supporting Figure 13: Original SDS-PAGE of the crosslinking between ARNOΔPBR and 
TMJM constructs in micelles (see Figure 36 a and b) 
12.5 % SDS-PAGE stained with Coomassie Brilliant Blue. The BS3 was used at two different 
concentrations: a) 1.5 mM (++) and b) 0.5 mM (+). 
a) 
b) 
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Supporting Figure 14: Original SDS-PAGE of the control of His-EGFR-TMJM-SBP 
assembly into bicelles (see Figure 39) 
15 % SDS-PAGE stained with Coomassie Brilliant Blue. L: Load; S: Supernatant; P: Precipitate.  
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Supporting Figure 15: Original Western Blots of the crosslinking between ARNOΔPBR and 
EGFR-TMJM embedded into bicelles (see Figure 40 a and b) 
BS3 crosslinking agent was incubated with two different HT-ARNOΔPBR concentrations, 10 µM (+) and 
50 µM (++) respectively, and bicelles containing His-EGFR-TMJM-SBP. Analysis was performed by SDS-
PAGE and a) Streptavidin Western Blot detecting the SBP-labeled EGFR-TMJM or b) anti-ARNO 
Western Blot. 
Streptavidin Western Blot 
Anti-ARNO Western Blot 
a) 
b) 
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Supporting Figure 16: Original Western Blot of the crosslinking between ARNO Sec7 and 
EGFR-TMJM embedded into bicelles (see Figure 41) 
BS3 was incubated with two different ARNO Sec7 concentrations, 10 µM (+) and 50 µM (++) respectively, 
and bicelles containing HT-EGFR-TMJM-SBP. Analysis was performed with SDS-PAGE and streptavidin 
Western Blot detecting the SBP-tagged EGFR-TMJM. 
 
Supporting Figure 17: Original Western Blot of the Crosslinking between ARNO Sec7 and 
EGFR-TMJM wild-type, sc1 and sc2 embedded into bicelles (see Figure 42) 
Crosslinking agent BS3 was incubated with 10 µM ARNO Sec7 and bicelles containing His-EGFR-TMJM-
SBP wild-type, scrambled version 1 (sc1), or 2 (sc2). Analysis was performed with SDS-PAGE and 
streptavidin Western Blot detecting the SBP-tagged EGFR-TMJM. 
 
Streptavidin Western Blot 
Streptavidin Western Blot 
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Supporting Figure 18: Original Western Blots of the crosslinking between ARNO PH and 
EGFR-TMJM wild-type, sc1 and sc2 embedded into bicelles (see Figure 43 a and b) 
BS3 was incubated with 10 µM Flag ARNO PH and bicelles containing His-EGFR-TMJM-SBP wild-type 
and scrambled version 1 (sc1) and 2 (sc2). The TMJM domains contained within bicelles had a 
concentration of 5 µM. Analysis was performed by SDS-PAGE and a) anti-Flag Western Blot detecting the 
N-terminal part of ARNO PH domain and b) streptavidin Western Blot detecting the SBP-labeled EGFR-
TMJMs. 
 
Flag Western Blot 
Streptavidin Western Blot 
a) 
b) 
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Supporting Figure 19: Original SDS-PAGE of the control of lz-EGFR-TS assembly into 
nanodiscs (see Figure 48) 
12.5 % SDS-PAGE stained with Coomassie Brilliant Blue. Empty nanodiscs (1), nanodiscs containing lz-
EGFR-TS (2) or lz-EGFR-TS alone (3). T: Total mixtures before incubation; S: Supernatant; P: Precipitate. 
 
Supporting Figure 20: Original Western Blots of the phosphorylation of lz-EGFR-TS into 
nanodiscs (see Figure 49) 
Western Blot analysis with anti-EGFR sc03 antibody (left panel) and pTyr antibody (right panel). 
 
lz-EGFR-TS plz-EGFR-TS 
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Supporting Figure 21: Original Western Blot of the phosphorylation of lz-EGFR-TS in 
nanodiscs in presence of ARNO Sec7, or Flag-ARNO Sec7, or Flag-ARNO PH (see Figure 
50, upper panel)  
Western Blot with anti-pTyr antibody. 
 
Supporting Figure 22: Original SDS-PAGE of the phosphorylation of lz-EGFR-TS in 
nanodiscs in presence of ARNO Sec7, or Flag-ARNO Sec7, or Flag-ARNO PH (see Figure 
50, lower panel)  
12.5 % SDS-PAGE stained with Coomassie Brilliant Blue. 
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Supporting Figure 23: Original SDS-PAGE and Western Blot of the control of EGFR-
TMJM assembly into nanodiscs (see Figure 51 a and b) 
A phospholipids-MSP1D1 mixture or phospholipids only were mixed with His-EGFR-TMJM-SBP. 
DMPC- and DPPC-phospholipids were used. In Figure 51 is reported only the left part of the gel with 
DMPC-phospholipids. L: Load; P: Precipitate; S: Supernatant; N: Nanodiscs; PL: Phospholipids. a) 15 % 
SDS-PAGE stained with Coomassie Brilliant Blue. b) Western Blot performed using streptavidin-800 
conjugated dye, recognizing the SBP-tag at the C-terminus of the TMJM peptide.  
 
SDS-PAGE 
Streptavidin Western Blot 
a) 
b) 
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Supporting Figure 24: Original SDS-PAGE and Western Blots of the GST pull-down at 25 
°C with DMPC-nanodiscs to analyze TMJM-Sec7 interaction (see Figure 52 a, b and c) 
T: Total protein; S: Supernatant after beads incubation; PD: Pulled-down fraction; B: Bead fractions were 
collected and analyzed. a) 15 % SDS-PAGE stained with Coomassie Brilliant Blue. b) Western Blot 
performed with streptavidin-800 conjugated dye, recognizing the SBP-tag at the C-terminus of TMJM 
peptide. c) Western Blot performed with anti-His antibody detecting the N-terminal part of MSP1D1 
protein and the N-terminal part of His-EGFR-TMJM-SBP construct. 
SDS-PAGE 
Streptavidin Western Blot 
His Western Blot 
a) 
b) 
c) 
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Supporting Figure 25: Original SDS-PAGE and Western Blot of the GST pull-down at 37 
°C with DPPC-nanodiscs to analyze TMJM-Sec7 interaction (see Figure 53 a and b) 
T: Total protein; S: Supernatant after beads incubation; PD: Pulled-down fractions were collected and 
analyzed. a) 15 % SDS-PAGE stained with Coomassie Brilliant Blue. b) Streptavidin Western Blot was 
performed with streptavidin-800 conjugated dye, recognizing the SBP-tag at the C-terminus of TMJM 
peptide. 
  
SDS-PAGE 
Streptavidin Western Blot 
a) 
b) 
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Supporting Figure 26: Original SDS-PAGE and Western Blot of the Ni-NTA Agarose beads 
pull-down at 37 °C to analyze TMJM-Sec7 interaction (see Figure 54 a and b) 
L: Loaded fractions before ARNO addition T: Total protein; S: Supernatant after beads incubation; PD: 
Pulled-down fractions were collected and analyzed. The left part of the gels was wrongly loaded. a) 15 % 
SDS-PAGE stained with Coomassie Brilliant Blue. b) GST Western Blot was performed with anti-GST 
antibody, recognizing ARNO. 
  
SDS-PAGE 
GST Western Blot 
a) 
b) 
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Supporting Figure 27: Original SDS-PAGE and Western Blot of BS3 crosslinking with 
nanodiscs containing EGFR-TMJM and ARNOΔPBR (see Figure 55 a and b) 
a) 15 % SDS-PAGE stained with Coomassie Brilliant Blue and b) Western blot using a streptavidin-800 
conjugated dye. No crosslinking between ARNO and EGFR-TMJM was visible using BS3 crosslinker. 
SDS-PAGE 
Streptavidin Western Blot 
b) 
a) 
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Supporting Figure 28: Original SDS-PAGE and Western Blot of DSS crosslinking of 
nanodiscs containing EGFR-TMJM and ARNOΔPBR (see Figure 56 a and b) 
a) 15 % SDS-PAGE stained with Coomassie Brilliant Blue and b) Western blot using a Streptavidin-800 
conjugated dye. 
 
 
SDS-PAGE 
Streptavidin Western Blot 
b) 
a) 
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